Wayne State University
Wayne State University Dissertations
January 2020

Incorporating Cardiac Substructures Into Radiation Therapy For
Improved Cardiac Sparing
Eric Daniel Morris
Wayne State University

Follow this and additional works at: https://digitalcommons.wayne.edu/oa_dissertations
Part of the Bioimaging and Biomedical Optics Commons, and the Physics Commons

Recommended Citation
Morris, Eric Daniel, "Incorporating Cardiac Substructures Into Radiation Therapy For Improved Cardiac
Sparing" (2020). Wayne State University Dissertations. 2441.
https://digitalcommons.wayne.edu/oa_dissertations/2441

This Open Access Dissertation is brought to you for free and open access by DigitalCommons@WayneState. It has
been accepted for inclusion in Wayne State University Dissertations by an authorized administrator of
DigitalCommons@WayneState.

INCORPORATING CARDIAC SUBSTRUCTURES INTO RADIATION THERAPY FOR
IMPROVED CARDIAC SPARING
by
ERIC DANIEL MORRIS
DISSERTATION
Submitted to the Graduate School
of Wayne State University,
Detroit, Michigan
in partial fulfillment of the requirements
for the degree of
DOCTOR OF PHILOSOPHY
2020
MAJOR: MEDICAL PHYSICS
Approved By:

Advisor

Date

© COPYRIGHT BY
ERIC DANIEL MORRIS
2020
All Rights Reserved

DEDICATION
To my family for their never-ending encouragement.
To the many friends who have always pushed me to do better and for their constant
support.
Most importantly, to my wonderful wife Rebecca for loving me, teaching me, and
sacrificing for me constantly throughout this journey.

ii

ACKNOWEDGEMENTS
I would like to thank my dissertation committee: Dr. Indrin J. Chetty, Dr. Ewart
Haacke, Dr. Ming Dong, Dr. Jacob Burmeister, and in particular my advisor Dr. Carri
Glide-Hurst for their continued support, never ending encouragement, and constructive
criticism throughout this process. I would also like to thank the rest of our research group:
Dr. Siamak Nejad-Davarani, Dr. Ryan Price, Dr. Josh Kim, Dr. Hoda Sharifi, and Claudia
Miller for the many insightful discussions and for sharing their expertise. Lastly, I would
like to thank Dr. Ahmed Ghanem, Dr. Simeng Zhu, and Kate Aldridge for their generous
contributions to this work. Henry Ford Health System holds research agreements with
Philips Healthcare. Research sponsored in part by an HFHS Internal Mentored Grant (C.
Glide-Hurst), NIH R01CA204189, and NIH R01EB016079. A portion of the data
acquisition costs were supported by the Breast Cancer Research Foundation.

iii

PREFACE
Note to the reader:
Chapters 3 and 4 presented in this dissertation have been previously published in
peer reviewed journals and each of the two parts of Chapters 5 and 6 are currently being
prepared for journal submission. As these manuscripts have been previously published
or currently being prepared for submission, they were originally intended to serve as
solitary documents. However, additional information has been added to assemble these
manuscripts here.
Chapter 3 was originally published as “Cardiac Substructure Segmentation and
Dosimetry Using a Novel Hybrid Magnetic Resonance and Computed Tomography
Cardiac Atlas” in 2018 in the International Journal of Radiation Oncology Biology Physics.
Chapter 4 was originally published as “Cardiac Substructure Segmentation with
Deep Learning for Improved Cardiac Sparing” in 2019 in the Journal of Medical Physics.
This manuscript received Editor’s choice and was selected for the journal’s cover art.
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CHAPTER 1 “CLINICAL MOTIVATION AND PROBLEM STATEMENT”
Cardiotoxicity from Radiation Therapy
Radiation therapy (RT) is a beneficial treatment option for approximately half of all
cancer patients and is recognized as a crucial component of treating cancer throughout
the world1. Over a quarter of all diagnosed cancers involve the thoracic region where
there is neighboring cardiac normal tissue, and these cancers remain the most common
cancer-related cause of death among American men and women 2. Weather cancers in
the thoracic region are localized or locally advanced, applications of RT have allowed for
curative and palliative treatment options3. However, RT can lead to secondary effects due
to the neighboring cardiac normal tissues within the irradiation field and cause cardiac
toxicity. Cardiac toxicity is a potentially devastating complication of cancer treatment and
occurs throughout, shortly after, or even many years after treatment4. Increased risks of
radiation-induced cardiac toxicities (RICTs) including acute (e.g. pericarditis) and late
(e.g. congestive heart failure, coronary artery disease, and myocardial infarction) have
been linked to dose from RT for many thoracic cancers including Hodgkin’s lymphoma5,
esophageal6, late stage lung7, and breast8.
In Hodgkin’s Lymphoma patients who have received RT, cardiovascular disease
is the most common cause of death including coronary artery disease, valvular heart
disease, congestive heart failure, pericardial disease, and sudden death9. Advanced
stage lung cancer survivors, who undergo some of the highest doses of RT to the heart,
exhibit the worst comorbidities across all cancers, with congestive heart failure being
prevalent10. Patients with centrally located lung tumors have also experienced cardiac
failure and pericarditis after stereotactic body therapy (SBRT)4,11,12. In a study by Hardy
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et al., it was found that ischemic heart disease was more common in patients with tumors
of the left lung as compared to the right after RT treatment7. Furthermore, a statistically
significantly larger risk for radiation-associated coronary damage was also found in leftsided early stage breast cancer patients, as compared to right-sided8. Several studies
have also shown that perfusion defects have been linked to excess cardiac dose13,14.
Marks et al. found that 40% of left-sided breast cancer patients had perfusion defects
from RT within just two years of their RT treatment13. If not addressed, the aforementioned
secondary cardiac effects from these thoracic cancer treatments may lead to ischemic
heart disease and even heart failure15.
RICT is more acute than previously expected, beginning only a few years after RT
and with elevated risk persisting for nearly 20 years16. Moreover, echocardiograms from
thoracic RT treatments have revealed real time changes due to the radiation 14. With life
expectancy in cancer survivors steadily improving (i.e. patients living to see the long-term
cardiac effects of their treatment), it becomes of paramount importance to mitigate RICT
while still optimizing cancer outcomes.
Current State-of-the-Art for Cardiac Risk Assessment
When an RT plan is being developed for a patient with cancer, the current standard
of care is to only delineate and consider the entire heart as a single organ and use simple
metrics like mean heart dose (MHD) and dose/volume relationships to evaluate cardiac
risks. Importantly, these whole-heart dose metrics do not provide any information about
where the dose is being distributed. The Quantitative Analysis of Normal Tissue Effects
in the Clinic (QUANTEC)17 report provides radiation dose tolerance recommendations for
organs at risk (OARs) via efforts from numerous investigators. Here, Gagliardi et al.
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considers dose to the heart as a single organ and recommends that less than 10% of the
heart receive greater than 25 Gy with the endpoint of long term cardiac mortality18.
Contemporary cooperative trials use similar volumetric and MHD endpoints19-21. In a large
population-based case control study with greater than 2,000 women undergoing breast
cancer RT16, Darby et al. found that cardiac damage was correlated with heart-absorbed
dose, with a 7.4% increase of ischemic heart disease risk per one Gray of dose
received16. It was also found that the MHD from left-sided breast cancer treatment was
5.4 Gy (range, < 0.1 to 28.6 Gy)22, which suggests a ~40% increase in relative heart
disease risk.
As the outcome remains poor for patients with locally advanced non-small cell lung
cancer (NSCLC), for example a 5-year overall survival less than 20%23, there have been
copious efforts24 to increase loco-regional control (i.e. objective tumor response plus
freedom from local progression)25 in lung cancer. Namely, dose escalation, or increasing
the total dose prescribed through the course of RT, has been used to try and increase
loco-regional control, although this has come at a cost. In a recent dose escalation trial
for locally advanced NSCLC (Radiation Therapy Oncology Group (RTOG) report 0617),
heart volumes receiving ≥ 5 and ≥ 30 Gy were independent predictors of overall survival26
and a patients’ quality of life27. Thus, efforts to reduce and better characterize radiation
dose in the heart, particularly in NSCLC where dose escalation is being implemented, are
advantageous.
Importance of Cardiac Substructures
The heart is complex and dose to sensitive substructures (e.g., coronary arteries,
ventricles, atria, great vessels, etc.) contained within the heart have been strongly linked
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to RICT16,28,29. Radiation dose to the left anterior descending coronary artery (LADA) has
been linked to an increased risk of radiation-induced cardiac morbidity30, myocardial
infarction31, and development of coronary artery calcifications32. In a study by Kataria et
al., a dependence between RICT and the maximum dose received by the LADA was
found33. They recommended that the maximum dose to the LADA be implemented for
OAR avoidance, rather than the mean dose, as it may be more analogous to a serial
structure33. Additionally, Hahn et al. showed that there were dose-volume indices for the
coronary arteries (i.e. V5 and V20) that were more accurate than the MHD in predicting
ischemic heart disease risk34.
The volume of the left ventricle (LV) receiving 5 Gy (LV-V5) has been shown to be
more predictive of acute cardiac events than the MHD28. Further, radiation damage to the
LV has been strongly associated with future acute coronary events 28. Similarly, higher
doses at the base of the heart, near the great vessels (ascending aorta (AA), superior
vena cava (SVC), and pulmonary artery (PA)) are directly related to worse patient
survival35. Lastly, the radiation induced affect in the heart will depend on where the dose
is delivered. For example, a study by Wang et al. assessed 112 NSCLC patients with a
8.8 year median follow up36. This study found that pericardial events were strongly
correlated with atrial dose, whereas, ischemic events were strongly correlated with
ventricular dose36.
There have been numerous multi-institutional studies aiming at assessing the
relationship between cardiac substructures and radiation dose. In a multi-institutional
cohort of nearly 800 SBRT lung cancer patients, doses to the left atrium (maximum dose),
SVC, atria, and vessels were significantly associated with non-cancer death37. In
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Hodgkin’s Lymphoma patients, the relative risk of death from cardiac diseases was
substantially decreased using subcarinal blocking38 while pericarditis was reduced when
left ventricular and subcarinal areas were shielded39. Importantly, recent sub-analysis of
a cooperative group trial for NSCLC (RTOG 0617), showed that doses to the atria,
pericardium, and ventricles were more strongly associated with survival than standard
dose/volume heart metrics40-42. Overall, mounting evidence suggests that local doses to
sensitive regions within the heart are strongly associated with RICT, yet challenges exist
for routine dose evaluation.
Current Challenges with Assessing Cardiac Substructures
While cardiac substructures have been shown to have importance for cardiac
toxicities, these structures are not visible on standard computed tomography (CT)
simulations (CT-SIMs) and thus are not typically considered in the treatment planning
process18. Magnetic resonance imaging (MRI), on the other hand, drastically improves
the visibility of the cardiac substructures43,44 as shown in Figure 1. There are several
reasons, as stated by Dweck et al., that MRI is the modality of choice for visualizing
cardiac substructures over CT44. Namely, it offers superior soft-tissue contrast, it is not
affected by the calcium blooming that hampers CT, and it does not involve exposure to
ionizing radiation44. However, most cancer patients do not undergo MRI due to high costs,
lack of insurance reimbursement, and accessibility barriers. Furthermore, most radiation
oncologists have limited experience delineating cardiac anatomy and manual contouring
can take several hours per patient45-48.
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Figure 1: Left: Axial planning CT, Middle: Axial T2 MRI, Right: Contoured axial T2 MRI.
Delineated substructures are outlined across the bottom with abbreviations defined in
the text.

While overall whole-heart displacement has been measured during conditions of
respiration49, little is known about the motion of most cardiac substructures. When
considering motion due to respiration, cardiac substructures have been shown to displace
greater than 1.5 cm in the dominant direction of respiration (superior-inferior axis)33,50. In
some clinical settings, left-breast cancer patients are treated in breath-hold conditions,
yielding mostly cardiac motion influences. In clinical RT, cardiac motion is not typically
managed as dose volume parameters for the whole heart are not significantly influenced
by motion from the cardiac cycle51. Cardiac motion management technology is also not
currently implemented into clinical linear accelerators. However, individual cardiac
substructures may move differently than the entire heart and each other. This was
observed in a study by Wang et al. who showed that the displacement of the LADA during
deep inspiration breath-hold (DIBH) varied substantially when compared to whole heart
displacement with maximal extents of the LADA over 7 mm (2.5 ± 1.4 mm average
excursion in DIBH)31. The coronary arteries and the ventricles have been reported to be
the most mobile regions of the heart during the cardiac cycle, displacing 3-8 mm between

7
end-diastolic and end-systolic phases52. Thus, planning organ at risk volume (PRV)
margins of 3-4 mm have been suggested for these specific substructures33,53. Given the
potential for varied sensitivity of cardiac substructures and their independent motion
trajectory from the rest of the heart and each other, it is important to give them further
consideration as the dose received by specific substructures may differ significantly from
the dose to the entire heart.
The Challenges of Cardiac Substructure Automatic Segmentation: Problem
Statement
Obtaining paired clinical MRI and CT data for the purposes of cardiac evaluation
presents a challenge as their acquisition is not standard of care. The MRIs used in this
study are acquired under breath-hold conditions and are not electrocardiogram (ECG)
gated, which means that they do not provide temporal data across the cardiac cycle.
Thus, respiratory motion is assumed to be negligible during the scan. However, due to
extended scan times and heart rate, at least 30 cardiac cycles are captured during the
scan. Therefore, the heart and its substructures on the T2-weighted and TrueFISP scans
are represented by their average position over the course of the scan. Additionally,
cardiac substructure variations in position arise from inter-fraction setup uncertainty which
will be quantified in this work.
Introducing cardiac substructures into treatment planning optimization causes an
additional challenge: not only is there a desire to lower the radiation dose to cardiac
substructures, but also the doses to other OARs from treatments near the heart, such as
the spinal cord, lungs, esophagus etc. need to be conserved and within clinical
tolerances. Additionally, in adding treatment planning objectives, it needs to be ensured
that target coverage is not compromised. This is further complicated by anatomical
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variations among patients. Simultaneously meeting current clinical tolerances for the
treatment target and the OARs, as well as the ability to spare sensitive cardiac
substructures might yield a drastic improvement in patient care.
This work, when taken together, will develop an image processing pipeline to
segment cardiac substructures to better quantify potential opportunities for enhanced
cardiac sparing in radiation therapy planning (RTP), which will be accomplished via the
following specific aims:
Specific Aims
1) Substructure segmentation using a novel atlas method using volumetric T2 MRI rigidly
registered to CT-simulation,
2) Further improve substructure segmentation efficiency and accuracy using deep
learning,
3) Quantify intra-fraction motion due to respiration, and inter-fraction setup uncertainties,
4) Translate the described technologies to MR-linear accelerator (MR-linac) and
treatment planning comparisons.
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CHAPTER 2 “IMAGING AND SEGMENTATION TECHNIQUES”
Summary of Computed Tomography and Magnetic Resonance Imaging
Imaging with CT has long been the standard-of-care for RTP due to its exceptional
geometric accuracy and spatial fidelity54. When a CT image is acquired, each voxel (i.e.
three-dimensional pixel) is assigned a numerical value called a CT number based on the
reading from the CT detector array. Thus, the CT number is proportional to the attenuation
coefficient (𝜇) at a particular voxel. The attenuation coefficient at each voxel is then
compared to that of water (𝜇𝑤𝑎𝑡𝑒𝑟 ), as shown by the following equation, for conversion to
Hounsfield Units (HUs).
𝐻𝑈 = 1000 ∗

𝜇−𝜇𝑤𝑎𝑡𝑒𝑟
𝜇𝑤𝑎𝑡𝑒𝑟

(1)

The HU is a measure of the radiodensity within a CT and is directly related to the
measured attenuation. Grayscale values are then assigned as a function of HU for display
purposes. Generating a CT image of a phantom with known electron density values can
then be used to convert from HU to relative electron density that is then inputted into the
treatment planning system for subsequent dose calculation. Thus, an additional benefit
of CT imaging of paramount importance is that it allows for a direct conversion from
measured attenuation to an object’s electron density to enable accurate dose
calculation55.
As the intensity in a CT image represents the x-ray attenuation at a certain point,
image intensities are mostly homogeneous among areas of soft-tissue. The limited range
of electron densities restricts the overall image contrast, thereby making it challenging to
differentiate between regions inside the heart, as shown on the left side of Figure 1. MRI

10
is often used as an adjunct imaging modality to CT, as it allows for increased soft-tissue
contrast (Figure 1, right), specifically in the setting of cardiac imaging56.
An MRI is obtained by measuring the net magnetization of the hydrogen atoms
that exist within tissues57. When a specimen is exposed to a strong enough magnetic
field, the nuclear spins of the hydrogen atom will be aligned either in the direction of the
applied magnetic field, or directly opposed to it57. The majority of atoms are in direct
alignment with the magnetic field as it is a lower energy state, which causes a net
magnetization (i.e. longitudinal magnetization)57. In order to measure a signal in MRI,
there must be a transverse magnetization present57. This transverse component is formed
by using a transmit coil to apply an external radiofrequency field (RF) at the same
frequency as the Larmor frequency until a peak transverse component is obtained for a
given sequence at which point that RF field is turned off 57. The rotating magnetization
leads to a current change in the receive coil allowing for detection of a signal 57. By the
appropriate use of magnet field gradients right after the RF pulse is applied, that signal
can be spatially encoded so that a Fourier transform can be applied to the signal to create
an image usually in either 2D or 3D57.
In short, MRI can be manipulated and tuned by adjusting various image sequence
parameters58, and it provides volumetric and multi-planar imaging at a broad range of
slice thicknesses58. The tissue dependence of the previously mentioned time constants
allows for MRI to provide the superior soft-tissue contrast when compared to CT56 and
leads to improved target and OAR visualization59,60 as discussed in the next section.
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Rationale for Magnetic Resonance Imaging Implementation
The segmentation of tumors on CT images is impeded due to low contrast and
ambiguous boundaries61 and can present large uncertainties in RTP for various cancer
types62-66. For example, in a nasopharyngeal carcinoma study completed by Emami et
al., the use of CT imaging alone for tumor delineation failed to include the entire extent of
the target67. This was made even more apparent by the increase in target volume on the
MRI of 74%67. In a similar study of over 250 patients, Chung et al. found that using MRI
allowed for the detection of intracranial tumor infiltration in over 40% of patients, whereas
the CT scan had negative findings68. In regards to pancreatic cancer, a recent study by
Gurney-Champion et al. showed that the availability of MRI images for target delineation
significantly reduced inter-observer variability in the majority of patient cases when
comparing to CT alone69. Regarding breast cancer radiotherapy, Hartogh et al. found a
4% increase (P < 0.001) in inter-observer agreement when using MRI for breast tumor
gross target volume delineation over CT70. Moreover, they found that for two out of 14
patients

the

entire

tumor

was

missed

(i.e.

dense

fibroglandular

tissue

or

macrocalcifications segmented instead of lesion) when using CT alone70. Lastly, the coregistration of MRI with CT allowed for a decrease in the local standard deviation of the
gross target volume from 4.4 to 3.3 mm71.
MRI is also valuable in the delineation of OARs. When delineating the brachial
plexus, Kong et al. discussed the necessity of incorporating MRI since the use of CT
alone presents challenges72. Bainbridge et al. summarized various studies on OAR
delineation in thoracic radiotherapy73. They found that even though the use of a CT-based
atlas improved contouring reproducibility in the heart and esophagus, delineation
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consistency further improved with the integration of MRI73. When conducting OAR
delineation in the abdomen, Wachter et al. found that defining the prostate apex on CT
would have led to 6-13 mm of additional treatment outside of the tumor that was defined
on MRI74. They recommend that MRI be used for delineation of OARs to avoid
unnecessary radiation to the anus and penile structures 74. Lastly, Khoo et al. evaluated
OAR segmentation ability in independent observers of the prostate, rectum, bladder, and
seminal vesicles and found that MRI provided an improvement to segmentation over CT
for each studied structure75.
One potential complicating factor in delineation accuracy occurs as a result of the
susceptibility of both CT and MRI to motion artifacts from patient movement during the
imaging session. When a patient breathes freely, the target will displace along the axis of
respiratory motion and appear elongated. To mitigate these motion artifacts and increase
reproducibility in patient position, breath-hold techniques are commonly incorporated. As
breath hold scans require the full cooperation of the patient, scan times characteristically
range from 10-25 seconds76. For this reason, sequences such as fast gradient echo (e.g.
TrueFISP) and turbo-spin echo are frequently utilized in MRI for thoracic and abdominal
regions where respiratory motion is considerable76,77. Four-dimensional CT (4DCT) or
four-dimensional MRI are commonly used techniques for patients that are physically
unable to undergo breath hold imaging. In 4DCT for example, a scan is acquired in free
breathing over numerous respiratory cycles as a large number of projections is required
for each breathing phase to provide an adequate signal to noise ratio78. During the scan,
the respiratory waveform is also recorded. Images are then binned by phase or by
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amplitude to generate multiple three-dimensional (3D) datasets at different stages of
breathing79.
Cardiac Imaging
The heart can be imaged through several techniques, including but not limited to,
radionuclide cardiac imaging, echocardiography, cardiac CT, and cardiac MR80. Cardiac
MR is advantageous because not only does it have superb soft-tissue contrast for
structure analysis, it also allows for the analysis of myocardial perfusion and function80.
In RT however, there is no standard MR imaging sequence for segmenting the
substructures of the heart as the concept of applying these structures to treatment
planning in radiotherapy is an emerging area of interest.
Whether cardiac segmentation is completed on MR images that are T1-weighted,
T2-weighted, or weighted as a combination such as T2/T1 (i.e. TrueFISP), the standard
of care for cardiac imaging is to suppress the blood (i.e. force it to be black on the image)
during the acquisition81. This causes an increase in contrast between the rapidly moving
blood and the cardiac muscle for improved visualization. Additionally, increased water
(i.e. edema), as well as infarction appear bright on T2-weighted images. T2-weighted
cardiac MR can also be used to differentiate acute coronary syndrome from non-acute
coronary syndrome, as well as if an infarction occurred recently82-84. Lastly, T2-weighted
cardiac MR allows for the distinction of the high risk location for both non-reperfused and
reperfused myocardial infarction85-87. For these reasons, volumetric T2-weighted images
are often included in protocols for cardiac MRI. The ViewRay MRIdian MR-linac
(ViewRay, Mountain View, CA) utilizes a balanced steady-state free precession (b-SSFP)
(i.e. TrueFISP) sequence. In the TrueFISP sequence, the signal is balanced and is
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directly related to the T2/T1 value of the tissue. Throughout this body of work, both
volumetric T2 images, as well as TrueFISP images were utilized.
The vast majority of cardiac imaging is acquired at a comfortable expiration88.
Although a patient may be able to hold their breath longer at end-inspiration, diaphragm
position between inspirations is much more variable than it is at a repeated expiration88.
In the absence of respiratory motion, the heart can still displace 3-8 mm between endsystolic (i.e. contraction to pump blood) and end-diastolic (i.e. relaxation after contraction)
phases, with the coronary arteries and the ventricles being the most mobile regions52.
Initially established for coronary artery visualization89, ECG gating may be used to acquire
images of the heart at a certain point in its cardiac cycle, through coupling the correlated
ECG pulse with the MRI data53. ECG gating is often triggered by the R-wave as it is the
strongest signal in the ECG pulse and represents the depolarization of the ventricular
myocardium which activates the pumping contraction90. ECG gating may occur
prospectively where imaging is triggered at predefined points in the cardiac cycle through
the R-wave timing91. It may also occur retrospectively where images and ECG waves are
collected over multiple cardiac cycles and rebuilt into specific intervals at a later time (e.g.
5% intervals between R-waves for a 20-phase ECG gated dataset)53. ECG gating allows
for cine cardiac motion studies where structural extent is examined. Protocols for
diagnostic cardiac imaging may include contrast-enhanced, off axis planes, and cine
sequences in order to evaluate cardiac anatomy and function. The latter two series are
not often acquired in the axial plane, leading to challenges integrating them into treatment
planning due to inaccurate co-localization and subsequent registration.
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Additionally, coronary artery segmentations may be improved through the use of
high resolution (e.g. 0.78 x 0.78 x 1.6 mm3) CT coronary angiography (CTCA) that uses
contrast-enhancement92 to drastically increase the visualization of the coronary artery
lumen and wall93. However, as acquiring CTCA predominantly occurs for evaluation of
vascular disease94 (i.e. not always considered standard of care in RTP), and MRI can
provide improved visualization without increased radiation dose or contrast, volumetric
MRIs are utilized in this work.
Image Segmentation Techniques
The segmentation of an image can be defined as the splitting an image into two or
more meaningful regions. More specifically, it is a process where each pixel in an image
is assigned a label, and pixels with similar labels may be linked such that a visual or
logical property is realized95. These groupings of pixels with the same label are called
delineations, or segmentations. Once RT images are acquired, tumors and OARs are
delineated, often by a physician, to enable consideration in the treatment planning
process. Conducting segmentation manually can present numerous problems including
being extremely time consuming and vulnerable to window and level settings47. Moreover,
manual segmentations can introduce inter- and intra-observer variability96.
Implementing automatic segmentation methods can drastically decrease the
required time it takes to generate clinically usable delineations. Methods for automatic
segmentation can be broadly split up into supervised and unsupervised. In unsupervised
image segmentation, only the image itself is considered. Thus, unsupervised
segmentation techniques utilize image intensity and gradient analysis, which perform well
when boundaries in the image are distinctly defined 97. On the contrary, supervised
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segmentation techniques integrate prior knowledge about the image 98. This prior
knowledge is usually in the form of other similarly annotated images that can inform the
current segmentation task (i.e. training samples). Based on a survey of the current
literature at present, six major categories of image segmentation methodologies have
been identified: (1) manual delineations, (2) image thresholding techniques, (3) graphbased approaches, (4) atlas-based approaches, (5) machine learning methods, and (6)
deep learning methods. The chief characteristics, limitations, and some examples of each
segmentation category are outlined in Table 1.
Segmentation
Method

Characteristics/Benefits

Examples

Limitations

Manual

-Visual inspection and
interpretation for manual
delineation96
-Simple and straightforward96

-Physician

-Time consuming96
-Vulnerable to window/level setting96
-Sensitive to inter and intra-observer
variability96

Threshold
(Binarization)

-Thresholds are selected
based on image histogram
or manually selected seed
pixel99
-Simple implementation
and highly efficient96

-Edge detection
-Seed growing

-Only two classes are generated100
-Difficult manual decision96
-Highly sensitive to heterogeneities96,
motion artifact96, and image noise99

Graph Based

-Image pixels are
expressed as nodes on a
graph99
-Can be used to enhance
thresholding techniques97

-Graph cut
-Maximum-flow
-Morphological
Watersheds

-More complex implementation than
thresholding99
-Can result in cutting small sets of
isolated nodes in a graph101
-Ideally suited for obtaining a rough
segmentation of an image’s principle
regions97

Atlas Based

-Form of supervised
learning where a
predefined library of
images informs new
segmentations102

-Probabilistic
atlases
-Statistical shape
models

-Number of selected atlases will affect
result103
-Long time to generate result104
-Can depend on deformable image
registration framework104

Machine
Learning

-A nonlinear classifier
where a model is trained
and tuned97
-Representations are built
from pre‐specified filters
and are not learned from
the image itself97

-Markov Random
Fields
-Conditional
Random Fields
-Random Forest
-Support Vector
Machine

-More complex structure than above
techniques97
-High computational cost due to
employing iterative schemes97
-May have redundant features that
cause overfitting97
-Filter bank needs to be designed
specifically for task97
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Deep Learning

-A model is trained and
tuned but features are
learned and guided by the
training data and are not
pre-specified97

-Artificial neural
networks
-Convolutional
neural networks
-Recurrent neural
networks

-Most complex structure97
-Possibility of overfitting if not enough
variation in training data105
-High computational cost97
-Long training times105

Table 1: Summary of characteristics, limitations and some common examples of various
broad segmentation techniques.

Image thresholding techniques, such as edge detection and seed growing
methods, are easy to implement and are highly efficient. Thresholding an image involves
selecting one or more points on an image’s histogram in order to bifurcate the image into
distinct regions. These methods can also involve the user selecting an initial seed pixel
and a value, for example τ. All pixels adjoining to the initial seed pixel with intensities ± τ
are included in the segmentation. This process is repeated with all included pixels until a
border is generated (i.e. pixel values greater than τ or less than -τ). These methods
present a difficult decision to the user and can be limited by heterogeneities, motion
artifacts, or noise in the image.
Unlike unsupervised methods, such as image thresholding and graph-based
techniques, supervised methods employ image delineations that have already been
generated on similar datasets. Several atlas-based methods have been used in various
applications of automatic segmentation and have been described in the literature 106-111.
The main differentiation between these atlas-based studies and others is the registration
algorithm for mapping image coordinates onto the atlas102. However, as inter-subject
registrations may yield considerable differences in shape, a trait that all aforementioned
atlas-based methods have in common is that the transformations used are non-rigid102.
The process of automatic segmentation with an atlas-based method is shown in Figure
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2.

Figure 2: Process of generating new segmentations on a target image set via atlasbased automatic segmentation.

The reference image set used for atlas-based automatic segmentation can be a single
image or a library of multifarious pre-segmented datasets similar to the image set to be
segmented, each with an associated set of ground truth contours102. A transformation
using deformable image registration is then applied to the reference image data set and
is assessed via a metric of accuracy (e.g. mutual information-based algorithms) to
measure agreement with the target image data set. An iterative optimization process can
then be used to refine the deformable image registration to improve the accuracy between
the reference and target data set. The final transformation matrix (i.e. deformation vector
field) can then be applied to the original ground truth contours to generate new
segmentations on the target image data set (segmentation mapping in Figure 2). To
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summarize, consider an atlas A, a reference image set R, and a target image set T, where
each point in R has a corresponding equivalent in T. This correspondence is represented
by the coordinate transformation F, that maps R onto T102. Thus, for a location (i,j) in T,
the corresponding location in domain R is F(i,j). Through the association of R with A, the
label at any location in T can be found using:102
(𝑖, 𝑗) ↦ 𝐴(𝐹(𝑖, 𝑗))

(2)

The transformation F represents the deformable image registration (DIR) that
characterizes an n-dimensional vector v97. Consequently, atlas based segmentation
methods can be time consuming (converging on an optimal v) and highly dependent on
DIR framework104.
Artificial intelligence is a technique that enables a machine to mimic the behavior
of a human. Machine learning is a subset of artificial intelligence, as shown by Figure 3
which enables machines to achieve artificial intelligence through algorithms and statistical
techniques trained with data. The training process informs the decisions made by the
machine learning framework which allows for improvement as experience is gained 112.
Supervised machine learning methods for the automatic segmentation of images
involves training and tuning a predictive model. Machine learning methods are able to
improve upon the previously mentioned segmentation techniques by incorporating past
labeled data. Machine learning utilizes numerous statistical tools to explore and analyze
this previously labeled data with image representations being built from pre-specified
filters tuned to a specific segmentation task. Although machine learning techniques are
more efficient with image samples and have a less complicated structure, they are often
not as accurate when compared to deep learning techniques for automatic image
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segmentation97.

ARTIFICIAL INTELLIGENCE
Approaches that allow a machine to emulate
the behavior of a human. The machine may
have the ability to recognize patterns, reason,
classify, learn, and make predictions.

MACHINE LEARNING
Algorithms that learn from pre-existing
data and make informed decisions
based on what was learned. Decision
making is improved with experience.

DEEP
LEARNING
Algorithms based on
neural networks that can
learn important image
features automatically to
discover hidden patterns
and information.

Figure 3: Relationship between and descriptions of artificial intelligence, machine
learning, and deep learning.

Conditional random fields (CRF) are an example of a machine learning technique
described in Table 1. The purpose of CRF are to create a relationship between the
observed evidence (i.e. the image) and the hidden “true states” (i.e. probability map) in
order to take the context of the image into account. The probability map (x pixels in Figure
4) has encoded neighborhood information that can be based on several image features
such as intensity, color, texture differences, edges, etc. The CRF seek to minimize the
energy function E(x,y) (Equation 5) that is built of energy potentials φ(x,y) (i.e. unary
potential, Equation 3) and ψ(x,y) (i.e. pairwise potential, Equation 4). The unary potential
encodes the local information about a given pixel and how likely it is to belong to a certain
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class. The pairwise potential encodes the neighborhood information that considers how
different a pixel’s label is from that of its neighbor. Thus, when the energy function E is
minimized, the pairwise term encourages smooth annotations and the unary term causes
annotations to become more localized (i.e. reducing holes in segmentations or far remote
island annotations).
𝑈𝑛𝑎𝑟𝑦 = ∑𝑖 𝜑(𝑥𝑖 , 𝑦𝑖 )

(3)

𝑃𝑎𝑖𝑟𝑤𝑖𝑠𝑒 = ∑𝑖,𝑗 𝜓(𝑥𝑖 , 𝑦𝑖 )

(4)

𝐸(𝑥, 𝑦) = 𝑈𝑛𝑎𝑟𝑦 + 𝑃𝑎𝑖𝑟𝑤𝑖𝑠𝑒

(5)

Figure 4: Relationship between pixels in the image to be segmented (yi) and the pixels
in the probability map (xi)113

Deep learning is a subset of machine learning, as shown by Figure 3, which was
originally designed to mimic the learning style of the human brain using neurons. Unlike
machine learning where the “useful” features for the segmentation process must be
decided by the user, with deep learning, the “useful” features are decided by the network
without human intervention. If an image is considered as the input to a convolutional
neural network (CNN), each pixel in the input image would then be fed to a neuron in the
input layer of the network, represented by purple circles in Figure 5. Each channel (blue
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lines in Figure 5) has a weight assigned to it, or wi, and all neurons have a unique number
associated with them called bias, or Bi. The biases and weights of a network are learnable
parameters that can either be initialized at 0, random values, or predetermined values 114.
The bias is added to the weighted sum of all inputs reaching a particular neuron and is
shown in the following equation.
𝐻 = 𝐵1 + (𝑛1 𝑤1 + 𝑛2 𝑤2 + ⋯ + 𝑛𝑖 𝑤𝑖 )

(6)

The value H is then applied to an activation function, with an example activation function
(σ) shown on the right of Figure 5. Thus, the activation function then becomes,
𝐴𝑐𝑡𝑖𝑣𝑎𝑡𝑖𝑜𝑛 𝑓𝑢𝑛𝑐𝑡𝑖𝑜𝑛 = 𝜎(𝐻)

(7)

The result of the activation function determines if the neuron gets activated. For example,
when using the sigmoid activation function shown in Figure 5, activation values greater
than or equal to 0.5 activate the neuron. Every activated neuron passes on information to
the following layers which continues in each layer until the second to last layer. The one
neuron activated in the output layer corresponds to the decision of the network (i.e. the
label of the pixel). This process occurs for all pixels in the training data and represents a
forward pass of the data.
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Figure 5: Left: An example of a neural network structure. Channels are represented as
blue lines and neurons are represented as circles with the input layers shown in purple,
the hidden layers in green, and the output layer in orange. Right: Equation and plot for
the sigmoid activation function.

After completing a forward pass of the training data, a backward pass then occurs
through a process called backpropagation. Backpropagation is used to adjust the weights
and biases to produce a well-trained network. Due to the training data having ground
truth, weights and biases may be adjusted based on the error at each neuron (i.e. the
difference between the current predicted value and the known truth value). The cost of
the network is the cumulative error across the entire training dataset. In total, the goal of
the backpropagation process is to compute the partial derivatives of each weight and bias
in the network (i.e. ∂C/∂wn and ∂C/∂Bn), so that the negative gradient of the cost function
may be applied to minimize the overall cost. The neural network is trained over copious
forward and backward passes of the training samples so that there is convergence in the
adjustment of the weights and biases. The typical number of utilized epochs ranges from
50 to 1000115 and training times can span from 20 minutes to 100 hours depending on
the size of the dataset and the employed hardware116. One forward pass and one
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backward pass (i.e., backpropagation process) of all the training samples is called an
epoch117.
Recently, CNNs using deep learning have been applied to the complicated task of
segmenting cardiac images with promising results118. This is achieved through the ability
of the deep learning neural network to automatically learn complex features from image
data rapidly. Coupling the ability for rapid feature extraction with advanced computer
hardware, such as graphical processing units (GPUs), has allowed for automatic
segmentation time to be radically decreased. A deep neural network (DNN) is able to
learn a mapping function between an image and a corresponding feature map (i.e.
segmented ground-truth) by incorporating multiple hidden layers between the input and
output layer (Figure 5). Deep learning applications may be limited by the size of datasets
made available in the field of radiation oncology. However, these limitations may be
circumvented through the utilization of image augmentation. The U-Net119 is a DNN
architecture that has shown great promise for generating accurate and rapid delineations
for applications in RT120.
The U-Net architecture was inspired by the original fully convolutional network from
Long et al.121 and was implemented initially by Ronneberger et al.119 in 2015. The U-Net
gets its name from its ‘U-shaped’ architecture, as shown in Figure 6. It was originally
implemented to segment biomedical image data in an end-to-end setting utilizing 30 total
annotated image sets. Starting from the top left of Figure 6, the input image (size 512 x
512) undergoes two convolutions to generate a multi-channel feature map (purple boxes
in Figure 6) with 64 initial feature channels. Next, a non-linear activation function is
applied, as discussed in Figure 5 above, followed by a maximum pooling operation. The
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maximum pooling operation reduces the x and y size by a factor of two for the feature
map, which acts on each channel separately, and then the number of feature channels is
doubled. This process of successive convolutions and maximum pooling operations (i.e.
contraction pathway) gradually increases the “what” while gradually decreasing the
“where.” In a standard classification neural network, such as the one shown in Figure 5,
the network would stop at this point and all feature maps would be combined into a single
output vector. However, the U-Net has an additional expansive path that creates a highresolution segmentation map. The expansion pathway (Figure 6, right) replaces the
maximum pooling operations with up-convolutions to increase the resolution of the feature
maps. Then, in order to localize, features from the contraction pathway are joined with
the up-convolved feature map through concatenation119. The U-Net is an end-to-end
solution with remarkable potential to segment medical images, even when the amount of
training data is scarce122.

Figure 6: Architecture for original U-Net by Ronneberger et al.119 with the contraction
path shown on the left and the expansion path shown on the right. The original input
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image has a size of 512 x 512. Feature maps are represented by purple rectangles with
the number of feature maps on top of the rectangle.

Overall, there are several commercial algorithms for automatic segmentation
already available, but their core mechanics fall within atlas-based measures instead of
machine learning strategies123. These atlas-based measures are highly reliant on the
amount of contrast in the target organ for segmentation 124. On the contrary, recent deep
learning techniques125,126 are well poised for the task of accurate automatic segmentation
with less reliance on organ contrast127,128 as the algorithm is designed to acquire higher
order features from raw data125. Overall, deep learning techniques offer the potential for
rapid and accurate cardiac substructure segmentations over other currently available
segmentation methods.
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CHAPTER 3 “CARDIAC SUBSTRUCTURE SEGMENTATION AND DOSIMETRY
USING A NOVEL HYBRID MAGNETIC RESONANCE COMPUTED TOMOGRAPHY
CARDIAC ATLAS”
Introduction
Increased risk of cardiotoxicity, including coronary artery disease and
cardiomyopathy, has been linked to RT for many cancer sites in close proximity to the
heart5-7. Moreover, major coronary events have been linked to radiation dose to the heart
with a ~7%/Gy increase in rate of ischemic heart disease16. Radiation dose from breast
cancer treatments specifically have also been correlated to myocardial infarction,
congestive heart failure, and cardiovascular death more than 10 years after RT 129.
Therefore, minimizing cardiac dose due to RT treatments is critical and has been given
recent attention130,131.
Currently, OAR dose limits for breast cancer RTP account for the entire heart
volume. For example, according to a cooperative group trial for left-sided breast cancers,
no more than 5% of the whole heart may exceed 20 Gy19. However, heart substructures
are not routinely included in RTP as they are not visible on standard CT-SIM datasets
and dose limits are not currently well established. Furthermore, dose to these cardiac
substructures may have prognostic inferences. In left breast cancer patients, the LADA is
often exposed to the highest treatment-related radiation dose16 and increased dose has
been linked to increased risk of late radiation induced cardiac morbidity 30. Additionally,
measurements of radiation dose to cardiac substructures, like the LV, may be useful in
the prediction of future acute coronary events28. By localizing these sensitive
substructures within the heart, we can then estimate the dose to these regions. This may
further our understanding of their potential roles in radiation-related cardiotoxicity.
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The current standard of care for radiation treatment planning is based on CT-SIM
to enable electron density mapping for dose calculation. However, cardiac substructures
are not easily discernible on standard CT-SIM datasets. Some single modality atlas
methods have employed contrast-enhanced CT45,132,133. For coronary arteries such as
the LADA, contrast-enhanced CT may aid in localization although the majority of the
structure is not discernible134. At present, contrast-enhanced CT (either diagnostic or for
CT-SIM) is not widely available for breast cancer patients, nor are they included in the
current National Comprehensive Cancer Network breast cancer recommendations 135 or
cooperative clinical trial group guidelines for delineation

136-138.

Thus, developing atlas

solutions that can be applied to widespread, clinically available data, such as standard
CT-SIMs, is advantageous.
MRI also improves the visibility of cardiac substructures43,44 as illustrated in Figure
1. Thus, numerous automatic segmentation methods have been established utilizing
MRI139. However, MRIs are not frequently acquired and integrated into routine RTP.
Recently, a multi-scale patch method was used to generate a multi-modality atlas (e.g.
cardiac MRI and contrast-enhanced CT) for automatic segmentation of 7 substructures47.
The purpose of the current study is to develop and validate a novel hybrid MR/CT
segmentation atlas with the overall goal of segmenting 12 sensitive cardiac substructures
and the whole heart on standard, non-contrast, treatment planning CTs. The completion
of this work offers potential for widespread implementation and may provide important
information for dosimetric assessment for OAR sparing.
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Methods
Image Acquisition
Thirty-one patients who underwent RT for left-sided whole-breast cancer were
enrolled on an Institutional Review Board approved study to acquire cardiac MRI scans.
T2-weighted acquisitions were performed on a 3T Philips Ingenia (Philips Medical
Systems, Cleveland, OH) with images acquired at end-expiration (EE). Patients were
positioned supine and imaged in a multi-coil configuration with a 32-channel dStream
Torso coil (Philips Medical Systems, Cleveland, OH) and a 20-channel integrated
posterior coil. Imaging parameters included an 8 mm slice thickness, in-plane resolution
0.7 x 0.7 mm2, and an echo time of 81 ms. This two-dimensional acquisition involved a
single breath hold at EE with an average total acquisition time across all patients of 22.1
± 4.4 seconds (range: 15.1-31.0 seconds).
Non-contrast CT-SIM was performed on a Brilliance Big Bore CT Simulator (Philips
Medical Systems, Cleveland, OH) with a 3 mm slice thickness. Eight patients underwent
4DCT while the other 23 patients underwent a CT-SIM under free-breathing conditions
(FBCT) based on institutional practices. FBCT and 4DCT images were acquired with an
in-plane resolution of 1.1x1.1 mm2 – 1.4x1.4 mm2, 120-140 kVp, and 275-344 mAs. All
patients were imaged in the supine position and immobilized on a Posiboard (Civco, The
Netherlands) with their arms above their head.
Image Registration
A local, cardiac-confined, rigid registration was performed between the noncontrast CT and axial T2-weighted MR in MIM (version 6.7.12, MIM Software Inc.,
Cleveland, OH). Rigid registrations were conducted using normalized mutual information
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as the similarity metric, which has been shown to robustly align multi-modality images140.
Visual inspection of the cardiac-confined rigid registration was performed by a radiation
oncologist before completing manual segmentations. To compensate for respiratory
motion, the 50% (EE) phase of the 4DCT was rigidly registered to the MRI for 8 subjects.
Despite 23 patients being imaged with FBCT at arbitrary phases of the breathing cycle,
visual inspection of the locally confined heart rigid registration by a physicist and radiation
oncologist revealed that the registration quality was adequate for delineation purposes.
Contour Delineation
A radiation oncologist delineated 12 cardiac substructures and the whole heart, as
outlined in Figure 7, with substructure selection based on CT and cardiac MRI autosegmentation atlases 132,139,141. Substructures were also selected based on their roles in
major cardiac function and proximity to the radiation field.
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Figure 7: Left: Axial planning CT, axial T2-weighted MRI, and contoured axial T2weighted MRI, shown at 4 different axial locations. Right: List of cardiac substructures
assessed in this study.

A radiation oncologist followed a published cardiac atlas consensus contouring
guideline141 to delineate the substructures on the CT using a MR/CT rigid registration with
a fixed window/level on CT (50/500 for large structures, 50/150 for cardiac vessels) and
giving preference to MR anatomical information. However, as the epicardial border of the
heart is visible on CT, the CT was used to generate the whole heart contour. Contours
were verified by a radiologist with a cardiac subspecialty and 30 years of clinical
experience.
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Atlas Generation
Non-contrast CT ground truth delineations derived from MR/CT hybrid information
for a subset of 20 patients were inputted into an intensity-based deformable registration
atlas in MIM. To perform a sample size estimation, an initial test cohort of 5 subjects was
evaluated. To achieve 80% power (medium effective size on a repeated measure
ANOVA, alpha error of 0.05 to compare the difference between 8 means), 10 patient
cases were required. However, because the Dice similarity coefficient (DSC) was not
normally distributed and a non-parametric Friedman test was to be used for analysis, the
sample size (n=10) was then divided by a correction factor of 0.955 (i.e. the asymptotic
relative efficiency)142, resulting in a required sample size of n=11 for the testing patient
cohort. Thus, the deformable registration atlas was applied to 11 validation patients (i.e.
test subjects).
To generate the hybrid segmentation atlas, a reference structure set was first
generated from a predetermined patient with average anatomy to act as a template 143.
The template patient was selected based on a moderate habitus, minimal motion artifact,
and standard heart geometry and anatomical position. A local, cardiac-confined, rigid
registration was then performed between the template patient and the 20 subsequent
patients, including the template patient. The process of applying the atlas to a test subject
is outlined in Figure 8. One of the 11 test subjects was then selected and a mutual
information-based algorithm144 was used to locate the atlas subject(s) that were deemed
the best matches to the test subject. A free-form DIR was then completed between each
selected atlas subject and the test subject. The commercially available free-form intensitybased DIR algorithm has limitless degrees of freedom and utilizes adequate regularity
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(i.e. penalty term weight) to ensure smooth deformation 145 and has been previously
validated in CT/CT registrations yielding high segmentation accuracy 146. Finally, the
generated deformation vector field was used to propagate the ground truth segmentations
from the best match to the test subject’s CT.
To optimize atlas performance, three atlas approaches were evaluated (1) singleatlas method, and two multi-atlas segmentation approaches (2) majority vote (MV) and
(3) Simultaneous Truth and Performance Level Estimation (STAPLE). The single-atlas
method (Figure 8, top row) deforms contours from the single best matching atlas subject
to the test subject whereas multi-atlas approaches (Figure 8, bottom row) use various
best matching atlas subjects. In MV, after multiple contours for the same substructure are
deformably propagated to the test subject, the most frequent contour at each voxel is
established as the true segmentation104. The STAPLE method uses a probability map to
create an estimate of the true segmentation from a collection of contours by using an
expectation-maximization algorithm147. The resultant segmentation is then formed by
optimally combining the existing contours through assigning weights based on sensitivity
and specificity147.
To further optimize segmentation, the number of multi-atlas matches was iterated
(3, 5, 10, and 15) for MV and STAPLE methods for the 11 validation datasets. Once final
contours were obtained, post-processing including contour smoothing and filling was
performed104. Image processing time was logged in MIM and tabulated for each approach
for a representative validation patient. Image processing was conducted on a 64-bit
Microsoft Windows PC with a quad-core Intel® Xeon® CPU-E5-1630 v4 at 3.70GHz and
16GB of memory.
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Figure 8: Process of generating an automatic segmentation with an atlas-based method
using both a single-atlas (top row) and a multi-atlas (bottom row). Abbreviations:
Majority vote (MV), Simultaneous Truth and Performance Level Estimation (STAPLE).

Atlas Validation
Atlas performance was assessed via DSC45,132,139 mean distance to agreement
(MDA)148, and centroid displacement between propagated and ground truth delineations
for the 11 test cases. The DSC is used to measure the spatial overlap between two
structures (Equation 8) and is a value from 0, representing no overlap, to 1, representing
perfect agreement.
DSC =

2|M∩N|
|M|+|N|

(8)

Where M and N are the volumes of the manually delineated and propagated
contour, respectively. MDA is used as a geometrical measure to assess the agreement
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between two contours by averaging the per voxel shortest distance from each point on
the test contour to the reference contour, with an increased agreement yielding a lower
MDA148.
To evaluate clinical acceptance of the auto-segmented contours, qualitative
consensus scoring was completed for 12 cardiac substructures and whole heart contours
on a subset of 5 of the 11 validation cases by 2 radiation oncologists and a radiologist
with a cardiac subspecialty. Scores were assigned on a 5-point scale149: (1) clinically
unacceptable, (2) major modifications required, (3) moderate modifications required, (4)
minor modifications required, (5) clinically acceptable.
Dosimetric Assessment
A dosimetric assessment of left breast cancer patients was conducted to illustrate
a potential clinical application of the validated atlas in the test cohort. For the 11 test
subjects, the clinically approved and delivered treatment primary whole breast (tangential
fields, 6-18 MV, 42.7-45.0 Gy) and boost (3D planned with 6-15 MV photons or 12 MeV
electrons to 10.0-16.2 Gy) plans were exported from the Eclipse Treatment Planning
System (Version 11.0, Varian Medical Systems, Palo Alto, CA) and into MIM for direct
dose summation. Dosimetric evaluation of the cardiac substructures included
measurements of the minimum, mean, and maximum dose to each substructure. The
MHD, LV-V5, and left anterior descending artery mean and maximum doses (LADA mean,
LADAmax) are highlighted as they have been shown to be predictive of acute cardiac
events16,28 and are important indicators for ischemic heart disease30,150.
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Statistical Analysis
Data are presented as mean ± standard deviation (SD). Statistical analysis of DSC
and MDA between atlas methods was performed using the Friedman test with a Wilcoxon
signed ranks test for post hoc pairwise comparisons and were Bonferroni corrected.
Statistical analyses between ground truth and auto-segmented volumes and doses were
performed using a two-tailed Wilcoxon signed ranks tests with P < 0.05 considered
statistically significant. All analyses were performed using SPSS version 25.0 (SPSS,
Chicago, IL, USA).
Results
Contour Generation
The average time for the manual delineation of the 12 cardiac substructures and
the whole heart was ~3 hours per patient. For a representative test subject, the atlas autosegmentations took between 1-10 minutes depending on the selected amount of atlas
matches. When applying the STAPLE method with 10 atlas matches to this same
representative patient, the radiation oncologist required ~30 minutes of additional time to
edit segmentations for all 12 substructures and the whole heart for clinical
implementation.
Atlas Performance Evaluation
Figure 9 outlines atlas performance for single-atlas, MV, and STAPLE methods
with 3, 5, 10, and 15 atlas matches for MV and STAPLE. Figure 9 (left) shows that median
DSC values across all structures were between 0.71 and 0.80 for the single-atlas method
and STAPLE method with 10 atlas matches (ST10), respectively.
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Figure 9: Validation patient Dice Similarity Coefficient (DSC) results over all
substructures (Left) and all high performing substructures (i.e. heart, cardiac chambers,
and great vessels) (Right). Boxplots and line indicate the interquartile range and
median, respectively. Whiskers indicate the minimum and maximum, with data points >
1.5 times the interquartile range and > 3 times the interquartile range marked by circles
and stars, respectively.

In general, atlas approaches performed similarly, yielding mean DSCs > 0.75 for
7/13 cardiac structures (heart, chambers, AA, and PA) over the 11 validation patients.
Table 3 outlines DSC results for the single atlas method and select high performing multiatlas methods. Across the 11 test subjects, all coronary artery segmentations had DSC
values < 0.42. The right side of Figure 9 summarizes the 11 validation patient mean DSC
results after exclusion of the coronary arteries, where median DSC values range from
0.75 to 0.85 for the single-atlas and ST10 method, respectively. In comparing atlas
methods, ST10 generated the highest mean DSC and lowest MDA values for all high
performing substructures (i.e. heart, chambers, and great vessels). The post hoc pairwise
comparisons, shown in Table 2, revealed that ST10 outperformed the single-atlas for all
substructures except the coronary arteries for both MDA and DSC (P < 0.05).
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DSC

MDA

Method 1/2
Single/MV10

Heart
0.95

AA
0.78

LA
0.01*

LV
0.63

RA
0.23

RV
0.01*

PA
<0.01*

PV
1.00

SVC
1.00

IVC
1.00

Single/ST10

<0.01*

<0.01*

<0.01*

<0.01*

<0.01*

<0.01*

<0.01*

<0.01*

<0.01*

<0.01*

ST3/ST10

0.03*

0.01*

<0.01*

0.01*

0.01*

<0.01*

<0.01*

<0.01*

0.02*

0.11

ST5/ST10

1.00

1.00

1.00

1.00

1.00

0.02*

0.05*

1.00

0.46

1.00

MV10/ST10

0.26

0.10

1.00

0.01*

0.26

1.00

1.00

<0.01*

<0.01*

<0.01*

Single/MV10

1.00

1.00

1.00

<0.01*

1.00

0.46

0.95

<0.01*

0.09

1.00

Single/ST10

<0.01*

<0.01*

<0.01*

<0.01*

<0.01*

<0.01*

<0.01*

<0.01*

0.01*

<0.01*

ST3/ST10

0.04*

0.02*

<0.01*

0.02*

0.04*

<0.01*

<0.01*

<0.01*

<0.01*

0.29

ST5/ST10

1.00

1.00

1.00

0.70

1.00

<0.01*

0.14

1.00

1.00

1.00

MV10/ST10

<0.01*

0.14

<0.01*

1.00

0.02*

0.18

0.01*

1.00

1.00

0.14

Table 2: Statistical pairwise comparisons of mean distance to agreement (MDA) and
Dice similarity coefficient (DSC) between select atlas methods for each high performing
substructure. Statistical differences are marked by a star and represent method 2
having a statistically higher median than method 1 (P < 0.05). Atlas methods are
defined as single-atlas (Single), Majority Vote (MV), and Simultaneous Truth and
Performance Level Estimation (ST) followed by the number of atlas matches.
However, the single atlas method’s DSCs and MDAs performed similarly to
STAPLE and Majority Vote when fewer than 5 atlas matches were used (P > 0.05, results
not shown). Regarding MDA, ST10 outperformed ST3 and ST15 for > 8 high performing
substructures. Additionally, ST10 outperformed ST5 for the RV and PA DSCs at the
expense of ~5 minutes processing time. Thus, all further analyses were conducted using
ST10.
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DSC from Atlas Application

Consensus
Score

Single

MV10

ST10

ST10

Heart

0.92 ± 0.03

0.94 ± 0.01

0.95 ± 0.01

4.2 ± 0.4

Left Ventricle

0.83 ± 0.04

0.88 ± 0.01

0.91 ± 0.01

4.6 ± 0.5

Right Atrium

0.80 ± 0.05

0.84 ± 0.04

0.87 ± 0.03

4.2 ± 0.4

Left Atrium

0.77 ± 0.03

0.84 ± 0.03

0.86 ± 0.03

3.8 ± 0.4

Pulmonary Artery

0.74 ± 0.07

0.81 ± 0.03

0.84 ± 0.03

4.0 ± 0.0

Ascending Aorta

0.73 ± 0.09

0.79 ± 0.07

0.84 ± 0.03

4.4 ± 0.5

Right Ventricle

0.71 ± 0.06

0.80 ± 0.05

0.83 ± 0.03

4.2 ± 0.4

Superior VC

0.67 ± 0.09

0.66 ± 0.08

0.80 ± 0.04

4.0 ± 0.7

Inferior VC

0.46 ± 0.23

0.55 ± 0.11

0.70 ± 0.07

4.0 ± 0.7

Pulmonary Vein

0.47 ± 0.13

0.50 ± 0.06

0.64 ± 0.06

3.2 ± 0.4

0.71 ± 0.08

0.76 ± 0.05

0.82 ± 0.03

4.1 ± 0.5

LAD Artery

0.15 ± 0.14

0.04 ± 0.04

0.27 ± 0.09

1.8 ± 0.8

RT Cor. Art.

0.14 ± 0.10

0.03 ± 0.05

0.22 ± 0.10

2.4 ± 0.9

LT Main Cor. Art.

0.05 ± 0.08

0.00 ± 0.00

0.12 ± 0.12

1.4 ± 0.5

Per Structure Mean ± SD

Average over Heart, Chambers,
and Great Vessels

Table 3: Mean and standard deviation (SD) results for select atlas methods showing the
Dice Similarity Coefficient (DSC) per substructure and across all high performing
substructures for the validation population (heart, chambers, and great vessels).
Consensus scores from physician grading of the ST10 method are also shown.
Abbreviations defined in text.

Segmentation Results for ST10
Figure 10 summarizes the mean MDA and DSC results between manually
delineated ground truth contours and ST10 atlas generated contours over the 11 test
cases. Over all 12 substructures and the whole heart, 9 had an MDA < 2.1 mm and a
mean DSC > 0.70, suggesting excellent atlas performance. The coronary arteries
performed the worst (mean DSC < 0.3 and MDA between 3.1-4.2 mm).
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Figure 10: Mean distance to agreement (MDA) (Left) and Dice similarity coefficient
(DSC) (Right) between ground truth and ST10 contours for all delineated substructures
(n = 11). Error bars represent the standard error of the mean.

Additionally, across the 11 test cases, over half of all contours had centroid
displacements < 3.0 mm, with largest shifts in the coronary arteries. The greatest centroid
displacements occurred in the superoinferior direction (predominantly superior). Three
out of 12 substructures (left main coronary artery, pulmonary vein, and right coronary
artery) had statistically significant differences in volumes between ST10 and manually
generated contours (P < 0.05). Figure 11 highlights agreement for all auto-segmented
cardiac substructures as compared to ground truth.
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Figure 11: Three-dimensional rendering of substructures showing agreement between
manually drawn ground truth (GT) contours and STAPLE 10 (ST) generated contours.

Qualitative Contour Grading using ST10
Physician consensus scores for the heart, ventricles, PA, RA, SVC, IVC, and AA
were found to require only minor modifications, typically at the inferior boundary (average
score: 4.2 ± 0.5). The pulmonary vein (PV) and LA scored between 3 and 4, requiring
moderate modifications. Major modifications were necessary for the LADA (1.8 ± 0.8) and
RCA 2.4 ± 0.9) although propagated contours were deemed useful for localization. The
left main coronary artery (LMCA) yielded the lowest average score (1.4 ± 0.5), suggesting
inadequate segmentation. The highest scoring segmentations occurred for the LVs and
AAs, with 3 and 2 subjects requiring no modifications, respectively. Excluding the
coronary arteries, average consensus scores across all validation patients were greater
than 4 (Table 3), suggesting only minor modifications were necessary.
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Dosimetric Assessment
Figure 12 shows a representative dose volume histogram (DVH) for a test subject
including the LV, LADA, and heart, as these structures fell within the tangential fields. All
other cardiac substructures received negligible radiation dose (mean dose < 1.5 Gy,
results not shown). The propagated contour yielded a LADAmean of 23.1Gy and LADAmax
of 44.9Gy, which was within 3.4% and 0.1% of ground truth, respectively (LADAmean of
22.4Gy, LADAmax 44.9 Gy).

Figure 12: Left: Axial cross section of a treatment planning CT for a representative
validation patient showing contours generated from STAPLE 10 (ST10) and ground
truth, as well as percentage dose delivered to the left breast (substructure colors not
represented in the dose volume histogram (DVH): Dark Blue-RA, Denim BlueRA_ST10, Pink-RV, Magenta-RV_ST10). Right: Corresponding DVH for the same
validation patient.

The Wilcoxon signed rank test showed no statistically significant differences
between ST10 and ground truth contours for the minimum, mean, and maximum dose to
the chambers and great vessels (P > 0.05). Additionally, there were no statistically
significant differences in LADAmax, MHD, and LV-V5 (P > 0.05). However, there was a
significant difference in dose for the LADAmean (P < 0.05). Excellent estimation of the dose
to the heart and LV was observed across the 11 test subjects for the propagated contours
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proving them to be robust for dosimetric endpoints. The summation of the primary and
boost treatment plans for the 11 validation subjects yielded no statistically significant
differences in dosimetric endpoints between ST10 and ground truth contours for the LVV5 (14.9 ± 7.0% vs. 15.3 ± 7.3%), MHD (2.7 ± 1.0 vs. 2.8 ± 1.0 Gy), and LADAmax (46.2
± 6.9 vs. 43.2 ± 9.0 Gy) (P > 0.05). However, the difference in LADAmean was statistically
significant (22.5 ± 11.2 vs. 18.3 ± 10.0 Gy) (P < 0.05).
Discussion
This work has optimized and validated a hybrid MRI/CT contouring atlas for cardiac
substructure segmentation with the overarching goal of applying it to non-contrast
enhanced CTs for RTP and dose assessment. After a promising segmentation approach
was identified (i.e. ST10), accurate delineations were obtained for the heart, chambers,
and great vessels (10 of 13 structures), although the coronary arteries were not
adequately segmented (DSC < 0.3). While the current retrospective dosimetric evaluation
focuses on cardiac substructures for left-sided breast cancer RT, the atlas may be applied
to other disease sites, such as advanced stage lung or esophageal cancer, which can be
explored in future work.
Although cardiac substructure atlases have been described in the literature, to our
knowledge, none have included hybrid MR/CT information for propagation to CT.
STAPLE was recently applied to delineate heart chambers on non-contrast enhanced CT
images via a fused contrast-enhanced CT132. With the introduction of MRI into our atlas,
our work outperformed that of Zhou for the heart chambers (average improvements in
DSC and MDA of 0.12 ± 0.02 and 2.8 ± 0.5 mm, respectively). A multi-atlas MV method
was used to automatically segment cardiac chambers on CT angiography scans from a
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large multicenter/multivendor database with little improvement in segmentation accuracy
with > 5 atlas matches45. When applying MV in our work, a slight improvement in median
and interquartile range was observed when using up to 15 atlas matches (Figure 9, right)
at the expense of computational time (~10 minutes/dataset). While Zhuang et al. did
incorporate MRI into their cardiac substructure atlas, they focused mostly on the large
structures such as the heart, chambers, AA, and PA47 and also used contrast-enhanced
CT. Our segmentation accuracy for ST10 was comparable for the same structures (DSC
and MDA within 0.01 and 0.5 mm, respectively) after applying the MRI/CT atlas to
standard RTP CTs.
One limitation is that ground truth contours were generated by a single radiation
oncologist. In their atlas implementation for automatic cardiac substructure segmentation
on contrast enhanced CT, Zhou et al. found that inter-observer variability increased for
the PV and coronary arteries where DSCs were less than 0.50 and MDAs were larger
than 4.0 mm across experts132. Even though ground truth segmentations in this work were
generated by a single radiation oncologist, contour verification by a radiologist and our
consensus scoring provided additional clinical interpretation by multiple observers.
Another limitation of this work is that the performance of the atlas has yet to be evaluated
for deep-inspiration breath hold, which has been shown to provide additional cardiac
sparing for left-breast cancer cases151. Finally, the volumetric T2-weighted cardiac MRI
scans were not optimized for RTP (slice thickness=8 mm) although in-plane resolution
was 0.7 x 0.7 mm2. Thinner slice thicknesses will improve contouring accuracy for small
volumes, however at the expense of reduced signal-to-noise ratio.
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The coronary arteries (i.e. LADA, RCA, and LMCA) were most challenging for our
atlas, which is consistent with other studies132,133,152. Potential causes of this include
complex and low contrast anatomy and image resolution limitations. Although we
accounted for respiratory motion by utilizing a local cardiac confined registration, cardiac
motion may have adversely impacted the MR/CT fusion accuracy which may introduce
additional uncertainty in small structures, such as the arteries. In these cases, manual
segmentation was difficult and required expertise. Additionally, significant motion from
respiration and the cardiac cycle may present challenges in identifying the coronary
arteries as they can often appear indistinct or noncontiguous 141. A recently reported
contouring atlas using landmarks like the atrioventricular and interventricular grooves has
also shown to be useful in segmenting the coronary arteries without the use of contrast 152.
The 9 outliers (Figure 9, right) are due to PV segmentations from 2 validation patients
where, in both cases, the atlas overestimated the volume and did not reach the inferior
extent of the ground truth contours. Additionally, the 3 extreme outliers (DSC < 0.4)
(Figure 9, right) were attributed to an inadequate IVC segmentation on a single patient,
likely due to the liver appearing homogeneous on non-contrast enhanced CT. Thus, artery
and vein segmentation will be further addressed in future work via the application of deep
convolutional networks, which have shown promise for ventricle segmentation 153.
The retrospective dosimetric evaluation revealed that for whole breast RT, few
cardiac substructures may require assessment. Nevertheless, the maximum dose to the
LADA (46.2 ± 6.8 Gy) was substantial, with possible consequences of acute cardiac
events28 and ischemic heart disease30,150. Future work may include the evaluation of
treatment planning strategies and extend this work to other disease sites that may benefit
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from cardiac substructure sparing (e.g. esophagus, lung, or lymphoma). Additionally,
further development of this atlas may incorporate the inclusion of cardiac valves and
segments of the LV152.
Conclusion
Overall, applications of the hybrid MRI/CT atlas offer future potential for robust
cardiac substructure sparing using standard simulation CTs that are in routine use for
treatment planning (i.e., non-contrast CT/4DCT) when an MRI is unavailable. As virtually
all patients receiving RT have a CT-SIM as needed for accurate dose calculation, our
approach offers strong potential for widespread application. Our hybrid MR/CT atlas
shows promise for cardiac substructure segmentation for use in routine treatment
planning and dose assessment.
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CHAPTER 4 “CARDIAC SUBSTRUCTURE SEGMENTATION WITH DEEP LEARNING
FOR IMPROVED CARDIAC SPARING”
Introduction
Increased risks of radiation-induced heart disease including acute (pericarditis)
and late (congestive heart failure, coronary artery disease, and myocardial infarction)
cardiotoxicities have been linked to dose from thoracic RT for lymphoma, lung, breast,
and esophageal cancers5-7,16. Radiation-induced heart disease presents earlier than
previously expected, beginning only a few years after RT and with elevated risk persisting
for ~20 years16. Importantly, dose escalation evaluation for locally advanced non-small
cell lung cancer in RTOG 061726 revealed that the volume of the heart receiving ≥ 5 and
≥ 30 Gy were independent predictors of survival26. Further, heart dose/volume metrics
are significantly associated with a patient’s quality of life27.
At present, dosimetric evaluation is currently limited to simplified heart
volume/dose relationships, such as those recommended by QUANTEC, where the heart
is considered a single organ. It is currently recommended that < 10% of the heart receive
> 25 Gy with the clinical endpoint of long-term cardiac mortality18. Despite having wholeheart dose limits, evidence suggests that dose to sensitive cardiac substructures may
lead to cardiac toxicities16,28,29 including cardiomyopathy, coronary artery disease,
pericardial, and conduction system diseases9. Specifically, an increased rate of cardiac
events and ischemic diseases have been associated with increased radiation dose to the
LV28, LA29, and LADA154. Patel et al. found that the maximum dose > 10 Gy to the LADA
was a significant threshold for increased odds of developing coronary artery calcification.
When compared to MHD, maximum dose to the LADA had a stronger association with
coronary artery calcification onset32. However, following these dosimetric thresholds is
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currently limited by the poor visualization and ability to delineate these sensitive cardiac
substructures on non-contrast CT-SIM scans.
Several studies have assessed atlas-based segmentation of cardiac substructures
in RT48,132,155 to avoid the time consuming (6-10 hours/patient) and tedious task of manual
delineation47. However, most atlases fail in segmenting the coronary arteries, with DSCs
between ground-truth and auto-segmentation of the LADA ranging from 0.090.2748,132,155,156. Incorporating multiple imaging modalities (i.e. contrast enhanced CT and
MRI) has improved visualization and yielded successful chamber and great vessel
segmentation, yet coronary artery segmentation remains an unmet need48,132.
Recently, DNNs, such as U-Net119, have shown great promise for generating
accurate and rapid delineations for RT120. Here, a DNN learns a mapping function
between an image and a corresponding feature map (i.e. segmented ground-truth). Payer
et al. implemented a U-Net for substructure segmentation and obtained a DSC of 94% in
the aorta as compared to ground-truth157. Various DNNs have been applied to medical
image segmentation120, specifically for cardiac substructure segmentation. These include
deep CNNs with adaptive fusion92 or multi-stage157 strategies, as well as generative
adversarial networks (GANs)158. Adaptation of these segmentation strategies have
greatly improved cardiac chamber157 and pulmonary artery92 segmentations on contrast
enhanced CTs (DSCs > 85%). Additionally, deep residual learning techniques are
currently being used to generate cardiac substructure segmentation models that are
robust against the presence or absence of image contrast 159. However, most of these
models have not been applied to conventional CT-SIM images and have yet to implement
segmentations of the PV and coronary arteries.
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The current work builds upon recent DNN results to develop an efficient and
accurate cardiac substructure deep learning (DL) segmentation pipeline that can be
implemented into routine practice on standard, non-contrast CT-SIMs, thus requiring no
additional image acquisitions. Here, training is performed via labeled MRI/CT pairs
inputted into a 3D U-Net coupled to predict cardiac substructure segmentations using a
single non-contrast CT-SIM input. We further improve agreement to ground-truth
delineations by introducing a 3D dense CRF as a post-processing step, which have been
recently merged with DNNs for state-of-the-art results in medical image segmentation160.
Overall, the overarching goal is to enable widespread implementation of DL to improve
cardiac sparing in RTP accomplished via cardiac sparing trials and improved risk
assessment evaluation.
Methods
Imaging and Ground-Truth Contour Delineation
Thirty-two left-sided whole-breast cancer patients, with 36 unique datasets, were
consented to an Institutional Review Board approved study and underwent cardiac MRI
scans (two-dimensional T2 single-shot turbo spin echo sequence, repetition time = 927.9
ms, echo time = 81 ms, voxel size = 0.7 x 0.7 x 8.0 mm3) at EE on a 3T Philips Ingenia
(Philips Medical Systems, Cleveland, OH). Imaging was completed in a single breath hold
(acquisition time = 22.1 ± 4.4s). Non-contrast CT-SIM images were acquired on a
Brilliance Big Bore CT simulator (Philips Medical Systems, Cleveland, OH) (voxel size =
1.1 x 1.1 x 3.0 mm3-1.4 x 1.4 x 3.0mm3, 120-140 kVp, and 275-434 mAs) with patients
immobilized in the supine position on a Posiboard (Civco, The Netherlands). Twenty-four
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patients were imaged under free breathing conditions, while the other eight underwent
4DCT.
To develop a mutual coordinate system between datasets, an automatic global
rigid registration between the T2 MR (moving image) and CT-SIM (target image) images
was performed in MIM (version 6.9.1, MIM Software Inc., Cleveland, OH). An automated
local rigid registration was then applied via a manually drawn cardiac-confined bounding
box. For both rigid registrations, normalized mutual information was used as the similarity
metric as it has been shown to perform well with multimodality image registration tasks140.
For patients who underwent 4DCT, the 50% phase was used as it most closely matched
the EE MRI.
The evaluation and approval of the co-registration of the T2 MRI to the noncontrast CT was performed through visual verification by a radiation oncologist. To
generate the contours, a consensus atlas was followed141 as implemented in our previous
work48. In brief, twelve cardiac substructures (left/right ventricles (LV, RV) and atria (LA,
RA), superior/inferior venae cavae (SVC, IVC), pulmonary artery/veins (PA, PV),
ascending aorta (AA), right coronary artery (RCA), left main coronary artery (LMCA), and
LADA) were manually delineated by a radiation oncologist and verified by a radiologist
with a cardiac subspecialty. Due to the enhanced soft tissue contrast that MRI provides,
preference was given to anatomical information from the MRI.
Data Preparation
All work was performed using an NVIDIA Quadro M4000 graphical processing unit
(NVIDIA, Santa Clara, CA). To improve generalizability, zero-mean normalization161
(subtracting the mean intensity from the image and dividing by the standard deviation of
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the image) was performed to maintain intensity consistency across MRI/CT datasets and
patients. To generate ground-truth images, substructure masks were combined into a
single image volume (ground truth (GT) image in Figure 13) with intensity values for the
12 substructures indexed every 20 grayscale values from 35 to 255 with no overlap
among substructures. MR and CT images were all resampled to a 650 x 650 mm in-plane
resolution using bilinear interpolation. Bilinear interpolation was also used to interpolate
MR images in the z-direction to match the 3 mm CT slice thickness (final voxel size of
1.27 x 1.27 x 3 mm3). Registered MR and CT image volumes were cropped to 64 slices
(in-plane dimension of 128 x 128 pixels), centered on the centroid of the whole heart and
padded with 32 blank slices both superiorly and inferiorly for a final size of 128 x 128 x
128 pixels.
Neural Network Architecture and Training
The proposed 3D U-Net, shown in Figure 13 was based on an existing architecture
designed for brain tumor auto-segmentation162 with several customizations as follows: (1)
including deep supervision, (2) training using the entire 3D image volume simultaneously
via multi-channel data inputs (i.e., MRI, CT, and cardiac substructure ground-truth
masks), (3) optimizing hyperparameters of a Dice-weighted multi-class loss function162,
(4) utilizing deconvolution in the upsampling process, and (5) optimizing the number of
feature maps used in the first layer.
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Figure 13: 3D U-Net architecture with CT and MR inputs in different image channels,
along with the ground-truth (GT) labels. Prediction maps are outputted for each
substructure.

This 3D U-Net is composed of a contraction pathway (Figure 13, left) to aggregate
high level information using context modules and an expansion pathway (Figure 13, right)
to combine feature and spatial information for localization162. Context modules (Figure 13,
left) were composed of a dropout layer with 30% probability between two 3 x 3 x 3
convolutional layers. Deep supervision was implemented by adding segmentation layers
at each step of the localization pathway (Figure 13, right). Deep supervision allows for the
injection of gradient signals deep into the network163, as it speeds up convergence and
enhances training efficiency when there is a small amount of available labeled training
data162,164. An elementwise summation with upsampling was then applied across all
added segmentation layers to generate the final segmentation. As coarse segmentation
results may yield unrealistic results, skip connections were applied (i.e. concatenation) by
fusing earlier layers in the network where the down-sampling factor is smaller to recover
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the original spatial resolution165. To rebuild high-resolution feature maps, deconvolution
was used in the localization pathway in order to learn the upsampling 166.
To minimize model overfitting (ensuring the model remains generalizable to the
hold-out dataset after being tuned to a training set), data augmentation 119 including
flipping, rotating (0-30°, 1° increments), scaling (± 25%, 1% increments), and translating
(10 pixels in the left-right, anterior-posterior, and superior-inferior directions) was applied.
Originally proposed as a novel objective function based on DSC167, a Dice-weighted multiclass loss function was used162,168 to manage the different image features among
substructures, as shown in Equation 9:
2

ℒ𝐷𝑆𝐶 = − |𝐵| ∑𝑏∈𝐵 ∑

∑𝑎 𝑥𝑎,𝑏 𝑦𝑎,𝑏

𝑎 𝑥𝑎,𝑏 +∑𝑎 𝑦𝑎,𝑏

(9)

As label encoding is not sufficient for model training, 𝑦 represents the ground-truth
segmentation map converted from categorical to binary variables (i.e. one-hot encoding).
For training voxel 𝑎 in class 𝑏, 𝑥𝑎,𝑏 and 𝑦𝑎,𝑏 represent the prediction and ground-truth,
respectively. As a larger DSC represents better overlap between ground-truth and the
prediction, the loss function is negative due to it being minimized during the training. Each
value of correspondence between both the training and validation datasets to groundtruth are represented by an average across all 12 substructures.
An adaptive momentum estimation optimizer169 was used along with randomly
initialized weights. Patience (i.e., number of epochs to wait without validation loss
improvement before reducing the learning) was also implemented during training. An
epoch is defined as one forward pass and one backward pass (i.e., backpropagation
process) of all the training samples117. Optimized hyperparameters included an initial
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learning rate of 5 x 10-4, 50% learning rate reduction, a batch size of 1, patience of 10
epochs, and 16 base filters in the first layer of the localization pathway.
Patient data was split into 25 patients for training data and 7 (11 unique datasets)
patients for a hold-out data set for network testing. No hold-out datasets used for testing
were implemented in the network training. Training data was split via random assignment
into 80% training and 20% validation data. Paired MRI and CT data were placed into
separate image channels along with indexed ground-truth labels for 25 patients to train
the 3D U-Net using the entire 3D MR and CT images and all substructures
simultaneously. Training was considered to be sufficiently converged when the training
error between two adjacent epochs (i.e. one forward and backward pass of all the training
samples) was less than 0.001117.
All work was performed using Windows 10 operating system in Python version 3.6.
The 64-bit Microsoft Windows system is equipped with a quad-core Intel® Xeon® CPUE5-1630 v4 at 3.70GHz and 16GB of memory. The employed graphics processing unit
was an NVIDIA Quadro M4000 with 8 GB of RAM and 1664 CUDA cores where Keras
2.0 was implemented with a TensorFlow backend.
Contour Post-Processing and Optimization
As coarse output maps from the DL network may containing holes and spurious
predictions from neural networks are common121, contour post-processing was performed
on the 3D U-Net output using a fully connected CRF170 that imposes regularization
constraints through minimizing an energy function113. A 3D-CRF model was developed
based on an initial two-dimensional implementation113 and optimized to refine
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segmentations by smoothing, filling holes and removing false positives, such as small
remote regions.
3D-CRF was implemented on a GPU for improved computation and inference time.
Inference here is with regard to the number of iterations applied to minimize the KullbackLeibler divergence113. Both bilateral171 (i.e. appearance kernel) and Gaussian113 (i.e.
smoothness kernel) pairwise energies were used to account for the grayscale intensity
similarity, as well as the spatial proximity of pixels. The applied kernel involves the sum
of a smoothness and appearance kernel which are shown in the following equations 113:
𝑠𝑚𝑜𝑜𝑡ℎ𝑛𝑒𝑠𝑠 𝑘𝑒𝑟𝑛𝑒𝑙 = 𝑘𝑠 = 𝑒𝑥𝑝 (−

𝑎𝑝𝑝𝑒𝑎𝑟𝑎𝑛𝑐𝑒 𝑘𝑒𝑟𝑛𝑒𝑙 = 𝑘𝑎 = 𝑒𝑥𝑝 (−

|𝑃𝛼 −𝑃𝛽 |

|𝑃𝛼 −𝑃𝛽 |
2𝜃𝑥2

𝑎𝑝𝑝𝑙𝑖𝑒𝑑 𝑘𝑒𝑟𝑛𝑎𝑙 = 𝑤1 ∗ 𝑘𝑠 + 𝑤2 ∗ 𝑘𝑎

2𝜃𝑥2
2

−

2

)

|𝑄𝛼 −𝑄𝛽 |
2𝜃𝑦2

(10)
2

)

(11)
(12)

where 𝑃 and 𝑄 represent Intensity and position vectors at pixel (𝛼, 𝛽). The smoothness
kernel works to remove small remote regions172 and is controlled by a scaling factor 𝜃𝑥 .
Parameter 𝜃𝑦 is an additional scaling factor in the appearance kernel, which controls the
degree of similarity in predicted pixels. The appearance and smoothness kernel are
equally weighted with weights 𝑤1 = 𝑤2 = 1.
CRF hyperparameters 𝜃𝑥 and 𝜃𝑦 were optimized automatically173 for each
substructure by stepping through different parameter values and then comparing
prediction results back to ground-truth through DSC. Based on the range of utilized values
found in the current literature113,174,175, full integer values from 1-80 were stepped through
for 𝜃𝑥 and in steps of 0.05 from 0-1 for 𝜃𝑦 , yielding a total of 100 individual tests. As it was
shown in113 that convergence may be reached in less than 10 iterations, 10 inference
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steps per substructure prediction were used173. Finally, predictions both with and without
CRF post-processing will be assessed by comparing agreement with ground-truth.
Network testing on the hold-out dataset was conducted using the remaining 11 test
patient CTs containing the heart and thorax from seven unique patients. Binary mask
segmentations were converted to contours in Digital Imaging and Communications in
Medicine (DICOM) format and imported into MIM.
Evaluations and Statistical Assessment
Quantitative evaluations between DL and ground-truth segmentations were
performed via DSC176, MDA (average of the shortest distance between all voxels of the
predicted and ground-truth segmentations148), Hausdorff distance (HD, maximum nearest
neighbor Euclidean distance177), and centroid displacement in three cardinal axes. DL
segmentations were also compared to our previously published multi-atlas (MA) results,
which implemented STAPLE with 10 atlas matches48 using a shared cohort of 11 test
subjects. Lastly, qualitative consensus scoring of DL segmentations was conducted to
evaluate clinical utility. Before the qualitative grading was performed, three physicians
(two radiation oncologists and a radiologist with a cardiac subspecialty) reviewed DL
segmentations from a patient who was excluded from the grading. The physicians were
instructed on the image grading system and a grading consensus scale was established
for each substructure and then applied for five unique patients. Qualitative consensus
scoring was completed on five of the test subjects as evaluated in our previously
published atlas study48. Scoring was completed using a 5-point scale48,149 as follows: (1)
not clinically acceptable, (2) clinically acceptable with major changes, (3) clinically
acceptable with moderate changes, (4) clinically acceptable with minor changes, (5)
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clinically acceptable. Contours were converted to a 0.25 mm high resolution display for
final evaluation in MIM.
For volume size similarity assessment, 2-tailed Wilcoxon signed-ranks tests were
performed between ground-truth and auto-segmented DL segmentations, with P < 0.05
considered significantly different. Statistical assessments using 2-tailed Wilcoxon signedranks tests were also used to compare DL segmentations to our previous MA method via
DSC, MDA, and qualitative consensus scores.
Results
Segmentation and Post-Processing Time
The initial manual ground-truth delineations of the 12 cardiac substructures
required ~ 3 hours per patient. The DL network stabilized in ~ 19.4 hours after training
the network for 200 epochs, including ~ 2 hours after implementing data augmentation.
Figure 14 shows the results for the training and validation datasets over the 200 epochs.
The final training and validation DSC values were 83.1% and 81.5%, respectively
(difference < 2%), which represents an average over all 12 substructures.
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Figure 14: 3D U-Net training and validation results over 200 epochs. Values for mean
Dice similarity coefficient (DSC) represent an average over all 12 substructures.

Augmentation led to an overall DSC increase of 5.0 ± 7.9% across all
substructures, with greatest improvements in the coronary arteries (LMCA = 18.6 ±
15.5%, RCA = 8.7 ± 9.1%, LADA = 7.8 ± 7.1%). Substructure contour generation (12
substructures) for a new patient using a single non-contrast CT-SIM dataset input took
5.0 ± 0.6 seconds. CRF post-processing time from a single test patient using 10 inference
steps for 12 substructures was 9.3 ± 0.3 seconds, for a total DL generation time of 14.3
seconds (range: 13.5-15.6 seconds).
CRF Post-Processing
CRF hyperparameter optimization revealed that differing values of (𝜃𝑥 ,𝜃𝑦 ) provided
maximal DSC when three different sets of optimized parameters were employed for (1)
coronary arteries and PV (2.0, 0.40), (2) superior/inferior venae cavae (2.0, 0.50), and (3)
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chambers and great vessels (8.0, 0.55). CRF applications lead to an average
improvement in DSC, MDA, and HD over all substructures of 1.2 ± 2.5%, 0.11 ± 0.31 mm,
and 5.58 ± 14.25 mm, respectively. The LMCA had the greatest improvement in DSC (6.2
± 6.6%, range: 1-22%) after CRF application, whereas the RV and RA saw the least
improvement (0.3 ± 0.2%, range: 0.0-1.0%). The LV showed the greatest improvement in
MDA (0.3 ± 0.5 mm, range: 0.0-1.2 mm) and HD (34.4 ± 23.0 mm, range: 0.1-64.7 mm)
after 3D-CRF application. Lastly, after applying CRF, the mean improvement in MDA
ranged from 0.04 to 0.21 mm over the 12 substructures.
Geometric Performance of Segmentation
DL segmentation results are presented in Table 4.
Segmentation Improvement
Substructures

Augmentation DSC

CRF HD (mm)

Final DSC

Final MDA (mm)

Chambers (LA, LV, RA, RV)

0.03 ± 0.03

10.23 ± 19.34

0.88 ± 0.03

1.53 ± 0.26

Great Vessels (SVC, PA, AA)

0.03 ± 0.05

3.59 ± 10.79

0.85 ± 0.03

1.24 ± 0.31

Inferior Vena Cava

0.00 ± 0.05

6.61 ± 15.23

0.78 ± 0.04

1.45 ± 0.45

Pulmonary Veins

0.05 ± 0.04

2.82 ± 4.41

0.77 ± 0.04

1.04 ± 0.21

Left Anterior Descending Artery

0.08 ± 0.07

0.16 ± 0.27

0.53 ± 0.08

1.90 ± 0.90

Right Coronary Artery

0.09 ± 0.09

5.01 ± 15.86

0.50 ± 0.09

1.97 ± 0.46

Left Main Coronary Artery

0.19 ± 0.16

0.65 ± 0.96

0.50 ± 0.18

1.27 ± 0.68

Coronary Arteries

Table 4: Improvement in automatic segmentation performance in Dice similarity
coefficient (DSC) after augmentation and in Hausdorff distance (HD) after
implementation of conditional random fields (CRF) post-processing. The table also
shows the final agreement to ground-truth via DSC and mean distance to agreement
(MDA). Additional abbreviations defined in the text.

Figure 15 presents comparisons between ground-truth and DL segmentations across
substructures (LMCA not shown). The best-case patient (Figure 15, right) had chamber
DSCs greater than 0.90 and MDAs less than 2 mm for all substructures with favorable
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results for the RCA (DSC = 0.72, MDA = 1.67 mm). MDA (Figure 17, left) across all 12
substructures was less than 2.0 mm (MDA = 1.46 ± 0.50 mm).

Figure 15: Comparisons between contours generated via deep learning prediction and
ground-truth (GT) in both two-dimensional axial slices (top) and 3D renderings (bottom)
for the worst (left), average (center), and best (right) cases.

Wilcoxon signed-ranks tests revealed no significant differences in cardiac
substructure volumes between DL and ground-truth (P > 0.05). Figure 16 summarizes
the centroid shifts in all cardinal axes. On average, the smallest displacements (< 2 mm)
occurred in the anterior-posterior direction for 11 substructures. The largest
displacements occurred in the superior-inferior direction.
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Figure 16: Substructure centroid displacements in the left-right (left), anterior-posterior
(right), and superior-inferior (bottom) directions. Legend: interquartile range = box,
median = line, minimum and maximum = whiskers, circles and stars = 1.5 and 3 times
the interquartile range, respectively.

DL vs. MA Segmentation
Figure 17 summarizes MDA and DSC results over 11 test cases and compares DL
with our previously developed MA method for the same cohort 48. MDA and DSC for all
cardiac substructures improved with DL. Specifically, DSC agreement to ground-truth
increased 3-7% for chambers, 9-11% for the superior/inferior venae cavae and PV and
reached 23-35% for the coronary arteries. On average, MDA improved by ~1.4mm with
DL, with greatest agreement in the SVC (MDA = 0.99 ± 0.15 mm) and worst agreement
in the RCA (MDA = 1.97 ± 0.46 mm). For four test CTs, our DL method yielded LMCA
contours, whereas our previous atlas-based model failed to produce any segmentation.
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Overall, DL provided a significant improvement (P < 0.05) over the previous MA method
for every substructure in terms of MDA and DSC.

Figure 17: Agreement between manually drawn ground-truth and auto-segmentation
methods (Blue: Previous multi-atlas method (MA), Red: Novel DL method) over 11 test
cases. Left: Mean MDA, Right: Mean DSC.

Qualitative Analysis
Physician consensus scores are summarized in Figure 18. All patients had
clinically acceptable contours (score of 5) for the LV, RA, and RV (results not shown),
while the SVC, PA, and PV had clinically acceptable contours for 4/5 patients with DL.
For the cardiac chambers, 6/20 comparisons between DL and MA methods were
equivalent, while all others improved by at least one grade with DL. The LMCA and RCA
had the lowest average scores of 3.0 ± 1.0 and 3.8 ± 0.4, respectively, with all other
substructures scoring an average of ≥ 4.4. DL provided significant improvements (P <
0.05) over the MA method for the LADA, RCA, PV, PA, SVC, LA, RA, and RV.
Improvements in 44/60 (5 patients, 12 substructures) qualitative scores were observed
with DL. For only one instance, DL scored worse than MA (AA: grade 4 to 3). For two

63
LADA segmentations, MA yielded a grade of 1 (clinically unusable) and improved to a 5
(clinically acceptable) with DL (Figure 18, right).

Figure 18: Qualitative consensus scoring (not clinically acceptable, clinically acceptable
with major changes, clinically acceptable with moderate changes, clinically acceptable
with minor changes, clinically acceptable) of five patients for the multi-atlas (MA) and
deep-learning (DL) based image auto-segmentations (chambers not shown). For each
substructure column, the MA and DL methods are shown on the left and right,
respectively.

Discussion
This work presented a novel DL pipeline to segment sensitive cardiac
substructures using a 3D U-Net with the principal goal of applying to non-contrast CTSIM for RT planning. Data augmentation and CRF post-processing improved DL contour
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agreement with ground-truth. Overall, our method provided accurate segmentations of
the chambers, great vessels and PVs, and led to promising results in coronary artery
segmentation on non-contrast CT-SIM datasets178.
While cardiac substructure segmentation has been explored previously, to our
knowledge, none have included paired MR/CT multi-channel data inputs to yield robust
segmentations on non-contrast CT inputs. Several atlas segmentation methods have
been recently published48,132,155 and report cardiac chamber DSCs > 0.75. However,
these methods have had limited success segmenting coronary arteries as atlas methods
rely on image registration quality and are unable to consider large amounts of patient data
due to computational demands179. Our work parallels recent applications of DNNs where
CTCA scans specifically optimized for cardiac imaging were utilized. Here, DSC in the
RA (87.8%)157 and PA (85.1%)92 were within 1% of our DL method, while we were within
5% of their chamber segmentation results. Our work adds to the current literature by
including additional substructures and allowing for predictions to be made on non-contrast
CT-SIM scans.
Data augmentation improved DL segmentation accuracy by ~5% across all
substructures. Although no comparison values exist in the literature for cardiac
substructure segmentation, this value is consistent with studies performed on liver lesion
segmentation180,181. One extreme outlier (greater than 3 times the interquartile range)
observed for the RV in the left-right axis occurred for the worst-case patient (Figure 15,
left), where the heart was rotated clockwise and shifted posteriorly/left. While this patient’s
anatomy was an anomaly, this result may be addressed in the future by further
augmenting the data (i.e., rotation > 30o). Furthermore, both the LADA and RCA had
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larger centroid shifts in the superior-inferior plane (Figure 16, bottom). This can be further
visualized in Figure 15 (left), where the inferior extents of the LADAs and RCAs were
underrepresented with some narrowing of these substructures observed in the midline
axial slice. To address this, recent atlas-based methods have restricted the size of the
LADA to 4 mm throughout its entire length156. Nevertheless, our DL pipeline performed
well for coronary artery contours on non-contrast CTs (DSC ~ 0.50, MDA < 2.0 mm),
particularly as compared to recent atlas results where coronary artery (LADA, RCA, and
LMCA) DSCs ranged from 0.09-0.2748,132,155 and had MDAs > 4 mm132. Coronary artery
segmentations may be improved through the use of high resolution (0.78 x 0.78 x 1.6
mm3) CTCA92 that use contrast and yield DSCs ~ 60%182. Additionally, implementing a
Dice loss function weighted on the inverse of the class size may improve the results for
smaller substructures such as the coronary arteries. Originally proposed by Crum et al.183,
the generalized Dice loss function has been shown to improve hyperparameter
robustness for unbalanced tasks (i.e. when each class is not represented equally in the
dataset), and improve overall segmentation accuracy for small structures 184.
While rare cases involved the removal of spurious remote predictions that resided
within the ground-truth delineation, 3D-CRF led to an overall improvement in
segmentation agreement. The coronary arteries experienced the greatest improvement
from CRF post-processing, with the LCMA improving ~ 6% in DSC. Additionally, there
were improvements in MDA up to 1.21 mm and 1.96 mm for the LV and LA, respectively.
Aside from removing spurious outlying points, CRFs also improved the smoothed
appearance of the segmentations as needed for clinical application185. CRF tuning
required different parameters for cardiac substructures based on size and shape, much
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like the work completed by Rajchl et al.186. The improvement in segmentation agreement
observed, along with the use of a 3D-CRF to remove spurious isolated regions, parallels
other emerging uses of 3D-CRF post-processing in medical imaging187,188. Although this
study implemented CRFs as a post-processing step, some current studies have
integrated CRFs into the utilized neural network and have seen improved segmentation
performance173,174,189 and can be explored in future work for possible coronary artery
segmentation improvement.
The overall time to generate DL segmentations on pre-processed CT-SIM data
was rapid: 14 seconds for all 12 substructures. This value can be compared to Mortazi et
al. who segmented seven cardiac substructures in ~ 50 seconds on high resolution CTCA
and 17 seconds on MRI92. Moreover, our previous MA method required ~ 10 minutes to
generate substructure contours per patient without post-processing48.
Although the in-plane resolution was 0.7 x 0.7 mm2, our study may have been
limited by the 8 mm slice thickness of the MRI. Despite our data augmentation techniques,
increasing the training sample size may further improve segmentation results. However,
similar training and testing cohort sizes with augmentation have been used previously 190.
While paired cardiac MRI/CT data are commonly limited for cancer patients, the training
cohort may be expanded in the future by applying our DL model to generate additional
ground-truth segmentations. Data quantity may also be increased through utilizing
unlabeled images for unsupervised learning via generative models such as, a cycle-191 or
a stacked-192 GAN, which implement multiple GANs for data synthesis. Recently, Zhang
et al.158 proposed a novel cardiac chamber segmentation method using a GAN integrating
cycle- and shape-consistency. They obtained DSCs comparable to atlas segmentations
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(DSC ~ 0.75) on CT and MRI by using ~ 14% of real data and augmenting their dataset
by incorporating synthetic MRI and CT data into training. Our model may be enhanced
similarly by incorporating synthetic images in the network training, while also providing
additional substructures, such as pulmonary veins and coronary arteries. Nevertheless,
even with the current limited training dataset, our results outperform other currently
available approaches. As shown in Figure 14, training and validation results increased to
a point of stability with a difference of < 2% after convergence. Moreover, to further limit
potential overfitting in this more limited cohort, data augmentation (i.e., flipping, scaling,
rotating, and translating) and model regularization (dropout = 0.3) were implemented.
As both the CT and MR images were acquired in breath hold conditions,
respiratory motion is assumed to be negligible during this study. However, due to
extended scan times and heart rate, one limitation of this study is that numerous cardiac
cycles are captured during imaging. Thus, the substructures are represented by their
average position over the course of the scan and cardiac motion is not taken into
consideration. Currently, cardiac motion is not managed clinically due to limitations in
available treatment technologies. Nevertheless, the magnitude of cardiac motion is on the
order of 3-8 mm52 suggesting internal motion may be incorporated into future margin
design as has been previously proposed33,53.
As MR-guided RT and MR-only planning become more prevalent, future work will
include training an MR-only model. It has been recently recommended that the LADA be
included as an avoidance structure in RTP32, thus a natural clinical endpoint of this work
includes dosimetric analysis and implementing cardiac avoidance strategies via accurate
and efficient cardiac substructure segmentation made possible by DL.
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Conclusion
These promising results suggest that our novel DL application offers major
efficiency and accuracy gains for cardiac substructure segmentation over previously
published MA results, using only non-contrast CT inputs. Future work involves further
refinement of coronary artery segmentation using conditional random fields as a recurrent
neural network and through expanding the patient cohort. Coupled with robust margin
design, improved cardiac sparing in treatment planning can be realized.
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CHAPTER 5 “QUANTIFYING INTRA-FRACTION MOTION AND INTER-FRACTION
SETUP UNCERTIANTIES”
Part 1 “Characterizing Sensitive Cardiac Substructure Excursion due to
Respiration”
Introduction
Radiation dose to the heart from thoracic cancer treatments can increase the
possibility of the patient experiencing diseases such as ischemic heart disease,
cardiomyopathy, and artery atherosclerosis193,194. Currently, only whole heart dose
estimates are considered for RTP in clinical practice16. However, recent studies have
shown that dose to individual substructures in the heart may be better indicators of future
cardiac events than whole heart dose metrics28. The superior soft tissue contrast that MRI
provides allows for these sensitive cardiac substructures to be visualized. However, the
use of MRI for thoracic cancer treatment is not the standard of care due to technical and
accessibility limitations. For example, CT is more prevalent for diagnosis because it
allows for lung nodule depiction down to 1-2 mm195, whereas MRI is sensitive to lung
nodules of 5-11 mm196. Additionally, MRI may be limited in the diagnosis of lung cancers
due to susceptibility artifacts caused by several air-tissue interfaces197. Through the use
of MRI to inform cardiac substructure delineations on thoracic CT images, our objective
is to quantify substructure excursion during respiration to identify dominant axes of
displacement per substructure. Based on our segmentation work described previously,
we were able to incorporate sensitive cardiac substructures into the treatment planning
process, however accurate radiation dose assessment may be complicated by respiratory
motion influences198. An example of the displacement of the heart over the respiratory
cycle is shown in Figure 19.
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Figure 19 displays both an end-inhalation (EI, 0% phase) and end-exhalation (EE,
50%, phase) 4DCT image for a representative patient. In both the axial and sagittal views,
a delineation of the whole heart on the EI phase is shown in red to reveal the cardiac
displacement in various axes. Additionally, there is a difference map on the right side of
Figure 19 for all cardinal axes.

Figure 19: Example of whole heart displacement in between respiration at end
inhalation (0% phase, column 1) and end exhalation (50% phase, column 2). Difference
maps of the 0% minus the 50% phase are shown in column 3 with a representation in
each cardinal axis. The end inhalation delineation of the heart is shown on each image
in red.

Several motion management techniques, including but not limited to, gating and
breath-hold, have been incorporated clinically to manage a patient’s respiratory motion
during radiation treatment or image acquisition199. DIBH techniques have been
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implemented in cancer treatments to position the heart further from the irradiation field for
left breast cancer treatments. However, even minor displacements can have a large
dosimetric effect when using highly conformal radiation therapy techniques like intensity
modulated radiation therapy (IMRT) or volumetric modulated arc therapy (VMAT)50,200.
These dosimetric effects are heightened when small structures, like the coronary arteries,
are introduced201.
Various studies have reported on how intra-fractional motion affects dose delivery
to the heart from thoracic cancer treatments. A study by George et al. studied the effects
of intra-fractional motion for breast cancer treatments using IMRT at three different types
of respiration (i.e. shallow, normal, and heavy)202. They found that lung and heart dose
increase with respiration202. Yue et al. expanded on these findings by studying how intrafractional motion affects changes in DVH metrics for left breast treatments using 10-phase
4DCT203. They found the maximum dose to the heart can vary up to 6 Gy in respiration 203.
Along with studying how intra-fractional motion in RT affects the heart in left-sided breast
cancer treatments using 10-phase 4DCT, El-Sherif et al. included the LV, and LADA201.
They found that even though the 95% confidence interval of the four-dimensional dose
was ± 0.5 Gy for the whole heart, it varied ± 8.7 Gy for the LADA.
In a similar fashion, Guzhva et al. completed a study using 10-phase 4DCT on 20
patients to analyze the cardiac and respiratory combined intra-fractional motion influence
on 12 cardiac substructures for patients undergoing RT for thoracic cancers 50. Cardiac
substructure segmentations were completed on the 50% phase and then deformably
propagated to the remaining phases50. They found that the largest centroid displacements
from intra-fractional motion were in the craniocaudal axis (i.e. superior-inferior), and that
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the cardiac chambers experienced the smallest displacements overall (largest
displacements in the coronary vessels)50. The work presented our study builds upon the
current literature by providing population results and including additional cardiac
substructures, such as the LMCA and the great vessels (i.e. SVC, AA, and PA).
Additionally, the current study provides volume statistics across respiratory phases and
a dosimetric analysis.
In this study, we utilized 4DCT data and DIR to quantify the excursion of 12 cardiac
substructures along with the whole heart during respiration to characterize displacement
and identify dominant axes of excursion. The work completed here may be used to
complete a future study on generating an accurate motion model for cardiac
substructures, from which a robust safety margin can be defined. These safety margins
would ensure adequate cardiac sparing and potentially prevent patients from
experiencing future cardiac toxicities.
Methods
Patient Cohort and Imaging
Eleven patients with cancer (8 left-sided breast cancer and 3 lung cancer patients)
were retrospectively reviewed on an Institutional Review Board approved study
conducted at the Henry Ford Cancer Institute. These patients either underwent 4-phase
(n=8, breast cancer patients) or 10-phase (n=3, lung cancer patients) non-contrast
4DCTs. All patients were imaged with a respiratory correlated 4DCT and cardiac gated
T2-weighted MR in EE. Reconstructed data was exported from the clinical scanners and
de-identified for analysis. The EE phase of the 4DCT was rigidly registered with the EE
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MRI and the registration was refined with an assisted alignment surrounding the heart
using MIM (version 6.9.1, MIM Software Inc., Cleveland, OH).
Segmentation of Ground Truth
Thirteen cardiac substructures including the heart, left/right ventricle (LV/RV),
left/right atrium (LA/RA), pulmonary vein (PV), pulmonary artery (PA), ascending aorta
(AA), superior/inferior vena cava (SVC/IVC), left anterior descending artery (LADA), left
main coronary artery (LMCA), and right coronary artery (RCA) were automatically
segmented using multi-atlas48 (n=8) and deep learning techniques204 (n=3) that used
hybrid MRI/CT information on the EE phase of the 4DCTs. These EE delineations were
verified and if needed, corrected by a physician before propagating contours to the other
phases. All physician segmentation delineations and corrections followed a recent
consensus contouring guideline for cardiac substructure segmentation141.
Physician verified contours on the EE (i.e. 50% phase) of the 4DCT were deformed
to the other phases using a constrained, intensity-based, free-form DIR based on Demons
which minimizes the intensity differences between two single modality datasets205. The
Demons DIR technique, originally proposed by Thirion et al.206, is widely used for its
accuracy and computational efficiency207. This same DIR algorithm from MIM software
has been implemented in several other CT to CT DIR studies and achieved high
accuracy51,208,209. Specifically, Piper et al. applied a known deformation to a CT volume
and found that this deformable image registration technique averaged 1.1 mm error from
the gold standard145.
The location of each substructure at end-inhalation (0%), end-exhalation (50%),
and two intermediate phases (25-30%, 70-75%) were evaluated in this study. To conduct
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the DIR, a box-based assisted alignment around the heart is completed. The DIR
workflow creates a set of grid control points using a coarse-to-fine, multi-resolution
approach and incorporates user-specified DIR locks208. Regularization is added to
discourage folds and tears in the deformation field208. The multi-resolution approach
prioritizes larger registration differences and then refines the registration to account for
smaller local changes, which allows for anatomical alignment even when there are large
differences present due to respiration208. With regard to expected registration uncertainty,
residual registration deformation errors in the lung were 0.8 ± 0.4 mm208. Once DIR was
used to propagate cardiac substructure segmentations to each phase of the 4DCT, final
contour verification was conducted by a radiation oncologist.
Analysis for Statistical and Quantitative Comparisons
Measurements of centroid locations, volume at each respiratory phase, as well as
maximum excursion between phases were exported from MIM for subsequent analysis.
Maximum excursions in each direction were reported as mean ± SD. The displacements
that exceeded 5 mm for each of the 3 cardinal axes were evaluated based on guidance
provided by the respiratory motion management report produced by the American
Association of Physicist in Medicine Task Group report number 76210. Paired t-tests were
employed for statistical analysis of each substructure to compare volumes of the contours
between all 4 phases. Any P-value less than 0.05 was considered as a statistically
significant difference. All statistical analysis was performed using SPSS version 25.0
(SPSS, Chicago, IL, USA).
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Dosimetric Analysis
Dosimetric assessment included all patients (n=11) and plans were originally
completed on the 50% phase. Assessment consisted of tabulating the mean (Dmean) and
maximum dose (Dmax) and locating the largest dosimetric change over the respiratory
phases. As different treatment sites (i.e. breast lung) are represented in this patient
cohort, percent variation in dose was also used to assess population values.
Results
Cardiac Substructure Centroid Displacement Summary
Centroid displacements for the left-right (L-R), anterior-posterior (A-P), superiorinferior (S-I), and vector shifts for the patient population are shown in Figure 20. Maximal
vector displacements ranged from 5-10 mm across substructures. Vector displacements
were largest for the IVC and the RCA, with displacements up to 17.9 mm. Of the three
cardinal axes, intra-fraction centroid displacements were observed to be the largest in the
S-I axis. Maximum displacements of greater than 5 mm were found for 24.8%, 8.5%, and
64.5% of the cases in the L-R, A-P, and S-I axes, respectively. As shown by the green
boxplots in Figure 20, 10 of the 13 structures considered in this study had median intrafraction centroid displacements that were equal to or greater than 5 mm of displacement
in the S-I axis, as shown in Figure 20. Further, only the S-I axis had a 95th data percentile
that extended past 15 mm (IVC). For 10/13 studied cardiac structures, data for the first
three quartiles was less than 5 mm in the L-R axis. With regard to outliers, seven out of
eight of the substructure outliers in the L-R axis can be attributed to a single patient, as
discussed further in Figure 22. Over all substructures, the A-P was the axis with the least
excursion. As shown in Figure 20, median excursions for 11/13 structures were smallest
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in the A-P axis. Table 5 also summarizes the L-R, A-P, and S-I maximal displacements
for each cardiac substructure over the patient population.

Figure 20: Intra-fraction centroid displacement comparison between all 13 structures for
each direction: left-right, anterior-posterior, superior-inferior, and vector. Boxplots, thick
line, and whiskers represent the interquartile range (IQR), median, and 5th and 95th
percentiles, respectively. Data points displayed as a small circle represent a value
greater than 1.5 times the IQR and the star represents a value greater than 3 times the
IQR.

With regard to regional displacement, Table 5 reveals that the great vessels (i.e.
the AA, SVC, and PA) had the least amount of excursion along each axis, also confirmed
by Figure 20. Both the IVC and the RCA, cardiac substructures at the inferior aspect of
the heart, had maximal centroid displacements that were greater than 15 mm. Figure 20
and Table 5 also reveal that the IVC was the substructure with the largest displacements
in the S-I axis. For the RCA, nine out of 11 patients had centroid displacements that
exceed 5 mm in the S-I axis while the IVC had eight patients exceed this threshold. The
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RCA and IVC each had the largest maximum vector displacements of greater than 9 mm,
as shown by Table 5.
Substructure

L-R (mm)

A-P (mm)

S-I (mm)

Vector (mm)

Heart (n=9)

2.5 ± 2.7

1.5 ± 1.4

5.9 ± 2.5

6.6 ± 3.1

LV

3.1 ± 2.6

2.4 ± 1.8

6.3 ± 2.8

7.6 ± 3.4

LA

3.4 ± 2.0

1.9 ± 1.3

6.0 ± 2.2

7.0 ± 2.7

RV

3.9 ± 3.1

2.1 ± 1.4

6.1 ± 3.0

7.7 ± 3.6

RA

3.7 ± 2.5

2.1 ± 1.7

6.2 ± 2.6

7.5 ± 3.1

PA

2.9 ± 2.2

1.6 ± 1.1

4.9 ± 2.0

6.0 ± 2.5

AA

3.1 ± 2.5

1.4 ± 0.6

4.0 ± 1.7

5.4 ± 2.4

SVC

2.8 ± 2.6

1.4 ± 0.9

5.0 ± 2.3

5.7 ± 2.8

PV

3.9 ± 2.6

2.0 ± 1.2

5.2 ± 1.6

6.5 ± 2.5

IVC

3.2 ± 2.7

3.8 ± 2.5

8.5 ± 3.3

9.8 ± 3.4

RCA

5.3 ± 4.1

2.6 ± 1.2

7.8 ± 3.7

9.8 ± 4.1

LADA

3.0 ± 1.5

4.1 ± 1.3

7.1 ± 2.6

8.7 ± 2.5

LMCA

5.0 ± 3.5

2.7 ± 2.0

5.8 ± 2.4

8.2 ± 3.1

Table 5: Maximum displacement of individual cardiac substructures over 11 patients
throughout the respiratory cycle in each cardinal axis (left-right (L-R), anterior-posterior
(A-P), and superior-inferior (S-I)) and vector displacements. Substructure abbreviations
defined in the text.

Volume and Statistical Analysis
The paired t-tests revealed that out of 39 volume comparisons per patient (13
structures, 4 phases), there were 4 instances in total where P < 0.05 for the volume
comparisons, showing reasonable maintenance of geometric and anatomical properties.
The average volume of the whole heart across all patients at the 50% phase was 742.9
cc. On average, the percent difference in volume for the whole heart between the 0% and
50% phases was 1.2 ± 0.5 %. The cardiac substructures with the largest variabilities in
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volume between EE and EI had average volumes greater than 70 cc (PA and cardiac
chambers) and are shown in Figure 21. The RA was the cardiac substructure with the
largest volume differences between EE and EI of 7.8 ± 6.5 % (range: 0.9 to 20.2 %).

Volume Percent Difference Comparison
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Figure 21: Volume percent difference between end-inhalation and end-exhalation for
select substructures over all studied patients

Excursion analysis of the 4-phase 4DCTs revealed that 52.5% and 31.9% of
maximum excursions occurred between the 0 and 50%, and the 0 and 70% (or 75%)
trajectories, respectively. Maximum excursions only occurred between the 0 and 30% (or
25%) phases 6.4% (9/141 instances) of the time.
Individual Patient Cases
Figure 22 shows substructure excursion between the 0% phase (bottom row) and
the 50% phase (top row) images for two representative patients. Results for these
patients are also shown in both the axial and sagittal axes. Patient 1 (Figure 22, left) was
selected as it experienced minimal centroid displacement for cardiac substructures over
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respiration. Patient 1 had smaller than average vector displacements for 11/13 cardiac
structures (LMCA had the largest vector excursion for this patient of 11.8 mm).
Even though the largest displacements were observed in the S-I axis across the
population (as stated in the section above), Figure 22 also shows Patient 9 (Figure 22,
right) as they experienced the largest L-R displacement across patients. This patient
exhibited the largest substructure displacements in the L-R axis (contrary to the S-I
tendency), with L-R intra-fraction displacements for 12 out of 13 cardiac structures
exceeding 5 mm and displacements up to 13.5 mm for the LADA. In reference to Figure
20, Patient 9 (Figure 22, right) accounts for eight out of nine of the substructure outliers
in the L-R axis (blue dots and stars). In the S-I axis, Patient 9 had centroid displacements
for all substructures greater than 5.0 mm and up to 8.7 mm.
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Figure 22: Two representative patients showing substructure excursion between 0%
(bottom row) and 50% phase (top row) images with the contours from each phase
shown on both image sets for the axial and the sagittal axes. Left: Patient 1 selected for
minimal displacement over respiration. Right: Patient 9 chosen for largest left-right (L-R)
displacement across patients. Cardiac substructure abbreviations are defined in the
text.

Figure 23 displays results for Patient 3, where the average displacements across
substructures for the L-R, A-P, and S-I directions were 5.1 ± 3.1 mm, 2.2 ± 1.6 mm, and
10.0 ± 3.8 mm, respectively. As can be seen, there were intra-fraction centroid
displacements for the RA and LV in the L-R axis (axial view of the 0% phase image),
while the LA and RV had negligible displacements (less than 1 mm). The sagittal view,
on the left of Figure 23, emphasizes that the maximum displacements occur in the S-I
axis for the LA, AA, and heart. The large excursions found for this case may be attributed
to the patient’s abnormal anatomy of preceding scoliosis. Additionally, the heart is rotated
into the left lung as can be seen in Figure 23.
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Figure 23: Representative patient (Patient 3) showing substructure excursion between
0% (bottom row) and 50% phase (top row) images with the contours from each phase
shown on both image sets for the axial (right) and the sagittal (left) planes.

Dosimetric Analysis
Over the eight studied breast cancer patients, the LADA Dmean varied 3.03±1.75
Gy (range: 0.53 to 5.18) throughout respiration. Whereas, whole heart D mean changed
0.18±0.09 Gy (range: 0.06 to 0.37). Figure 24 shows two representative breast cancer
patients with the heart, ventricles, and LADA displayed over respiratory phases. Both
Patient 2 and Patient 6 were treated to 42.72 Gy in 16 fractions for a stage 1A malignant
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neoplasm of the left breast. For these patients the LADA (Figure 6, green) had a D mean
that varied >3.5 Gy in respiration.

Figure 24: Dose volume histograms for Patients 2 (Left) and 6 (Right) showing the
dosimetric variation across respiratory phases for the heart and select cardiac
substructures. Substructure color gradient transitions from dark to light as the
respiratory phases pass from the 0% to the 70% phase, respectively. Cardiac
substructure abbreviations defined in the text.

Patient 9 (shown in Figure 22, right) received RT for a malignant neoplasm of the
upper right lung bronchus (non-small cell lung cancer) of 60 Gy in 20 fractions. Of the
three lung cancer patients studied, Patient 9 experienced the largest changes in dose
across respiratory phases, which is shown in Figure 25. Patient 9 experienced an average
change in Dmax of 3.2±2.9 Gy (range: 0.46 (PA) to 9.05 Gy (RA)) across cardiac
substructures. With regard to Dmean, the average change across substructures was
2.2±1.8 Gy. For the other two lung cancer patients, no cardiac substructure had Dmean
differences >1.4 Gy (Dmax differences up to 5.6 Gy).
Figure 25 shows DVHs for Patient 9 displaying the dosimetric variation across
respiratory phases for the great vessels (top), the cardiac chambers (middle), and the
coronary arteries (bottom). Each DVH also shows the dosimetric variation in respiration
across the whole heart, which is shown in red. The great vessels and chambers had more
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variation in dose throughout respiration as compared to the whole heart (Figure 25).
Specifically, although changes in Dmean for the heart were <0.5 Gy, the SVC (shown in
blue in Figure 25, top) had a Dmean difference up to 5.4 Gy. The bottom of Figure 25 also
shows a DVH displaying coronary artery dosimetric variation in respiration. The LMCA,
shown in burgundy, experienced a change in Dmean up to 4.6 Gy.
Patient 3, represented in Figure 23, received RT for a malignant neoplasm of the
left breast (state IIIA, T2, N2) of 45 Gy in 25 fractions. Between the 25% and 75% phase,
the RV experienced an 8.7 Gy change in Dmax. Regarding Dmean, the LADA experienced
a 4.2 Gy change between the 0% and 25% phases. For both Patient 3 and Patient 9
however, changes in Dmax and Dmean for the heart were <0.5 Gy. The DVHs outlined
highlight an increased dosimetric sensitivity through local dose changes that is not
captured by the whole heart.
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Figure 25: Dose volume histograms for Patient 9 showing the dosimetric variation
across respiratory phases for the great vessels (top), the cardiac chambers (middle),
and the coronary arteries (bottom). Substructure color gradient transitions from dark to
light as the respiratory phases pass from the 0% to the 70% phase, respectively.
Cardiac substructure abbreviations are defined in the text.
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Discussion
By leveraging multi-phase 4DCT data, this work sought to quantify the intrafractional displacement of sensitive cardiac substructures throughout the respiratory
cycle. Automatic segmentations were generated on the 50% phase of the 4DCT using
previously validated multi-atlas and deep learning methods48,204. DIR was used to
propagate physician delineated ground truth segmentations of 12 cardiac substructures
and the whole heart to all other 4DCT phases. Intra-fraction centroid displacements over
the 4DCT data were analyzed to determine the dominant axes of excursion.
While other studies have evaluated intra-fraction heart displacement, our work
helps to further quantify the primary axis of the displacement by quantitatively defining
the excursion of the substructures contained within the heart. The work completed in this
study is similar to that of a study by Guzhva et al. where they utilized 4DCT data with
contour propagation in order to show the displacement experienced by the heart and its
substructures due to respiration50. Guzhva et al. also propagated from the 50% phase to
the other phases and then manually revised segmentations for final analysis50. They
found that vector intra-fractional displacement of the cardiac substructures ranged from
7 to 15 mm and was dominantly in the S-I axis50. Similarly, our work agrees with those
findings in that substructure excursion from respiration was predominantly in the S-I axis,
and maximal vector displacements ranged from 5 to 10 mm. Our study improved on the
work conducted by Guzhva et al. by considering the LMCA and the LADA as separate
cardiac substructures and through the consideration of the great vessels (i.e. SVC, PA,
and AA)50. The current study also considered radiation dose and cardiac substructure
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volume at different phases in respiration. However, both studies were limited as neither
accounted for inter-observer contouring variability.
With regard to the volume comparison between substructure volumes at EE and
EI, it was found that the whole heart volume had small insignificant changes (~1%), which
parallels results by Yue et al.203. Moreover, the dosimetric analysis in this work revealed
that, although changes in Dmean and Dmax for the whole heart were less sensitive to
respiration (< 0.5 Gy), large dose differences for individual substructures were
experienced. This study also found that cardiac substructures towards the superior extent
of the heart, the great vessels (i.e. AA, SVC, and PA), had the smallest displacements in
each axis, where substructures at the inferior extent of the heart, the RCA and the IVC,
had the largest displacements. Limited data are available for direct comparison, however
it has been reported that tumor excursion in caudal lung lobes displace the most over the
respiratory cycle211. Additionally, in a study by Wang et al., their 4DCT data showed that
lung tumors with close proximity to the diaphragm experienced the most respiratory
motion212. In the present study, the largest substructure centroid displacements occurred
for the IVC, which is located at the inferior aspect of the heart, and passes through the
diaphragm at the vena caval foramen213.
One limitation of this work is that the intra-fraction motion of cardiac substructures
occurred in free breathing respiration and not under DIBH conditions. There have been
abundant studies confirming that DIBH reduced cardiotoxicity risk214. However, it has also
been shown that this reduction in risk may be accompanied by large inter-fraction setup
errors215-217. The limitation of uncertainties associated with the DIR process (as outlined
by American Association of Physicist in Medicine Task Group report number 132 218) were
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mitigated as segmentations at each phase of respiration were manually verified and
corrected. Another limitation is that isolating cardiac excursion was not possible with
respiratory-correlated 4DCTs, and thus, the excursions presented in this work
represented a contribution from both respiratory and cardiac motion. However, it has been
previously reported by Tan et al. that the LV and coronary arteries are the most mobile
cardiac substructures through the cardiac cycle, displacing between 3-8 mm between
end-diastolic and end-systolic phases in three dimensions52. Thus, cardiac motion may
be managed through incorporation in future planning organ at risk volume design. This
work may also be limited in that only four phases of the 4DCT were used instead of 10.
However, in a recent 10-phase 4DCT study, there was no mention that all 10 phases
were required or were at all advantageous over 4-phase 4DCT50. Additionally, our study
presents statistics on which phases the maximum centroid displacement occurred
between, which is a unique contribution.
This work included both breast and lung cancer patients, which may have
contributed to differing dominant axes of motion from cardiac and respiration influences.
Guzhva et al. did find that patients with Hodgkin’s lymphoma had a tendency to have
larger displacements in the S-I axis than patients with lung cancer, which could be due to
the comorbidities accompanying smoking or otherwise compromised lung function (i.e. a
hyperinflated lung)50. Therefore, inconsistencies in patient anatomy could also cause
uncertainty in determining the dominant axes of excursion and may be circumvented
through expanding the patient cohort, or grouping by disease site. Nevertheless, this work
was done in order to validate the need for consideration of cardiac substructures through
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the incorporation of a motion model. This would provide an opportunity to decrease
cardiotoxicity risk during radiotherapy treatment.
Conclusion
This work characterized the independent intra-fraction displacement of the cardiac
substructures through the respiratory cycle. This work has importance for possible cardiac
substructure PRV generation for patients who are unable to comply with breath-hold
conditions for thoracic cancer treatments. Future work to determine the dosimetric effect
of sensitive cardiac substructure displacement in respiration is warranted.

89
Part 2 “Inter-Fraction Cardiac Substructure Displacement Assessed Via MRGuided Radiation Therapy”
Introduction
RT doses to the heart are strongly linked to cardiac toxicities such as coronary
heart disease, heart failure, and even cardiac death 15,16. Cardiotoxicity is often reported
for breast, lung, and esophageal cancers as well as Hodgkin's disease5,6,8. In RTOG
061726 evaluating dose escalation for locally advanced NSCLC, volumes of the heart
receiving ≥ 5 and ≥ 30 Gy were independent predictors of a patients’ quality of life27 and
overall survival26. Yet, the heart is complex and dose to substructures (e.g., coronary
arteries, ventricles, atria, great vessels, etc.) contained within the heart have been
strongly linked to radiation-induced cardiac morbidity30 and future acute coronary
events28,219. Thus, recent attention has been focused toward local radiation dose
deposition to substructures contained within the heart. Sub-analysis of RTOG 0617
revealed that atrial, ventricular, and pericardial doses showed a stronger association with
overall survival than using standard whole heart dose metrics40,41,220. Furthermore, an
association has been found between the incidence of coronary stenosis to the radiation
dose received by the coronary arteries221, thus underscoring the need for cardiac
substructure-specific dose assessment.
However, one significant challenge with assessing dose to cardiac substructures
is that they are difficult to discern on non-contrast treatment planning CTs and not typically
considered in the treatment planning process18 due to their limited soft tissue contrast as
shown in Figure 26 (center). MRI, on the other hand, substantially improves the visibility
of cardiac substructures (Figure 26, right)43,44. Magnetic resonance-guided RT (MRgRT)
offers significant advantages compared to x-ray based technologies for delineation,
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localization, tumor tracking, and adaptive radiation therapy. Tumor and OAR visualization
using 0.35 T MRgRT has been shown to be superior to cone-beam computed tomography
(CBCT)222. MRgRT allows for simultaneous tracking to monitor intra-fraction motion
during treatment delivery223 while avoiding radiation exposure due to the continuous
imaging.
In a prospective Phase 1 trial for MR-guided adaptive radiation therapy for ultracentral lung cancer, the proximity of the lesion to the heart triggered plan adaptation for
multiple treatment fractions, suggesting that inter-fraction displacement of the heart may
be substantial224. Prior studies have shown that the average inter-fraction displacements
of the whole heart and the LADA are typically < 7 mm in each orthogonal direction with
the S-I displacement typically the greatest due to diaphragm motion 49,225,226. To date,
limited data are available to quantify inter-fraction displacement of other substructures
other than the LADA. This study sought to leverage longitudinal MRgRT data to quantify
inter-fraction displacements of 12 cardiac substructures to facilitate safety margin design.
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Figure 26: (Top Left) ViewRay MR-linear accelerator, and two patient examples
showing: (Middle) Treatment Planning CT that is low contrast and does not show
sensitive cardiac substructures, (Right) 0.35 Tesla MR dataset with cardiac substructure
contours evident and delineated via deep learning-based segmentation. Abbreviations
defined in the text.

Methods
Patient Methods for Low-field MRI
After obtaining Institutional Review Board approval, we retrospectively analyzed
radiotherapy treatment data for 20 patients who underwent daily MRgRT using a ViewRay
MRIdian 0.35T MR-linac (ViewRay, Mountain View, CA) (Figure 26, top left). Eleven
patients had lung masses (64% metastatic and 36% primary bronchogenic malignancies),
five had mediastinal and chest wall lesions, and the remaining four patients had liver
tumors (i.e. hepatocellular carcinoma). SBRT was prescribed to 75% of the study cohort
(4-5 fractions/patient) and the remaining were treated with conventionally fractionated
IMRT (14-30 fractions/patient). All cases underwent 0.35 T MRI simulation (MR-SIM) on
the MR-linac in the same respiratory condition used for treatment (11 imaged in EE, 7 in
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EI, and two in free breathing). Breath-hold scans were conducted using a 17-25 second
acquisition (1.5×1.5×3.0 mm3 resolution) while the free breathing scans utilized a 3minute acquisition (1.5×1.5×1.5 mm3 resolution). For each image acquisition, a b-SSFP
sequence was utilized (TrueFISP, Siemens, MAGNETOM Avanto, Syngo MR B19).
TrueFISP is commonly used in cardiac imaging due to its high signal-to-noise ratio and
imperviousness to motion artifacts227,228. The first 3-4 daily MR scans for all cases were
evaluated for cardiac substructure displacement (total = 79 fractions).
Cardiac Substructure Segmentation
Inter-fraction motion was assessed for 12 cardiac substructures including the
left/right atria (LA, RA), ventricles (LV, RV), superior/inferior venae cavae (SVC, IVC),
ascending aorta (AA), pulmonary artery/veins (PA, PV), LADA, right coronary artery
(RCA), and left main coronary artery (LMCA). Of the 20 total patients studied, initial
cardiac substructure segmentations were generated on MR-SIM datasets using a
previously validated cardiac substructure segmentation atlas48 for 11 patients. For the
remaining 9 patients, cardiac substructures were automatically generated using a threedimensional deep learning U-Net204 that was developed at a later date. The deep learning
U-Net was implemented as it yielded reductions in substructure generation time and
improved segmentation accuracy as compared to the atlas method. After the
substructures were segmented on the initial MR-SIM image, the outputted segmentations
were validated by one of two radiation oncologists. Contours underwent final verification
by the more experienced of the two radiation oncologists with manual modifications made
as needed to ensure clinically viable segmentations were rendered regardless of the initial
segmentation approach.
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A commercially available intensity-based free-form DIR algorithm (MIM Software,
Cleveland, OH) was used to propagate contours from the MR-SIM image to each daily
MRI, yielding a total of 3-4 registrations per patient (79 unique daily MRIs across all
patients). Final propagated contours were again verified by one of two radiation
oncologists and corrected as needed. In order to assess the inter-fraction substructure
displacement due to daily patient positioning, a final translation-only rigid registration
between the MR-SIM image and each daily MRI was performed by a physicist with an
emphasis on aligning the PTVs. Figure 27 displays an example of substructure variation
in position at breath-hold between MR-SIM and daily fractions for a representative patient.

Figure 27: Example of substructure variation in position at breath-hold between MR
simulation (MR-SIM, left), daily fraction 1 (center), and daily fraction 4 (right) for a
representative patient. Substructure abbreviations are defined in the text.

Statistical Analysis and Data Extraction
A MIM workflow was developed to export centroid and volume information for the
substructures after tumor-based rigid registrations. Inter-fraction differences for each
cardiac substructure were quantified via centroid analysis in each cardinal direction, as
well as in vector displacement. A two-tailed Wilcoxon signed ranks test was used to test
for statistically significant differences in volume between the MR-SIM and each daily MRI,
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for each substructure. A P-value less than 0.05 was considered statistically significant.
All statistical analyses were conducted using SPSS version 26.0 (SPSS, Chicago, IL).
Planning Organ at Risk Volume Generation
ICRU 62 recommends the inclusion of a margin for OARs for the consideration of
geometric uncertainties in RT229,230. This margin, called the planning organ at risk volume
(PRV), is a measure to account for both systematic and random uncertainties in the
radiation therapy process230. Random errors in RT can cause the dose distribution to blur
by displacing high/low isodose lines closer/further from the region of interest 230.
Systematic errors displace the entire dose distribution closer or further from the region of
interest230. Using the MR-SIM as the reference, mean centroid displacements and SD for
each patient and substructure were calculated. The systematic error (Σ) was calculated
by taking the SD of the mean displacement and the random error (σ) by calculating the
root-mean-square of the SD53. Of note is that a measure of uncertainty induced by
breathing is not included in this calculation as 18 out of 20 patients were treated in breathhold conditions231. The PRV was calculated to accommodate daily setup variations based
on a previous study by McKenzie et al.230 with coefficients selected where the PRV
maximum dose does not exceed the OAR maximum dose in 90% of cases230,231.
𝑃𝑅𝑉 = 1.3 ∗ 𝛴 + 0.5 ∗ 𝜎

(13)

Results
Patient Population Results
Across the heart and substructures, inter-fraction displacements for 18.5% (L-R),
17.4% (A-P), and 23.1% (S-I) fractions were greater than 5 mm. Fewer than 3.7% of all
structures displaced at least 10 mm in any direction over the studied fractions, and these
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were often due to lack of compliance with breath-hold conditions. Table 6 summarizes
the maximum excursions across the patient population for all cardiac substructures in the
L-R, A-P, S-I, and vector displacements.

Structure
Heart (average ± SD mm)
% within 10 mm
% within 5 mm
Left/Right Ventricles

Left/Right Atria

Great Vessels

Left Anterior Descending Artery

Right Coronary Artery

Left Main Coronary Artery

L-R
2.5 ± 1.6
100.0
91.4
3.0 ± 2.8
96.2
83.5
3.0 ± 2.5
96.8
82.3
2.7 ± 2.4
97.5
87.8
3.6 ± 3.5
94.9
75.9
3.7 ± 3.0
96.2
69.6
4.1 ± 4.2
91.1
78.5

A-P
1.6 ± 1.7
100.0
91.4
2.9 ± 3.0
96.8
82.3
2.8 ± 2.8
96.8
82.9
2.3 ± 2.4
98.3
86.9
4.7 ± 4.4
89.9
65.8
3.7 ± 3.3
93.7
73.4
2.8 ± 2.8
96.2
87.3

S-I
3.1 ± 2.3
100.0
85.7
2.9 ± 2.5
97.5
80.4
3.2 ± 2.9
96.2
81
3.1 ± 2.5
98.3
80.2
3.9 ± 3.4
94.9
65.8
4.2 ± 3.1
93.7
65.8
3.4 ± 3.0
94.9
74.7

Vector
4.8 ± 2.4
94.3
57.1
5.9 ± 3.7
89.2
48.7
5.9 ± 3.8
88.6
46.8
5.5 ± 3.2
92.4
51.9
8.2 ± 5.1
74.7
30.4
7.5 ± 4.3
74.7
36.7
6.9 ± 4.7
84.8
43.0

Table 6: Average displacement for heart substructures for all studied MRI guided
radiation therapy fractions with respect to the MRI simulation. Abbreviations Left-Right
(L-R), Anterior-Posterior (A-P), Superior-Inferior (S-I).

For the chambers, the median absolute displacements were 2.4, 1.8, and 2.4 mm
in the L-R, A-P, and S-I directions, respectively. The RCA shifted similarly in all axes
(median shifts 3.3-3.9 mm) whereas the LADA had the highest A-P, S-I, and vector shifts
of all substructures evaluated. The great vessels (i.e. SVC, PA, and AA) showed a
tendency to have larger displacements in the S-I direction, with 44.7% of shifts being
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greater than 3 mm, whereas only 35.4 and 26.6% of displacements were observed in the
L-R and A-P directions, respectively. Larger S-I displacements likely reflect the larger
axial MRI slice thickness (3 mm vs. 1.5 mm) for most (18/20) patients.

Figure 28: (Top row) Left ventricle and left anterior descending artery (bottom row)
displacement across all treatment fractions with respect to positioning at MR simulation
across each cardinal axis.

Figure 28 shows the absolute centroid shifts from the MR-SIM for the LV (top) and
LADA (bottom) across all four treatment fractions and in the L-R (Figure 28, left), A-P
(Figure 28, center), and S-I (Figure 28, right) axis. Patients 7 and 11 exhibited the largest
shifts (greater than 10 mm) in the L-R axis for the LV. Patient 7, who underwent SBRT
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for an enlarged mediastinal lymph node is shown in the top row of Figure 29. Figure
29 shows the MR-SIM image (left) and the fraction 4 MR image (right) localized to the
centroid of the LV. Note the marked movement of LV, RV, LADA, RCA and RA in contrast
to the heart that encountered minimal movement. Substructure delineations from each
scan are represented on both images and reveal substructure shifts after a translationonly rigid registration to align the PTVs. Similarly, Patient 11 exhibited the largest
displacement of the LV between MR-SIM and the fourth treatment fraction in the L-R axis.
Patient 11 underwent RT for a malignant neoplasm of the lower left lung lobe and is
represented in the bottom row of Figure 29.
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Figure 29: Patients 7 (top two rows) and 11 (bottom two rows) who experienced large
left-right shifts between MR-simulation (left) and daily treatment (right). For each patient,
both axial and coronal views are displayed for both the MR-simulation and the daily
treatment. The lung contours highlight the lack of breath-hold compliance.
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While most LADA shifts shown in Figure 28 were less than 10 mm, fraction 3 for
patient 6 had a LADA centroid shift greater than 18 mm. Patient 6 received SBRT for a
pulmonary nodule and is represented in Figure 30. Figure 30 shows both the axial (top
row) and sagittal (bottom row) axes at the centroid of the LADA with the planned treatment
dose. Note the marked movement of RV, LV, and LADA displacement, particularly in the
inferior direction, moving the substructures further away from the high dose region.
Substructure delineations from both the MR-SIM and fraction 3 images are represented
on both images and represent substructure shifts after a translation-only rigid registration
to align the PTVs.

Figure 30: Displacement of cardiac substructures and planned dose between the 0.35 T
MR simulation on axial (top row) and sagittal (bottom row) axes compared to fraction 3
0.35 T MRI for Patient 6 undergoing stereotactic body radiation therapy for a pulmonary
nodule. Substructure abbreviations defined in the text.

Patient 20 received SBRT for an anterior liver dome hepatocellular carcinoma and
is represented in Figure 31. SBRT localization at our institution includes an initial bony
alignment conducted at breath-hold and then breath-hold compliance is assessed using
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landmarks such as the dome of the diaphragm or liver. Once confirmed, a soft tissue
match is then conducted in the tumor region. In the case of Patient 20, Fraction 2, the
clinical net soft tissue correction from bony alignment for this case was 1.35 cm in the
lateral direction. Figure 31 shows the displacement of select cardiac substructures
between the MR-SIM (Figure 31, top left) and the second treatment fraction (Figure 31,
top right) along with the planned dose. Figure 31 also highlights a DVH illustrating the
expected dose to cardiac substructures at both timepoints. As can be seen in Figure 28,
Patient 20 had the largest centroid displacement for the LV over any other displacement
in the A-P axis. Additionally, the second fraction of this patient’s treatment, shown in
Figure 31, had centroid displacements for the LV greater than any other fraction for this
patient by more than 5 mm. The DVH shown in Figure 31 shows that after the alignment
of the treatment target shown in red, the substructures in the fraction 2 placement
received additional radiation dose. More specifically, the mean dose to the IVC increased
by 3.6 Gy when comparing MR-SIM planning dose to the second treatment fraction.
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Figure 31: Top Row: Displacement of cardiac substructures and planned dose between
MR-simulation (MR-SIM) in an axial view compared to fraction 2 MR for Patient 20
receiving stereotactic body radiation therapy for anterior liver dome hepatocellular
carcinoma. Bottom: Dose Volume Histogram (DVH) showing planning dose to cardiac
substructures at both timepoints. Substructure abbreviations defined in the text.

Planning Organ at Risk Volume Calculation
Table 7 shows the calculated systematic and random errors across cardiac
substructures, as well as the PRV.
Systematic Error (Σ)

Random Error (σ)

PRV (mm)

Substructure

L-R

A-P

S-I

L-R

A-P

S-I

L-R

A-P

S-I

LV

2.19

2.25

1.97

2.16

2.30

2.07

4

4

4

LA

2.29

2.24

2.72

1.79

2.05

1.91

4

4

4

RV

2.16

1.87

1.70

1.89

1.97

1.92

4

3

3
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RA

1.86

2.28

2.04

1.64

2.14

2.23

3

4

4

PV

2.17

1.67

1.66

2.33

1.92

2.13

4

3

3

PA

1.91

1.46

1.81

1.98

2.02

1.86

3

3

3

AA

2.12

1.74

1.93

1.60

1.88

1.98

4

3

3

SVC

1.76

2.19

1.61

1.62

1.72

2.29

3

4

3

IVC

1.27

1.88

2.67

2.20

2.12

2.92

3

4

5

RCA

2.37

2.32

2.33

2.17

2.81

2.43

4

4

4

LADA

2.74

2.53

2.69

2.51

3.23

2.60

5

5

5

LMCA

3.11

1.86

2.31

3.24

2.39

2.23

6

4

4

Table 7: Systematic (left) and random error (center) used to calculate the planning
organ at risk volume (PRV) (right) across 12 cardiac substructures for the population (n
= 20)

As shown by Table 7, isotropic margins of 4 mm were determined for the LV, LA,
and RCA. The largest isotropic margin of 5 mm was calculated for the LADA, while the
LMCA had a 6 mm margin in the L-R axis. The great vessels (i.e. SVC, PA, AA)
experienced the smallest PRVs with the majority of axes being 3 mm.
Discussion
By leveraging MRgRT, this work sought to quantify the inter-fraction displacement
of sensitive cardiac substructures over the SBRT treatment course. Recent MRgRT
advances and auto-segmentation work were utilized to accurately and efficiently delineate
12 cardiac substructures. Centroid shifts over unique longitudinal MRgRT data were
analyzed and allowed for safety margin design.
The trends observed in this current work are largely consistent with those from
prior studies. One study by Jagsi et al. investigated the inter-fraction reproducibility of the
LADA of 10 patients who underwent adjuvant RT for breast cancer under active breathing
control49. The displacements of the LADA from the planning CT scan to that from 11
treatment fractions were assessed at EE and DIBH states with spine-based image
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registration49. They reported the long-term reproducibility, defined as the SD, of the LADA
position to be 4.5 mm in the L-R, 3.3 mm in the A-P, and 6.0 mm in the S-I axis at EE,
and 2.7 mm in the L-R, 3.4 mm in the A-P, and 6.8 mm in the S-I axis during DIBH49. In
the current study, the displacements of the LADA were 3.6 ± 3.5 mm (L-R), 4.7 ± 4.4 mm
(A-P), and 3.9 ± 3.4 mm (S-I) which are consistent with the values reported by Jagsi et
al.49. Two prior studies investigated the inter-fraction displacement of the heart. One
series by Alderliesten et al. included breast cancer patients who received adjuvant RT at
DIBH215. The heart position relative to the breast surface, as captured by surface imaging
with AlignRT system, was measured with a planning CT and daily CBCTs215. Based on
data from 378 fractions of 20 patients, the displacement of the heart was 2.1 ± 2.0 mm
(L-R), 0.8 ± 3.3 mm (A-P), and -2.2 ± 7.8 mm (S-I)215. In a similar study by Comsa et al.,
the largest average “shift of heart position” (measured as the distance between the heart
and the chest on daily CBCT images) at moderate DIBH in five breast cancer patients
was reported to be 6.2 mm226. In comparison, our study reported a heart displacement of
2.5 ± 1.6 mm (L-R), 1.6 ± 1.7 mm (A-P), 3.1 ± 2.3 mm (S-I), and 4.8 ± 2.4 mm (vector),
which agree with these prior studies. However, our study is unique as it is the first study
to report inter-fraction displacements of several cardiac structures other than the heart
and LADA.
PRVs for 12 cardiac substructures were calculated in this study. Li et al. utilized
20-phase electrocardiogram gated data and a reference of the end-systolic phase to
determine PRVs for coronary arteries53. Using the method of margin calculation
mentioned here (previously proposed by McKenzie et al. for small and/or serial
organs230), they calculated a range of margins between 3-8 mm53. Similarly, Topolnjak et
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al. studied the geometrical uncertainty of the heart using left-sided breast cancer
patients231. They calculated PRVs from inter-fractional motion of the whole heart, derived
from CBCT images, to be 1.6, 1.4, and 2.1 mm in the L-R, A-P, and S-I, respectively231.
The values from these two studies can be compared to the 3-6 mm range of PRVs derived
from the current study. The discrepancy from Li et al. is likely due to their coronary artery
segmentations being standardized at 2 mm diameter, whereas our coronary artery
segmentations were not standardized and were larger (~4-6 mm). Whereas, Topolnjak et
al. had smaller PRV values as they only assessed the whole heart.
One limitation of our study is that the utilized MR images were not cardiac gated
and therefore did not take into consideration cardiac motion. As the image acquisition
time ranged from 17 seconds to 3 minutes, numerous cardiac cycles were captured
throughout the course of imaging and therefore, the cardiac substructures are
represented by their average position over the course of the scan. The cardiac motion
captured in these scans may have presented challenges in identifying the coronary
arteries as they can become indistinct and noncontiguous141. This was managed by
consensus ground truth segmentations being generated by two radiation oncologists.
Although cardiac motion can be on the order of 3-8 mm52, it is currently not taken into
consideration clinically as cine-angiography or echocardiography are required232. Yet, as
the cardiac substructure excursions from this work are on the order of cardiac motion, the
internal motion may be merged with the inter-fraction variability in a future safety margin
design. Topolnjak et al. incorporated a term for the PRV calculation to accommodate
respiratory motion which is not addressed in this work as 18 out of 20 patients were
treated in breath-hold231.
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Another limitation of this work is that only 0.35 T TrueFISP MRgRT datasets
acquired at breath-hold were evaluated. To translate the work to other field strengths such
as the 1.5 T offered with the Unity MR-linac (Elekta AB, Stockholm, Sweden), the deep
learning segmentation pipeline would need to be retrained for the higher field MRI
datasets for the MRI sequence of interest. Additionally, the increased signal-to-noise ratio
at higher field strengths may provide an improvement to automatic segmentation
accuracy. Nevertheless, the inter-fraction substructure displacements quantified at a low
MRI field strength under breath-hold conditions may be applied regardless of field
strength.
As current studies are considering cardiac substructures in RT, it is crucial that
inter-fraction variation is considered. Patel et al. has recently recommended that the
LADA is incorporated as a cardiac substructure to avoid during the RT planning process
due, as radiation dose to it has been strongly tied to coronary artery calcification 32. A
study by Aldridge et al. found that the integration of cardiac substructures into the reoptimization of retrospective thoracic RT plans drastically reduced radiation dose to
sensitive cardiac substructures233. This reduction was achieved with a negligible increase
in plan complexity while maintaining PTV coverage and clinical endpoints for other critical
OARs233. Examples of cardiac substructure sparing through VMAT was shown by Ferris
et al. who achieved significant improvements in mean dose to the chambers, great
vessels, and coronary arteries234. These studies outline the importance in considering
cardiac substructures in planning which will require adequate setup and motion margin
consideration.
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The increased presence of RT indications for peri-cardiac tumors, especially
metastatic lesions, mandate the development of realistic cardiac sparing margins.
Anisotropic cardiac substructure-specific planning margins for OARs may be warranted
to accommodate differential inter-fractional shifts. While these results suggest that these
margins may need to be patient-specific, more precise margin definition will require
further confirmation in a larger cohort stratified by respiratory status and accounting for
systematic and random uncertainties.
Conclusion
This exploratory work quantified the inter-fraction displacement of critical cardiac
substructures and is a first step in deriving substructure-specific safety margins to ensure
highly effective

cardiac

sparing.

Individual

cardiac

substructure

displacement

demonstrated variability in magnitude and dominant axis, suggesting that anisotropic
substructure-specific PRVs may be warranted. These findings require validation in a
larger cohort for applications in prospective clinical trials.
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CHAPTER 6 “TREATMENT PLANNING COMPARISONS AND TRANSLATING
TECHNOLOGIES TO AN MR-LINAC”
Part 1 “Incorporating Sensitive Cardiac Substructure Sparing into Radiation
Therapy Planning”
Introduction
Cardiac toxicity is a major complication of cancer treatment and can occur during,
shortly after, and even many years after treatment has been delivered. Long-term follow
up of patients undergoing thoracic radiation, such as lymphoma, lung, breast, and
esophageal cancers, has shown that in particular, RT can lead to radiation-induced
cardiac toxicities such as congestive heart failure, pericardial effusion, coronary artery
disease, and myocardial infarction5-7.
Yet, when a patient’s RT plan is created, only simple whole heart metrics (i.e.
MHD) are routinely considered for cardiac risk assessment in the current standard of care.
The QUANTEC report assesses dose to the heart as a whole and recommends less than
10% of it receives greater than 25 Gy (in 2 Gy fractions) to keep the conservatively
estimated risk of long term cardiac mortality less than 1%18. Importantly, these wholeheart dose metrics do not provide any information on where dose is distributed.
The heart is a complex organ and dose to its substructures (e.g., coronary arteries,
ventricles, atria, great vessels, etc.) have been strongly associated with radiation-induced
cardiac morbidity30 and future acute coronary events28,219. For example, dose to the LADA
has been linked to an increased risk of myocardial infarction31 and development of
coronary artery calcifications32. Similarly, higher doses at the base of the heart (i.e.
ascending aorta, superior vena cava, and pulmonary artery) are associated with lower
rates of patient survival35. Importantly, recent RTOG 0617 sub-analyses suggest that
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dose to the atrial and ventricular cardiac substructures are more strongly associated with
survival than assessing dose/volume relationships to the entire heart volume40,41,235. In a
recent study by van den Bogaard et al.28, dose to the LV-V5 predicted major coronary
events better than MHD. A study by Hoppe et al. highlighted the importance of quantifying
substructure dose as the MHD becomes less correlated to substructure dose with
increasingly conformal delivery236. Furthermore, a study by Jacob et al. outlines how the
MHD does not accurately predict dose to the LV and coronary arteries237.
To date, reducing dose to sensitive cardiac substructures has been severely
limited because they are not readily visible on standard x-ray-based imaging used for
both RT planning (i.e. CT-SIM) and RT delivery (i.e. CBCT). Thus, leveraging the superb
soft tissue contrast of MRI may be advantageous, as MRI improves cardiac substructure
visibility43,44. Furthermore, the recent introduction of MR-linacs (Figure 32, left) has
yielded improved tumor and critical structure visualization at 0.35 T MRI as compared to
CBCT222. MRgRT allows for continuous anatomical visualization of the patient’s heart and
target volume throughout treatment which may offer advantages for improved cardiac
sparing. Therefore, to advance towards mitigating cardiotoxic side effects from RT,
approaches for considering cardiac substructures during treatment planning are urgently
needed.
This work sought to apply a multimodality workflow (treatment planning CTs
coupled with low-field MR-linac MRIs) to integrate sensitive cardiac substructures into
treatment planning. This multi-modality workflow allowed us to quantify potential
dosimetric advantages for improved cardiac sparing through plan re-optimization and for
cases that may benefit, beam angle modifications.
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Figure 32: (Left) ViewRay 0.35T MR-linac, (Middle) treatment planning CT, (Right)
0.35T MR dataset with cardiac substructure contours evident and delineated. PTV:
planning target volume (malignant neoplasm of lower left lung bronchus). Cardiacrelated abbreviations are defined in the text.

Methods
Patient Cohort and Image Acquisition
Fifteen patients with 16 pericardial lesions (i.e. 16 individual plans) who underwent
MRgRT for upper thoracic treatments of the lung, mediastinum, and esophagus were
retrospectively reviewed on an Institutional Review Board approved study. Of these, 11
were treated with stereotactic body radiation therapy (3-5 fractions to a total dose of 3050 Gy), 2 underwent conventional fractionation (25-35 fractions to a total dose of 50-70
Gy), and the remaining three were moderately hypo-fractionated (14-20 fractions to a total
dose of 36-60 Gy). Patients were imaged in various breathing states (7 end-exhalation, 7
end-inhalation, 2 free-breathing) on a 0.35 T ViewRay MRIdian linear accelerator
(ViewRay, Mountain View, CA).
All patients were imaged with a b-SSFP (i.e. TrueFISP) acquisition sequence
(Siemens, MAGNETOM Avanto, Syngo MR B19) with 15/16 patients with mobile tumors
undergoing daily 17-25 second MRIs (1.5×1.5×3 mm3) under breath-hold conditions. One
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patient with a left chest wall lesion could not tolerate breath-hold and thus underwent a
175 second free-breathing MRI for treatment planning. TrueFISP is commonly used in
cardiac imaging due to high signal-to-noise ratio and imperviousness to motion
artifacts227,228. All treatment planning was conducted and dose was calculated on a noncontrast CT-SIM in a manner similar to what has been reported for MRgRT of thoracic
lesions224. All CT-SIMs were acquired on a Brilliance Big Bore CT Simulator (Philips
Medical Systems, Cleveland, OH) with a 3 mm slice thickness. MR and CT-SIM sessions
were conducted on the same day and patients were immobilized in the supine position
using molded vacuum cushions.
Segmentation and Registration
Assessed cardiac substructures included the heart, left/right ventricles (LV, RV),
atria (LA, RA), superior/inferior venae cavae (SVC, IVC), ascending aorta (AA),
pulmonary artery/veins (PA, PV), left anterior descending artery (LADA), right coronary
artery (RCA), and left main coronary artery (LMCA). For 11 patients, a cardiac
substructure segmentation atlas48 automatically generated the cardiac substructures on
the CT-SIM dataset for treatment planning with the final contours displayed on the lowfield MRI at Figure 32, right. For the remaining 5 patients evaluated at a later date,
automatic cardiac substructure segmentation on the CT-SIM was performed using a
three-dimensional U-Net204, a deep learning model that improved the accuracy and
substructure generation time as compared to the atlas method.
While automatic segmentation methods (i.e. multi-atlas and deep learning
methods) provided initial substructure contours on the CT-SIM datasets, a radiation
oncologist consulted the co-registered low field MRI to modify and confirm the final

111
contours used for treatment planning. As shown by the lack of contrast in the planning
CT (Figure 32, center), the enhanced soft tissue contrast from the MRI assisted the
generation of more reliable cardiac substructure delineations on the corresponding
planning CT. Co-registration involved an automatic rigid registration based off a manually
drawn, local, cardiac confined bounding box. Normalized mutual information was used as
the similarity metric as it has been shown to accurately align multi-modality images140.
Treatment Planning
For all patients, the CT-SIM was used as the primary image set for treatment
planning as has been reported in the literature for MRgRT of thoracic lesions 224. The coregistration of the low-field MR image to the CT-SIM to elucidate the cardiac substructures
was a critical step in allowing the physician to verify the cardiac substructure autosegmentations. Step-and-shoot IMRT planning was used to generate all 16 RT plans at
a dose rate of 600 cGy/minute. The MR-linac utilizes a fast Monte Carlo dose calculation
algorithm238 and plans were calculated using a 1x1 mm dose grid with 1% dose
uncertainty239. Plans were prescribed to 95% of the planning target volume with total
doses for the original treatment plans varying from 30-70 Gy delivered in 4-35 fractions.
The original treatment plans for all patients included clinical dose constraints for whole
heart endpoints. Specifically, less than 15.0 cc of the whole heart was to receive 24-42
Gy and a maximum dose no greater than 30-40 Gy (ranges were dependent on
prescription dose). All clinical treatment plans met physician objectives using standard
QUANTEC240,241 and TG-10131 dosimetric endpoints for OARs.
Along with adding substructure segmentations retrospectively to the original
clinical treatment plans for dose assessment, all plans were re-optimized to spare cardiac
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substructures (SPARE plan). Strategies for substructure sparing included evaluating the
original plan to identify which cardiac substructures were near the PTV and thus received
the most dose. Optimization objectives were then added with increased priority on the
substructures receiving higher doses. If the dose limit was unachievable, constraints were
relaxed with the overall objective to minimize substructure dose. If the dose to a particular
substructure was minimal in the original plan, an additional objective was added in the
IMRT optimization to ensure consistency was maintained.
In addition to adding substructures to the optimization, possible further cardiac
sparing improvement was also assessed through modifying the beam arrangement (New
Angles plan) after the substructures had already been incorporated into the optimization.
Each plan was evaluated for the presence of beams entering or exiting the heart that
could potentially be removed or modified to further spare the heart and substructures.
The proximity of the patient’s lesion to the heart was evaluated as a potential reason for
a patient benefiting from beam angle modification. IMRT techniques were used for all
SPARE and New Angles plans with the substructures integrated into the optimization
while maintaining tumor volume coverage and minimizing OAR dose. Table 8 outlines the
dosimetric considerations during plan optimization, derived from the literature, when
cardiac substructures were included. All plans were converted using the equivalent dose
to 2 Gy fractions (EQD2, α/β = 2) for evaluation.
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Substructure

Mean Dose

Maximum Dose

Additional
Endpoint

Right Ventricle

-

Minimize42

V4542

Left Ventricle

-

Minimize42

LV-V528
V4542

Minimize37

V4542

-

V4542
D9037

Left Atrium
Right Atrium

8.5 Gy35
Minimize42,242
8.5 Gy35
Minimize42

Superior Vena
Cava

8.5 Gy35

-

PA, PV, AA

8.5 Gy35

-

Left Anterior
Descending Artery

Minimize243

< 10 Gy32
Minimize243

V4542

RCA, LMCA

-

-

V4542

Table 8: Summary of cardiac substructure sparing utilized in planning optimization for
the re-optimization (SPARE) plan and the New Angles plan. Abbreviations defined in
the text.

Dosimetric and Statistical Assessment
Original, SPARE, and when applicable, New Angle plans were exported from the
ViewRay planning system and imported into MIM (version 6.9.4, MIM Software Inc.,
Cleveland, OH) for automated evaluation. Dosimetric assessment included mean doses,
LV-V5, and Dose to 0.03 cc (D0.03cc, surrogate for maximum dose) for 12 cardiac
substructures and the whole heart. To ensure clinical acceptable plans were still
achieved, differences in PTV coverage and dose to the OARs were also assessed. Lastly,
total MU and treatment time were evaluated and compared to the original clinical
treatment plan as metrics of plan complexity. Dosimetric and planning data were
summarized via mean ± SD. As the data was not normally distributed, dosimetric
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comparisons for each metric were conducted using a 2-tailed Wilcoxon signed ranks test
with P < 0.05 considered statistically significant. Statistical assessments were conducted
in SPSS version 25.0 (SPSS, Chicago, IL).
Results
Contour Generation and Plan Complexity
The treatment time per fraction (a metric of plan complexity) across the 16 patients
after plan re-optimization was 6.57 ± 3.50 minutes (range: 2.60 to 12.41) for the clinical
treatment plan and was 6.93 ± 3.27 minutes (range: 2.75 to 11.99) after re-optimizing (P
> 0.05). The percent difference between the original and re-optimized delivered MUs was
1.7 ± 11.3 % (range: -21.6 to 15.8%) which were not statistically different (P > 0.05).
Four patients benefited from New Angles plans where the number of original
treatment beams (range: 7 to 11) shifted between -1 and +3 (range: 8 to 14). For two of
the four patients, lesions were directly adjacent to the heart (i.e. a pericardial lymph node
and a malignant neoplasm of the lung (Figure 37)). The other two patients presented with
upper lung lobe lesions that were greater than 9 cm away from the heart. The average
treatment time for these patients after beam angle modification was 6.12 ± 3.68 minutes
which was not significantly different (P > 0.05) from the original treatment time for these
4 patients (6.54 ± 3.31 minutes). Lastly, the number of MUs for patients benefiting from
beam angle modification were 9.5 ± 16.8% (range: -16.6 to 23.8%) different on average
from the original plan (P > 0.05).
Cardiac Substructure Sparing
The radiation dose to the whole heart after plan re-optimization met all clinical
objectives240,241. All sparing plans significantly reduced the MHD (P < 0.05) with an
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average reduction of 0.7 ± 0.6 Gy (range: 0.1 to 2.5 Gy). Further, D0.03cc to the heart was
reduced by 8.6 ± 12.1 Gy (range: -8.6 to 39.9 Gy) across all patients after plan reoptimization (P < 0.05).
Figure 33 outlines a subset of dose objectives from Table 8 representing the
difference in radiation dose received by the LADA, LA, and LV between the original and
clinical treatment plans across all 16 patients. Re-optimized SPARE plans reduced LADA
mean and D0.03cc (0.0 to 63.9% and 0.0 to 17.3 Gy, respectively, Figure 33 left). For the 5
patients that had LADA0.03cc doses greater than 10 Gy (threshold for coronary artery
calcification32 presented in Table 1), 4 were brought below 10 Gy after re-optimization
(average reduction for these patients was 13.4 ± 7.0 Gy). D0.03cc for the remaining patient
was reduced from 29.0 to 11.2 Gy. Moreover, patient 6 (Figure 33) had a 4 Gy reduction
in mean dose to the LADA after plan re-optimization. Similarly, D0.03cc to the LV was
reduced in 14 cases (range: 0.05 to 12.85) with 10 patients having greater than 1.5 Gy
reductions. A large reduction (> 7%) in LV-V5 was observed in 6 cases (Figure 33, right)
and was significantly reduced over all patients (P < 0.05). LA mean dose (Figure 33,
center) was either equivalent or reduced (average reduction 0.9 ± 1.2 Gy) for all SPARE
plans. For Patient 3, the left atrial mean dose was reduced below 8.5 Gy which has been
shown to be a threshold associated with decreased survival35. Lastly, the left atrial
maximum dose that has been significantly associated with non-cancer death37 was
reduced by 2.3 ± 6.4 Gy across all 16 patients.

116

Figure 33: Dose sparing possible by incorporating cardiac substructures into IMRT
optimization during MR-guided radiation therapy planning. The mean dose for all 16
patients is shown for the left anterior descending artery (left) and the left atrium (center).
The left ventricular volume receiving 5 Gy (LV-V5) is shown on the right.

Table 9 summarizes the change in mean dose and D0.03cc to all cardiac
substructures. The mean doses to all substructures and the heart were significantly
reduced after re-optimization (P < 0.05). Moreover, D0.03cc was significantly reduced after
plan re-optimization in 8/12 substructures, as well as for the whole heart. The LMCA mean
and D0.03cc doses were reduced for all patients and was the substructure with the largest
reduction in mean dose across all patients (average reduction in LMCA mean dose: 1.13
± 1.15 Gy). Lastly, the volume of the heart receiving 25 Gy (V25) was significantly reduced
on average (n = 12 patients who met the V25 threshold) by 1.08 ± 1.47% (P < 0.05).
Further cardiac substructure dose sparing beyond re-optimization was achieved
for 4 patients with beam angle modification where the mean dose reduction across all
substructures was 0.6 ± 0.4 Gy (highest reduction in PA of 1.5 ± 2.0 Gy). The D 0.03cc,
mean dose, and V25 to the heart were further reduced by 5.4 ± 4.1 Gy, 0.5 ± 0.7 Gy, and
4.2 ± 2.9%, respectively. For the LV, after re-optimization coupled with beam angle
modification, D0.03cc and LV-V5 were further reduced by 2.1 ± 2.9 Gy and 2.0 ± 1.9%,
respectively. Lastly, the SVC D90 improved 3.3 ± 4.0% after the beam angles were
modified.
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Organs at Risk (OARs) and Planning Target Volume (PTV) Coverage
All re-optimized plans met the original clinical prescription dose to the PTV while
doses to the OARs met all objectives based on clinically acceptable guidelines 240,241.
Table 9 outlines the average change in the mean dose and D0.03cc for the PTV and OARs.
Across all patients, the esophagus had a negligible change in mean dose after plan reoptimization (0.25 ± 0.70 Gy, P > 0.05). Additionally, differences in clinical endpoints such
as the volume of the lung receiving 20 Gy (V20) and volume of the esophagus receiving
35 Gy (V35) were negligible after re-optimization (P > 0.05). No statistically significant
changes were observed in the mean dose, D0.03cc, and other clinical endpoints for the
PTV and OARs (P > 0.05).
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Structure
PTV
Organs at Risk

Spinal Cord
Total Lung
Esophagus

Heart and
Substructures

Heart
LV
LA
RV
RA
AA
PA
PV
SVC
IVC
LADA
LMCA
RCA

Average Change After Re-optimization
D0.03cc (Gy)
Mean Dose (Gy)
Other Clinical Endpoint
1.95 ± 3.67
0.37 ± 1.85
PTV95: 0.03 ± 0.21 Gy
0.06 ± 0.25
0.38 ± 1.37
1.32 ± 2.70
-0.01 ± 0.26
V20: 0.03 ± 0.71 %
0.39 ± 4.06
0.25 ± 0.70
V35: 0.53 ± 2.46 % (n=5)
-8.57 ± 12.06*
-0.68 ± 0.60*
V25: -1.08 ± 1.47* % (n=11)
-3.27 ± 4.08*
-0.53 ± 0.70*
LV-V5: -6.33 ± 5.57* % (n=12)
-0.85 ± 1.22*
-2.30 ± 6.42
-0.55 ± 0.74*
-4.12 ± 4.81*
-0.52 ± 0.94*
-1.38 ± 4.47
-0.83 ± 1.13*
-2.23 ± 3.42*
-0.95 ± 1.60*
-2.84 ± 8.53
-0.89 ± 1.09*
-2.71 ± 5.69*
-1.08 ± 3.65*
-0.57 ± 1.19*
D90: -0.10 ± 1.23 Gy*
-0.16 ± 0.38*
-0.74 ± 1.91
-0.91 ± 1.18*
-4.05 ± 5.32*
-1.13 ± 1.15*
-1.31 ± 1.55*
-0.65 ± 1.26*
-1.64 ± 3.38*

Table 9: Change in D0.03cc and mean dose after plan re-optimization for the planning
target volume (PTV), heart and its substructures, and other organs at risk. The asterisk
indicates significant reduction in dose after re-optimization. N = 16 for all structures
except for the esophagus where n = 10. For the heart V25, esophagus V35, and LV-V5,
results were reported only for structures with a non-zero value for the corresponding
dosimetric endpoint. There were no significant increases in dose after re-optimization.
Abbreviations are defined in the text.

For the four patients that benefited from beam angle modification, negligible
changes were observed for all of the PTV D95 metrics (range: 0 to -0.30 Gy) and 3 out of
4 patients’ D0.03cc (< 0.5 Gy). However, one patient had an increase in D0.03cc of 3.7%, or
6.2 Gy, with beam angle modification when compared to the original clinical treatment
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plan. Negligible changes (< 1%) in clinical endpoints were observed for the esophagus
(V35 and V50) and lungs (mean dose and V20) as compared to the original clinical
treatment plan while the spinal cord D0.03cc was reduced by 2.3 ± 1.9 Gy with beam angle
modification as compared to re-optimization alone.
Individual Patient Results
Figure 34 shows DVHs for three patients selected to represent an example of the
least effective cardiac substructure sparing (Patient 1), highly effective sparing (Patient
2), and an average case (Patient 13). Each DVH shows the PTV, involved OARs, and
relevant cardiac substructures for both the original clinical treatment plan and the reoptimized plan. Patient 2 benefited from beam angle modifications, and thus, that plan is
represented as well. Figure 34 highlights that for the patients shown, negligible
differences (< 1 Gy) were observed for the mean lung dose and D0.03cc to the spinal cord
indicating comparable plan quality was achieved even when cardiac substructure sparing
was implemented. Radiation doses to the whole heart and total lung (results not shown
for all patients) were reduced for all patients after re-optimization, with even further
reductions after beam angles were modified. For patient 2, the mean esophageal dose
decreased by 3.0 Gy from the original clinical plan and 4.5 Gy from the reoptimized plan
after modifying the beam angles, all while reducing the mean.
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Figure 34: Dose volume histograms (DVH) for three patients of the least effective
cardiac substructure sparing (Patient 1), highly effective sparing (Patient 2), and an
average case (Patient 13) showing dose from the original clinical treatment plan and
after re-optimization. The modified beam angle plan is also shown for Patient 2.
Abbreviations defined in the text.
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Figure 35 illustrates the initial clinical treatment plan of a malignant neoplasm of
the lower left lung bronchus (left) treated to 48 Gy in 4 fractions and the corresponding
cardiac SPARE treatment plan (right) for Patient 11. This figure highlights cardiac
substructure sparing with greater than 10 Gy reductions in D0.03cc to the LV, LA, and PV.
Specifically, note the removal of the 5 and 10 Gy isodose lines from many heart
substructures (LA, AA, RA, PV, and RV) after the re-optimization.

Figure 35: (Left) Initial clinical treatment plan and (Right) corresponding cardiac SPARE
treatment plan. The planning target volume (PTV) is shown in red. Abbreviations
defined in the text.
Figure 36 shows the clinically used radiation treatment plan for Patient 2 (DVH also
shown in Figure 34) that originally met all whole-heart dose endpoints for a locally
advanced lung cancer patient treated to 60 Gy in 20 fractions. Cardiac sparing after reoptimization is shown with the original clinical treatment plan shown (top left), the cardiac
SPARE plan (top right), and the difference map (bottom left). The dose metric table
(bottom right) highlights that standard whole heart dose metrics (< 3 Gy and < 2%
absolute difference) do not reflect the local dose deposition that the substructure metrics
are able to capture. For example, the LV-V5 was reduced from 30.6% to 14.7% after reoptimization. Furthermore, the mean dose to the AA was reduced by ~6 Gy and the LADA
D0.03cc was reduced below 10 Gy (threshold for coronary artery calcification32 presented
in Table 8) with sparing.
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Figure 36: Top row: (Left) Clinically treated plan for an advanced stage lung cancer
patient. (Right) Cardiac substructure spared plan. Bottom row: (Left) Dose difference
map (clinical less cardiac spared plan) highlighting major dose reductions to cardiac
substructures. (Right) Dose metric table showing select standard whole heart dose
metrics and substructure metrics. Maximum dose defined as dose to 0.03 cc volume.
Abbreviations defined in the text. DVH shown in Figure 34.

Optimal beam arrangements led to further cardiac substructure dose reduction in
4 patients. Figure 37 shows the original clinical plan (left), re-optimized SPARE plan
(center), and New Angles plan (right) for Patient 5 who had a left lung cancer treated to
48 Gy in 4 fractions. This figure shows that although there was a slight change for the
cardiac substructures after plan re-optimization (mean reduction over all substructures:
0.2 ± 2.1 Gy), increased sparing after beam angle modification was possible (mean
reduction over all substructures: 1.0 ± 1.4 Gy). For example, the mean dose to the
pulmonary vein was only reduced by 0.2 Gy after re-optimization but was further reduced

123
by another 1.1 Gy after beam angle modification. Moreover, beam angle modification
allowed for further sparing of the LADA and LA with mean dose reductions of 0.9 and 0.8
Gy, respectively, as compared to the SPARE plan.

Figure 37: Top row: Original clinical plan (left), re-optimized SPARE plan (center), and
New Angles plan (right) for a patient with a left lung tumor. Bottom row: Difference maps
comparing the re-optimized SPARE plan and the New Angles plan to the original clinical
plan. Difference maps are the original plan less the new plan. Abbreviations are defined
in the text.

Discussion
This work introduced cardiac substructures into CT-based treatment planning
incorporating a co-registered low-field MRI to quantify potential dosimetric advantages for
improved cardiac sparing. This was completed through the retrospective re-optimization
of treatment plans, as well as modifying the original beam angle arrangement to minimize
cardiac substructure radiation dose, all while attempting to maintain PTV coverage and
continuing to meet clinical endpoints for other critical OARs.
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Even though current cooperative trials use volumetric measures based only on
MHD endpoints19,20, introducing cardiac substructure segmentation into radiation
treatment planning may help better study and define radiation-induced cardiac injury.
Some studies have aimed to investigate the dosimetric impact of different types of therapy
on cardiac substructure sparing. A study by Ferris et al.234 evaluated cardiac substructure
sparing for optimized VMAT and intensity modulated proton therapy (IMPT) and found
that cardiac-optimized plans led to statistically significant improvements in mean dose to
the chambers, great vessels, and coronary arteries. Our findings agree with Ferris et al.
with respect to significant reductions in the maximum dose to the LADA and RV (greater
than 4 Gy on average) while maintaining or improving clinical OAR (e.g., lung, esophagus,
and spinal cord) constraints and PTV coverage. Likewise, Lester et al.244 created reoptimized VMAT plans to reduce radiation dose to the coronary arteries and cardiac
valves. At present, few studies have integrated cardiac substructures into treatment
planning optimization. Ferris et al. evaluated cardiac spared plans using VMAT and IMPT
with CT for locally advanced non-small lung cancer patients with a conventional
fractionation to 60 Gy under free-breathing conditions234. Lester et al. focused on cardiac
spared planning for mediastinal lymphomas by incorporating ECG-gated CT and coronary
angiography acquired at deep inspiration breath hold244. These patient populations were
different from the present study of 11 out of 16 lung cancer stereotactic body radiation
therapy cases (3-4 fractions) with 7 end-exhalation, 7 end-inhalation, 2 free-breathing to
test different conditions. In addition, the present study incorporated a low-field MRI as an
adjunct to treatment planning CTs whereas the Lester et al. study used CT
angiography244. While MRgRT was employed in this work, the dosimetry strategies of re-
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optimization using cardiac substructures and beam angle arrangement modification are
applicable to other x-ray-based treatment planning modalities as our atlas and deep
learning substructure segmentations work on CT-SIM image inputs.
Negligible increases in treatment time per fraction and MUs delivered after plan reoptimization were observed, suggesting similar complexity of the radiation treatment plan.
Moreover, even though the modified beam angles plans involved either adding or
removing beams in the revised treatment plan, the differences in treatment time per
fraction and MUs delivered were negligible (P < 0.05).
Modifying the beam angle and number of beams used to consider cardiac
substructures after the plan has been re-optimized also has the potential to increase
cardiac substructure radiation sparing. However, much like the findings by Lester et al.244,
the results were patient specific as lesion location and proximity to the heart and its
substructures played a role in if the patient would benefit from plan re-optimization and
beam modification. Patients that benefited from beam angle modification varied in both
the number of beams added or removed and in the proximity of the lesion to the heart
(i.e. directly adjacent). So, although beam angle modification was shown to provide
improvements over solely re-optimizing the plan for select cases (4/16 cases), reoptimization alone provided the majority of cardiac substructure sparing. Tumor location
also plays a role in the extent a substructure is able to be spared. For example, the LA
for Patient 2 was directly adjacent to the tumor volume yet the mean dose difference after
re-optimization of the LA as shown in Figure 33 revealed only minor improvement (< 1
Gy) was possible. Thus, this suggests that sparing substructures closer to the tumor

126
volume may be difficult although accurately quantifying the dose to substructures offers
value for clinical risk assessment.
There was a statistically significant sparing of mean dose to all studied cardiac
substructures achieved after plan re-optimization. This may be due to the added weight
in the optimizer for when the substructures are included. However, Figure 36 highlights
that standard whole heart dose metrics had decreased sensitivity to a cardiac sparing
treatment planning approach, whereas individual substructure endpoints clearly identified
dosimetric, and clinically meaningful gains (i.e., associated with clinical outcomes). The
insufficiency of quantifying the MHD alone has been recently affirmed by studies
recommending the inclusion of cardiac substructures as RT treatments become more
conformal (i.e. intensity modulated RT)245,246. For example, the LV-V5, which has been
shown to be more predictive of acute cardiac events than mean heart dose 28, was
reduced ~15% and the mean dose to the AA was reduced by ~6 Gy, suggesting that with
confirmation in a larger cohort, further sparing may offer potential for improved survival 35.
This underscores the importance of using more sensitive metrics for dose evaluation and
not simple whole-heart evaluations that are currently being implemented.
Respiratory motion was managed via breath-holding for the majority of the
patients. At breath-hold, there is still the potential impact of cardiac motion which was not
accounted for in this study due to not having cardiac gated 0.35 T MR-linac images. It
has been shown that even under breath-hold conditions, cardiac substructures may
displace ~5-7 mm throughout the cardiac cycle

247,248.

Thus, incorporating a PRV

representing the variability of the cardiac substructures over a patient’s imaging and
treatment course will be the next step of this work. However, as substructure PRV
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recommendations do not currently exist for each substructure and this study was unable
to account for cardiac motion, they were beyond the scope of the current work. This may
be possible through the use of van Herk’s formalism249, which was used by Levis et al.248
to estimate PRVs for the coronary arteries. Additionally, while this work was based off of
CT-based treatment planning that enables more widespread applicability to x-ray-based
approaches, MR-only treatment planning is gaining popularity, and a future direction
includes translating the work to MR-only plans. Furthermore, increasing the size of the
patient cohort with varied target locations will help identify the patient geometries that will
benefit most from cardiac substructure sparing. However, the size of the patient cohort in
the current study is consistent with the previously mentioned studies where 7-8 patients
were used244,248. This may be completed through applying this work to a prospective
clinical trial, like that of Jacob et al.129, or be applied to multi-institutional studies, such as
the study recently completed by Dess et al.250, to determine if cardiac substructure
dosimetric sparing has an effect on clinical outcomes.
Conclusion
This work applied a multimodality workflow to enable robust dose sparing of
cardiac substructures, as well as maintain PTV and OAR doses. New treatment plans did
not substantially increase delivery time or required monitor units, suggesting a negligible
increase in plan complexity when cardiac substructure sparing was introduced. Validation
in a larger cohort with appropriate margins will offer the potential to reduce radiationrelated cardiac toxicities and the dose assessment of currently overlooked radiosensitive
substructures.
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Part 2 “A Deep Learning Cardiac Substructure Pipeline for MR-Guided Cardiac
Applications”
Introduction
Radiation dose from thoracic RT treatments is strongly associated with radiationinduced heart disease, which includes both acute and late cardiotoxicities 5,6,16. In RT, the
current standard of care is to delineate and consider the entire heart as a single organ
and use simple metrics like MHD and dose/volume relationships to evaluate cardiac
risks18. Importantly, these whole-heart dose metrics do not provide any information about
where the dose is being distributed. Yet, radiation dose to individual cardiac
substructures, like the LV, LA, and LADA, have been more strongly linked to late cardiac
morbidities than the commonly used whole-heart dose metrics28,41,42. However, cardiac
substructures are not currently considered in treatment planning as they are poorly
visualized on standard CT simulation datasets18. With the improved soft tissue contrast
provided by MRgRT, sensitive cardiac substructures can now be visualized in MR-guided
treatment planning (Figure 38) and considered for dose evaluation. Recently, MRI has
been coupled with a linear accelerator offering this increased visibility of tumors and
OARs in real time251. Still, even with proper visualization, online delineation of cardiac
substructures is impractical as it may take over four hours per patient45,46.
Several recent atlas-based techniques have been developed for automatic cardiac
substructure segmentation48,132,155. Yet, atlases require long processing times179 and are
heavily reliant on the quality of image registration between new patients and those
existing in the atlas. DNNs including the U-Net204, GANs158, and CNNs92 have also been
applied for automated cardiac substructure segmentation and have shown great promise
for rapidly generating contours.
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Cardiac substructure segmentation for RT applications has been primarily focused
on CT datasets as this is the imaging modality that is the standard of care for generating
a patient’s radiation treatment plan132,155. On CT images, studies by Zhou et al. and
Kaderka et al. were able to achieve good agreement in the cardiac chambers with DSCs
greater than 0.7132,155. The U-Net, originally designed by Ronneberger et al.119 for medical
image segmentation, has been applied to both MR and CT volumes for state-of-the-art
segmentation results157,204. Through incorporating the U-Net, Payer et al. was able to
achieve excellent agreement between aorta volumes when comparing generated
segmentations to physician delineated ground truth 157. Similarly, our previous work
yielded DSCs ≥ 0.84 in the cardiac chambers by training a multi-channel (3.0 T MRI and
CT) 3D U-Net for predictions on non-contrast CT204.
Regarding MR-only results, Mortazi et al. conducted automated segmentation of
seven substructures using a 3D b-SSFP sequence acquired in free breathing at 1.5 T in
17 seconds using a multi-planar deep CNN with adaptive fusion92. Similarly, Avendi et al.
utilized a deep CNN and stacked auto-encoders combined with a deformable modelbased approach to automatically segment the left ventricle252. This was completed using
a b-SSFP sequence acquired with a dedicated eight-element cardiac coil for cardiac
gating and during end-expiration breath hold92,252,253.
There are numerous strategies to improve the variability and diversity of available
data, without the need to collect new unique samples, which is referred to as data
augmentation. Data augmentation has been shown in numerous studies to improve autosegmentation accuracy, as well as minimize model overfitting92,204,252. The use of interfractional data for model augmentation has been incorporated previously, such as in the
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study by Brion et al., where the utilization of a patient’s daily cone-beam CTs had, for the
purpose of augmenting the deep learning model, been shown to significantly increase
segmentation accuracy in RT254. However, this method of deep learning model
augmentation has not been implemented for applications in MRgRT.
To address the unmet need of cardiac segmentation for MRgRT, we have
implemented a novel custom DL framework to efficiently generate segmentations on lowfield (i.e. 0.35 Tesla) MRI with the overarching goal of integrating cardiac substructures
into daily dose assessment and to facilitate enhanced cardiac sparing. This work
developed and validated an efficient and accurate deep learning pipeline for automated
segmentation of 12 cardiac substructures on MR-linac images. The novelty of this work
lies in the custom deep learning framework was developed for low-field MR-linac images
where daily inter-fractional MR images were incorporated for data augmentation (Figure
38). The successful completion of this work will enable the integration cardiac
substructures for dose assessment and improved cardiac sparing for future MR-linac
implementation in prospective clinical trials using MRgRT.

Figure 38: Axial views at the same thoracic level highlighting positional variations in
cardiac substructures acquired at breath-hold between various 0.35T MR-linac fractions
for a representative patient. Abbreviations: MR = magnetic resonance; PV = pulmonary
vein; LV = left ventricle; RV = right ventricle; LA = left atrium; RA = right atrium; AA =
ascending aorta; RCA = right coronary artery; LADA = left anterior descending artery.
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Methods
Patient Cohort
Twenty-three patients who underwent RT for either thoracic or abdominal cancer
were retrospectively reviewed on an Institutional Review Board approved study. Patient
treatments ranged from 30-70 Gy in 4-35 treatment fractions. Treatments consisted of
esophageal, right and left lung, chest wall, lymph node (pericardial), stomach (gastric
lymphoma), and liver dome lesions. Of the 23 patients, 17 were SBRT and the other 6
were conventional treatments.
Imaging Methods
Patients were imaged using a balanced T1/T2 b-SSFP sequence (TrueFISP,
Siemens, MAGNETOM Avanto, Syngo MR B19) on a 0.35 Tesla ViewRay MRIdian linear
accelerator (ViewRay, Mountain View, CA). The TrueFISP sequence is often used in
cardiac imaging due to its high signal-to-noise ratio and imperviousness to motion
artifacts227. The four utilized scans are outlined in Table 10 where each used a flip angle
of 60°, phase encoding in the anterior posterior plane, and a transversal orientation. The
generalized auto-calibrating partially parallel acquisitions, or GRAPPA method, was
utilized for breath-hold sequences to accelerate image acquisition255.
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Sequence

Slices

Time
(s)

FOV
(cm3)

Resolution
(cm3)

TE
(ms)

TR
(ms)

Bandwidth
(Hz/Px)

GRAPPA

1

80

17

45x45x24

0.16x0.16x0.30

1.62

3.83

385

2

2

144

25

50x45x43

0.15x0.15x0.30

1.27

3.00

599

2

3

288

172

50x45x43

0.15x0.15x0.15

1.45

3.37

535

N/A

4

240

175

54x30x36

0.15x0.15x0.15

1.45

3.38

534

N/A

Table 10: Description of utilized MR sequences and their different parameters.
Abbreviations: FOV = field of view; TE = echo time; TR = repetition time; Px = pixel;
GRAPPA = generalized auto-calibrating partially parallel acquisitions.

Twenty-one patients were treated under breath-hold conditions (17-25 seconds, 14 endinhalation and 7 end-exhalation, 1.5x1.5x3 mm3) and two under free breathing conditions
(3-minute scan, 1.5 mm3 isotropic resolution) as shown in Figure 39.

Figure 39: Axial MR slices for 3 patients illustrating end-exhalation breath-hold (Left: 17
seconds, Center: 25 seconds) and free breathing (Right: 3 minutes) conditions with
physician delineations of select cardiac substructures. Abbreviations: PV = pulmonary
vein; LV = left ventricle; RV = right ventricle; LA = left atrium; RA = right atrium; AA =
ascending aorta; RCA = right coronary artery; LADA = left anterior descending artery.

Clinical imaging included an MR-simulation (MR-SIM) and 3-4 daily MRI series per
patient for a total of n=114 unique image sets (4-5 unique daily MRIs) with an example
patient’s daily MRIs shown in Figure 38. To avoid preferential weighting due to the number
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of fractions, if a patient underwent a treatment with more than four daily fractions, the first
four were used. Ground truth segmentations of 12 cardiac substructures were delineated
on each patient’s MR-SIM. The manual segmentation effort of the ground truth was split
between two radiation oncologists. The more experienced of the two radiation oncologists
verified delineations for every patient. Studied cardiac substructures included the left/right
ventricles (LV, RV) and atria (LA, RA), superior/inferior vena cavae (SVC, IVC),
pulmonary artery/veins (PA, PV), ascending aorta (AA), left anterior descending artery
(LADA), right coronary artery (RCA), and left main coronary artery (LMCA). Deformable
image registration (DIR) was then used to transfer segmentations from the MR-SIM to
each daily MRI using a commercially available free-form intensity-based registration (MIM
Software, Cleveland, OH). This DIR algorithm has limitless degrees of freedom, employs
regularity (i.e. penalty term weight) to ensure the deformation was smooth145, and has
provided high segmentation accuracy (i.e. lowest mean absolute difference in a
comparison of eleven different deformable image registration algorithms) for previous
single-modality (e.g. CT to CT or MR to MR) registrations146. All propagated contours
were then verified and corrected as needed with a split effort between two radiation
oncologists. The more experienced radiation oncologist then completed a final verification
of each patient and each daily image set for continuity. MR images were resampled to 1
x 1 x 1.5 mm3 and then cropped to a 128 x 128 in-plane resolution over 64 slices. Image
cropping was competed around the heart centroid and then padded axially to 128 x 128
x 128.
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Deep Learning Methods
Figure 40 shows the deep learning architecture of the modified 3-dimensional Neural
Network (i.e. 3D U-Net) used in this study. This architecture is based off of a previously
validated 3D U-Net204 but has been optimized for the end point of automatic predictions
on low-field MR images. In total, eighteen patients, with 90 total unique MRIs, were used
to train a 3D U-Net on all 12 substructures simultaneously in 3D.

Figure 40: 3D U-Net architecture for cardiac substructure segmentation with low field
MR inputs. Predictions were outputted for each substructure.

The 3D U-Net shown in Figure 40 comprises of contraction and expansion
pathways. The contraction pathway utilizes context modules (previously described 204) to
aggregate high-level feature information (Figure 40, left)162. The expansion pathway
allows for the assembly of feature information for localization (Figure 40, right)162. As
shown by the blue boxes in Figure 40, deep supervision was also implemented and was
described previously204. To maximize information gained from high resolution features,
double convolutions were used in the first and second layers of the 3D U-Net. Strided
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convolutions were used instead of maximum pooling operations in the context pathway
(Figure 40, left) as they have been shown to increase model accuracy if the computational
load allows256. An adaptive momentum estimation (Adam) optimizer169 was used with an
initial learning rate of 5e-4, a batch size of 1, and randomly initialized weights. During
training, if the validation loss did not improve within 20 epochs (i.e., one forward pass and
one backward pass of all the training samples), the learning rate was reduced by 50%.
Training data (n = 18 unique patients) was split into 78% (n = 79 unique image sets)
training and 22% validation data (n = 20 unique datasets or 4 unique patients). The 78/22
split was used to ensure only complete individual patient datasets were considered in
either the training or validation datasets. Sixteen input filters were used initially, and filter
number doubled along the context pathway.
A loss function based on Dice allows for a way to circumvent the imbalanced ratio
of foreground to background pixels in medical images105. Additionally, as the training data
has ground truth segmentations, optimizing DSC is what is desired throughout training.
As the DSC is to be maximized to improve the segmentation result, the loss function
needs to be minimized and is thus represented in Equation 14257.
𝑈𝑛𝑤𝑒𝑖𝑔ℎ𝑡𝑒𝑑 𝐷𝑖𝑐𝑒 𝐿𝑜𝑠𝑠 = ∑𝑡 1 − 𝐷𝑆𝐶𝑡

(14)

The Dice-weighted loss function allows for multiple classes (i.e. substructures t ∈ T) to be
learned during the training and is shown in Equation 15258.
𝑇𝐷𝑆𝐶 =

∑𝑡∈𝑇 𝑤𝑡 ∗𝑡𝐷𝑆𝐶 +𝛼
∑𝑡∈𝑇 𝑤𝑡 +𝛼

(15)

Where wt is each class’s predicted weight. For numerical stability, a small value α is
included258. The specific problem of substructure segmentation involves classes that are
highly imbalanced due to differences in size and shape. Furthermore, as easily
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segmented substructures comprise most of the loss and dominate the gradient, we
applied a variable weighting scheme using a Dice-weighted focal loss, as shown in
Equation 16257.
1⁄
𝛽

𝐹𝑜𝑐𝑎𝑙 𝐷𝑖𝑐𝑒 𝐿𝑜𝑠𝑠 = ∑𝑡 𝑤𝑡 (1 − 𝐷𝑆𝐶𝑡

)

(16)

The value β is a tunable hyperparameter and as it increases, the well segmented classes
are down-weighted259). This focal Dice loss function emphasized the more difficult
substructure segmentation tasks to manage any class imbalances as extreme class
imbalances overwhelm the cross-entropy loss during training. Additionally, the focal DSC
loss function helps to minimize the false known correlation between a larger volume and
an improved DSC118. Furthermore, the focal Dice loss function has been shown to
improve hyperparameter robustness for unbalanced tasks, and improve overall
segmentation accuracy for small structures260.
Materials
Experiments were performed using Python v3.6 in Windows 10 (64-bit 10 core
Intel® Xeon® CPU-E5-2690 v4 at 2.60 GHz and 112 GB of random-access memory
(RAM)) with an NVIDIA Tesla P100 GPU with 16 GB of RAM and 3584 CUDA cores
(Keras 2.0 with TensorFlow backend). Beyond including 3-4 daily MRIs per patient, data
were augmented through flipping, rotating (0-30°, 1° increments), scaling (± 25%, 1%
increments), and translating (up to 10 pixels in 3 cardinal planes). These augmentation
techniques, along with a 50% dropout, were implemented to minimize model overfitting.
Post-Processing, Testing, and Parameter Optimization
We further improved the agreement to ground truth delineations by introducing
fully connected 3D dense CRF as a post-processing step160,204. The 3D CRF post-
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processing has been described in detail in our previous work204 and was used to correct
for remote island segmentations and improve overall smoothness. Five unique test
patients (n=5 as only MR-sim datasets were considered for testing) were held out from
the training patient cohort. DSC and MDA were used to compare DL segmentations to
ground truth. The learning rate schedule was tuned for optimal segmentation (i.e. initial
learning rate, decay, and patience). Lastly, the β hyperparameter from the above equation
was assessed at integer values from 2-5.
Statistical Assessment
Two-tailed Wilcoxon signed ranks tests were completed for statistical analysis
between ground truth and auto-segmented volumes, with P < .05 considered statistically
significant. Volumetric and geometric measures were assessed. All statistical analysis
was completed in SPSS (Version 26.0, Chicago, IL).
Results
The model stabilized after training for 340 epochs (training error < 0.001) which
took 32 hours to complete. Substructure contour generation for a new patient input took
20 seconds. Wilcoxon signed ranks test revealed that there 11/12 cardiac substructures
did not have significant differences in volume between 3D U-Net auto-segmentations and
ground truth for any cardiac substructure (P > 0.05). There was, however, a 0.47 cc (or
80%) average difference in LMCA volume which was statistically significant.
Shown in Table 11 are DSC results across the analyzed cardiac substructures.
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CTCA
MR Literature
Literature (High
(1.5T –
Resolution
3.0T)92,157,252
0.4mm3)182

Substructure

0.35T MR-linac
Focal Dice Loss
+ CRF (n=5)

Hybrid Diagnostic
3T MR/CT-SIM +
CRF204 (n=11)

Left Ventricle

0.89 ± 0.02

0.91 ± 0.01

0.88-0.92

-

Left Atrium

0.83 ± 0.02

0.87 ± 0.02

0.81-0.88

-

Right Ventricle

0.84 ± 0.02

0.84 ± 0.02

0.77-0.88

-

Right Atrium

0.84 ± 0.04

0.87 ± 0.02

0.83-0.87

-

Great Vessels

0.78 ± 0.05

0.81 ± 0.00

0.72-0.79

-

Left Main CA

0.42 ± 0.14

0.50 ± 0.18

-

0.60-0.70

Right CA

0.43 ± 0.11

0.50 ± 0.09

-

0.60-0.70

Left Anterior
Descending CA

0.45 ± 0.10

0.53 ± 0.08

-

0.60-0.70

Table 11: DSC for current method using a 3D U-Net with focal Dice loss for low field MR
(n = 5 test patients, column 2), previously published 3D U-Net with hybrid diagnostic 3T
MR/CT information (n = 11 test patients, column 3)204, current literature for cardiac
substructure segmentation at 1.5-3.0T, and high-resolution CTCA data (voxel size 0.4
mm3) from the literature across substructures. Abbreviations are defined in the text.

It was found that DL provided accurate segmentations for the chambers (DSC = 0.85 ±
0.01), great vessels (DSC = 0.78 ± 0.05), and pulmonary veins (DSC = 0.70 ± 0.08). DSC
for the coronary arteries was 0.43 ± 0.10. The results in Table 11, column 2, reflect a β
value of 4 (Equation 16), which yielded the highest DSC values across test patients. Table
11 also reveals DSC results from our previous work204 where cardiac substructure
segmentations were generated on non-contrast CTs. Lastly, Table 11 shows DSC results
from the current literature for the cardiac chambers and great vessels at MR field
strengths between 1.5T and 3.0 T and for coronary artery segmentations generated on
CTCA.
MDA results across all cardiac substructures are shown in Figure 41.
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Figure 41: Mean distance to agreement (MDA) results across all cardiac substructures
for the current MR-only deep learning model (blue, n = 5) and the previous hybrid
MR/CT deep learning model204 (red, n = 11).

As shown in Figure 41, MDA across all substructures was less than 3 mm. The IVC and
SVC experienced the smallest MDA across test patients of 1.7 ± 1.0 mm and 1.8 ± 0.8
mm, respectively. The LADA had the largest MDA on average of 2.9 ± 1.4 mm. Centroid
displacements for all cardiac substructures between the manually generated ground truth
and the DL auto-segmentations in the L-R, A-P, and S-I axes are shown in Table 12. On
average centroid displacements between manually drawn ground truth and DL were 2.15
± 2.52 mm in the L-R, 2.10 ± 1.38 mm in the A-P, 3.39 ± 2.67 mm in the S-I.
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Substructure

L-R (mm)

A-P (mm)

S-I (mm)

LV

0.82 ± 0.65

1.24 ± 1.20

1.04 ± 0.55

LA

1.32 ± 0.68

0.98 ± 0.57

3.26 ± 0.80

RV

1.08 ± 0.39

1.78 ± 1.68

3.40 ± 4.01

RA

0.98 ± 0.47

1.30 ± 0.76

2.70 ± 2.53

AA

0.80 ± 0.84

1.06 ± 1.52

1.62 ± 1.42

SVC

0.46 ± 0.29

0.92 ± 0.89

2.12 ± 2.54

PA

1.90 ± 1.47

5.06 ± 1.57

3.20 ± 2.29

IVC

0.70 ± 0.79

2.00 ± 2.30

2.16 ± 2.65

PV

8.98 ± 7.82

2.36 ± 3.38

3.56 ± 2.05

LADA

5.30 ± 5.74

4.72 ± 3.15

10.58 ± 5.91

RCA

2.54 ± 1.77

1.74 ± 1.23

6.18 ± 6.73

LMCA

0.96 ± 1.06

2.02 ± 1.55

0.86 ± 0.26

Table 12: Centroid displacements for all cardiac substructures between the manually
generated ground truth and the DL auto-segmentations in the L-R, A-P, and S-I axes

Three-dimensional results for the best case, Patient 1, are shown in Figure 42.
Patient 1 was diagnosed with esophageal cancer and was treated to 32 Gy in 13 fractions.
For the cardiac chambers, great vessels, and IVC, (9/12 substructures) DSCs were
greater than 0.80 for this patient. With regard to the coronary arteries (i.e. LADA, LMCA,
and RCA), DSCs were greater than 0.55 and MDA was 1.60 ± 1.03 mm. When comparing
the RV, AA, and LADA, for example from Figure 42, the deep learning segmentations
appear more smoothed due to the application of CRF for post-processing.
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Figure 42: Three-dimensional results for the best case, Patient 1, showing both coronal
and sagittal views of the manually drawn ground truth compared to the MR-only deep
learning model segmentation predictions. Substructure abbreviations are defined in the
text.

Shown in Figure 43 are axial images displaying results for Patient 2 and Patient 4.
Each axial image shows both manually segmented ground truth segmentations, as well
as DL auto-segmentations. Patient 2 was diagnosed with a malignant neoplasm of the
upper right bronchus (limited stage small cell cancer) which was treated to 60 Gy in 20
fractions. The malignant neoplasm, shown in the left side of the top left image in Figure
43, caused the DL model to be unable to generate a segmentation prediction for the right
PV (manually drawn ground truth shown in pink). For this reason, Patient 2 had the lowest
DSC value for the PV across test patients of 0.57. Patient 4, shown on the right side of
Figure 43, was diagnosed with a malignant neoplasm of the lower left lung lobe
(adenocarcinoma grade 2) which was treated to 48 Gy in 4 fractions. Located in the center
of both images for Patient 4 is a high intensity artifact. As nothing like this was included
in the training cohort, this artifact negatively affected the PA, LA, and LMCA automatic
segmentation results for Patient 4, as can be seen in Figure 43.
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Figure 43: Axial images for two different test patients (Left: Patient 2, Right: Patient 4)
revealing how abnormal patient anatomy or image artifacts affected deep learning
automatic segmentation results. Each axial image shows both manually segmented
ground truth segmentations, as well as DL auto-segmentations

Shown in Figure 44 is an axial MR slice comparing the manually drawn ground
truth and DL segmentations for Patient 5. Patient 5 was diagnosed with liver cell
carcinoma with an anterior dome lesion which was treated to 50 Gy in 5 fractions. Figure
44 also shows the delivered dose.
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Figure 44: Axial MR slice comparing ground truth (GT) and deep learning (DL)
segmentations for a patient undergoing liver treatment. Substructure abbreviations are
defined in the text.

Discussion
This work developed a novel deep learning pipeline to segment cardiac
substructures with the principle goal of applications in MRgRT. Several methods were
used for data augmentation including the unique contribution of incorporating 3-4 daily
MR images per patient to improve model accuracy and to minimize model overfitting. This
pipeline lead to accurate segmentations of the chambers and great vessels and yielded
promising coronary artery results on low-field MR images.
With the importance of cardiac substructures being shown in the pathogenesis of
radiation-associated heart disease, automatic cardiac segmentation has been the topic
of much recent exploration132,139,204. However, to our knowledge, it has not been applied
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to images for applications in MRgRT. Additionally, for RT applications, the use of daily
MR images for each patient provides a unique methodology for data augmentation. Atlasbased models have been widely explored for cardiac substructure segmentation yielding
DSCs greater than 0.75 in the chambers and great vessels, but fail to segment the
coronary arteries (DSCs less than 0.27)48,132,155. Atlas methods are limited as they rely
heavily upon the quality of a registration between patients and are unable to consider
large amounts of patient data179.
This current work follows more closely current applications of deep neural
networks where hybrid MR/CT information was used to train the model 204, or studies
where CTCA was utilized92,157. When comparing to our previous study that utilized hybrid
MR/CT information, shown in Table 11, cardiac chamber and great vessel results from
the current study were within 0.04 DSC. Coronary artery DSC results from the present
study were within 0.08 DSC, as can be seen in Table 11, which is promising as this study
did not incorporate contrast-enhancement or cardiac gating. This work adds to the current
available literature by allowing for substructures to be automatically generated on lowfield MR images for applications in MRgRT.
To further improve automatic segmentation accuracy, fully connected 3D CRF
were implemented for post-processing of cardiac substructures and was discussed in
length in our previous work204. Several data augmentation techniques were also utilized
to create variation in the model training and enhance automatic segmentation results.
However, despite including 3-4 daily MRIs to augment the data for each patient, automatic
segmentation agreement may improve with a larger training cohort. Nevertheless, studies
with training and validation sizes similar to this one have been used previously190,204.
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Centroid displacements were largest in the S-I axis likely due to the larger slice
thickness of 3 mm for each of the five test patients, as compared to the 1.5x1.5 mm inplane resolution. As there is a known correlation between signal-to-noise ratio and MR
field strength261, similarity results using the strategy described in this work may be
improved upon at higher field strengths, which should be assessed. At 1.5 Tesla, Mortazi
et al. utilized an image resolution of (1.6~2) × (1.6~2) × (2~3.2) mm92, which is
comparable to what was used in this study. When comparing DSC results for the AA, PA,
and cardiac chambers, results from the current study were within 0.04 and exceeded their
AA DSC by 0.0792. It is important to note, however, that MRIs from the current study were
not ECG gated. MR-linacs do exist at field strengths of 1.5 Tesla, such as the Unity MRlinac (Elekta AB, Stockholm, Sweden). However, considering images at a different field
strength would require the deep learning segmentation pipeline to be retrained as there
would be variation in image intensity and relevant features.
The utilized MR images were not cardiac gated and therefore, we did not account
for cardiac motion in this study. Even though cardiac displacements can be 3-8 mm52,
cine-angiography or echocardiography would be required, and they are currently not
considered clinically232. Respiratory motion was accounted for through breath-hold
techniques in 21/23 patients, but scan acquisition times ranged from 17-25 seconds and
consequently captured multiple cardiac cycles. Thus, the delineated cardiac
substructures used in training represent an average position over the scan course. This
cardiac motion captured in the MR may introduce inter-observer variability by presenting
difficulties in coronary artery segmentation as they can become indistinct and
noncontiguous141. To combat this, cardiac substructure segmentations were verified by
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two radiation oncologists. Cardiac motion may be considered in future studies through
the implementation of a safety margin around the substructure which has been previously
proposed33,53.
Now that cardiac substructures can be generated efficiently on low-field MR
images, dosimetric analysis and strategies for cardiac avoidance can be considered.
Recently in RT planning, the LADA has been suggested as an avoidance structure 32.
Additionally, numerous recent studies have employed cardiac SBRT treatments for noninvasive radio-ablation for arrythmias198,262, cardiac fibromas263, and other cardiac
indications264. Efficient and accurate automatic segmentation of cardiac substructures for
MRgRT may be a useful application to cardiac SBRT studies for rapid OAR and target
localization.
Conclusion
Even at the decreased in-plane resolution of the low field MR-linac, our
implementation of a novel 3D U-Net has provided promising preliminary results for cardiac
substructure segmentations. This significant work opens the door to conduct studies on
determining cardiac substructure dosimetric limitations through a prospective clinical trial
using MR-guided radiation therapy. This work also has applications in future
methodologies for cardiac SBRT.
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CHAPTER 7 “CONCLUSIONS AND FUTURE WORK”
Summary of Findings
In this body of work, several image processing pipelines were developed and
validated to segment cardiac substructures to better quantify potential opportunities for
enhanced cardiac sparing in RTP. Specifically, pipelines were generated for automatic
segmentation on non-contrast CT and low-field MRI to lay the groundwork for future
prospective studies on the radiation dose to cardiac substructures.
In Aim 1, the automatic segmentation of 12 cardiac substructures and the whole
heart on non-contrast CT was achieved through optimization of a novel intensity-based
deformable registration atlas that employed a volumetric T2 MRI rigidly registered to CTSIM datasets. Three atlas approaches were assessed including a single-atlas method
and two multi-atlas approaches (i.e. MV and STAPLE with 1-15 atlas matches (MV1MV15 and ST1-ST15)). Segmentation performance was also assessed via consensus
scoring by three physicians. When averaged over five validation patients, all three atlas
approaches performed similarly with seven out of 13 cardiac structures (heart, chambers,
AA, and PA) having DSC > 0.75. ST10 was deemed a promising segmentation approach
as it provided the highest DSC and lowest MDA for 8/10 substructures, and half of all
validation contours had centroid displacements < 3.4 mm. Dosimetric assessment of the
ST10 generated segmentations revealed no statistically significant differences from
ground truth for LADAmax, MHD, and LV-V5 (P > 0.05). Qualitative consensus grading
revealed that eight substructures required minor modifications in order to become
clinically acceptable. With average DSCs < 0.3, the coronary arteries were not segmented
adequately but provided value for general localization. It was found that, on average,
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automatic cardiac substructure segmentations for a single patient required ~10 minutes.
This initial work is significant in that it offers potential to accurately localize large cardiac
substructures on standard non-contrast CT for radiation sparing even when an MRI is
unavailable and laid the groundwork for the next aim of the work to further improve
substructure segmentation efficiency and accuracy using deep learning.
The second Aim, covered in Chapter 4, focused on further improving substructure
segmentation through inputting paired MRI and CT data into separate image channels to
train a 3D neural network. The network was trained in ~19 hours using the entire 3D
image along with deep supervision and a Dice-weighted multiclass loss function. The
hyperparameter optimization of the 3D CRF showed that maximal accuracy was achieved
when cardiac substructures were grouped into three categories, which correlated to
substructure size and complexity. Implementing 3D CRF as a post-processing measure
improved DSC results by 1.2 ± 2.5%. Similarly, it was found that augmenting the data
improved the DSC results by 5.0 ± 7.9%. For the coronary arteries, DSC improved by
26.4 ± 4.2% from the previous MA method. In total, with the DL method, the MDA across
all substructures was less than 2 mm. There were four instances where the DL model
was able to generate automatic segmentations for the LMCA, where the multi-atlas
method failed. From the qualitative consensus grading, it was found that the DL method
provided clinically acceptable segmentations in all 5 validation patients for three out of
four cardiac chambers. When comparing qualitative consensus grades to the previous
MA method, improvements were seen in ~75% of cases with the DL method. Overall,
generation of automatic substructure segmentations took ~14 seconds per patient as
compared to ~10 minutes for the multi-atlas method. This work is significant in that state-
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of-the-art cardiac substructure segmentation, requiring a single, non-contrast CT input,
was achieved rapidly and more accurately than other methods presently available.
The first portion of Chapter 5 was dedicated to characterizing the excursion of
cardiac substructures due to respiration. Measurements of cardiac substructure centroid
at 4 phases of respiration over 11 patients showed that overall shifts were largest in the
S-I plane and for cardiac substructures at the inferior aspect of the heart (i.e. the IVC and
RCA). The IVC and the RCA had maximum excursion displacements > 6 mm (maximum
vector displacements of greater than 9 mm). Over all substructures, the A-P was the axis
with the least excursion, and substructures at the base of the heart had smallest
displacements (i.e. the great vessels). As shown in Figure 20, median excursions for
11/13 cardiac structures were smallest in the A-P axis (median displacements for all
substructures were less than 5 mm). It was found that the whole heart volume had
insignificant volume changes (~1%) between EE and EI, which parallels results by Yue
et al.203. Moreover, dosimetric analysis across respiratory phases revealed that, although
changes in Dmean and Dmax for the whole heart were less sensitive to respiration (< 0.5
Gy), large dose differences for individual substructures were experienced. Thus, this work
reveals the lack of sensitivity in only considering measurements of the whole heart. As
substructure motion throughout the respiratory cycle is not considered in radiotherapy
treatment planning, this work is significant in that quantifying substructure changes over
the respiratory cycle allows for their potential use in improving OAR sparing during
radiation treatments, especially when a patient is unable to comply with breath-hold
conditions for thoracic cancer treatments.
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Another challenge in the evaluation of cardiac substructure doses is the interfraction setup uncertainties that may occur over the treatment course and potential
challenges with intra-fraction motion due to respiration as presented in Chapter 5 part 2.
Because the variability of cardiac substructure position after tumor localization has not
been well characterized, the work completed in part one of this Aim leveraged unique
longitudinal MRgRT data to evaluate inter-fraction displacements of cardiac substructures
to facilitate safety margin design. Cardiac substructures were generated utilizing the
previously mentioned multi-atlas and deep learning methods for automatic segmentation.
It was found that across the heart and substructures, inter-fraction displacements for
18.5%, 17.4%, and 23.1% were > 5 mm (i.e. threshold for motion management210) in the
L-R, A-P, and S-I axis respectively. For the chambers, the median absolute
displacements were less than 2.5 mm in any cardinal plane. Generally speaking, S-I
displacements were larger than the other axes, largely due to the axial MRI slice
thickness. Individual cardiac substructure displacement demonstrated variability in
magnitude and dominant axis, where PRVs from 3-6 mm were determined as anisotropic
substructure-specific margins. Thus, anisotropic cardiac substructure-specific planning
margins for OARs may be warranted to accommodate differential inter-fractional shifts.
This work is significant in that quantifying the inter-fraction displacement of critical cardiac
substructures is a first step in deriving substructure-specific safety margins to ensure
highly effective cardiac sparing. Furthermore, the cardiac substructure segmentations
from this study laid the groundwork for the second portion of Aim 4 of translating
automated cardiac substructure segmentation into low-field MRgRT planning.
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Aim 4, the final Aim, which was described in Chapter 6, investigated translating
these previously described technologies to an MR-guided environment using an MR-linac
and treatment planning comparisons. The goal of the first part of this Aim was to translate
automated cardiac substructure segmentation into CT-based planning for low-field
MRgRT and quantify potential dosimetric advantages for improved cardiac sparing
through plan re-optimization and for cases that may benefit, potential beam angle
modifications. It was found that while cardiac sparing plans did reduce the MHD (0.7 ±
0.6 Gy), whole heart dose metrics do not reflect the local dose deposition that the
substructure metrics were able to capture and were not as sensitive. It was also found
that four out of 16 patients benefited from new beam arrangements, leading to further
dose reductions. However, the results were patient specific as lesion location and
proximity to the heart played a role in if the patient would benefit from plan re-optimization
and beam modification. Although beam angle modification was shown to provide
improvements over solely re-optimizing the plan for select cases, re-optimization alone
provided the majority of cardiac substructure sparing. The new treatment plans did not
substantially increase delivery time or required monitor units (P > 0.05), suggesting a
negligible increase in plan complexity when cardiac substructure sparing was introduced.
Additionally, there was no statistical difference in clinical endpoints to the PTV, lung,
esophagus, or spinal cord after re-optimization. Moreover, even though the modified
beam angle plans involved either adding or removing beams in the revised treatment
plan, the differences in treatment time per fraction and MUs delivered were negligible.
This work is significant in that it provides dose assessments of the radiosensitive cardiac
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substructures that are currently overlooked in the RT clinical setting, which may help
better study and define radiation-induced cardiac injury.
Lastly, part 2 of Aim 4 outlined the development and validation of a deep learning
cardiac substructure pipeline for MRgRT applications. Here, cardiac substructures were
automatically segmented through a novel deep learning pipeline optimized for the
principle goal of applications in MRgRT on low-field MRI. The use of daily MRIs for each
patient provided a unique methodology for data augmentation and led to accurate
automatic segmentations of the cardiac chambers, great vessels, and IVC. Additionally,
even though the utilized patient images were at a decreased resolution, not contrastenhanced, and were not cardiac gated, promising results were also yielded for the
coronary arteries. When comparing to our previous study that utilized hybrid MR/CT
information, cardiac chamber and great vessel results from the current study were within
0.04 DSC and coronary artery DSC results were within 0.08 DSC. In total, it was found
that substructure contour generation for a new patient input took ~20 seconds. Centroid
displacements were largest in the S-I axis likely due the larger slice thickness of 3 mm for
each of the five test patients, as compared to the 1.5x1.5 mm in-plane resolution. This
work is significant in that it opens the door to conduct studies on determining cardiac
substructure dosimetric limitations through a prospective clinical trial using MRgRT.
Additionally, strategies for cardiac avoidance can be considered.
Overall, we have provided the ability to automatically and efficiently generate
accurate cardiac substructure segmentations on both non-contrast CT and low-field MRI,
quantify their excursion in respiration and between daily fractions, as well as through
dosimetric analysis, show the utility of their inclusion in radiation therapy planning.
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Limitations and Future Work
Although much has been completed to incorporate cardiac substructures into RT
for improved cardiac sparing, widespread implementation is still hindered by challenges
that were outside the scope of this work. Additionally, there are some improvements that
may be made upon this work including the consideration of cardiac motion, coronary
artery segmentation accuracy, and further refining the deep learning methodology.
To build a dynamic motion model of the heart, a 3D MRI with cine information and
high temporal resolution would be required. This type of data can be acquired during a
cardiac angiography scan, but it is not the standard of care in RT. Thus, the available
data and sequences are not optimized for the endpoint of creating a cardiac motion model
and would possibly require a prospective clinical trial which could be completed in future
work. Most of the patient data from the studies covered here come from a pre-existing
Breast Cancer Research Foundation Study where the utilized sequences were optimized
for an endpoint unrelated to our study. The MRIs used in this body of work, both the T2weighted single-shot turbo spin echo and the TrueFISP sequence, are taken under
breath-hold conditions and are not ECG gated (i.e. they do not provide temporal data
across the cardiac cycle). Therefore, respiratory motion is assumed to be negligible
during the scan. However, due to extended scan times and heart rate, several cardiac
cycles are captured during the scan. Thus, the heart and its substructures on the T2weighted and TrueFISP scans are represented by their average position over the course
of the scan. For the purpose of this work, the average position of the cardiac
substructures, with an added PRV generated from inter-fractional motion, provides a good
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surrogate for representing how the cardiac substructures might be handled clinically and
for treatment planning comparisons.
Clinically, cardiac motion in RT is not managed, as dose volume parameters for
the whole heart are not significantly influenced by motion from the cardiac cycle 51.
Additionally, there are uncertainties in the magnitude of the long delivery time, which can
be upwards of 10 minutes, versus the frequency of the beating heart, as well as the interfraction setup uncertainty between treatments. Yet, there is work being done to suggest
planning organ at risk volumes (3-4 mm33,53) as the coronary arteries and the ventricles
are the most mobile regions of the heart, displacing 3-8 mm between end-diastolic and
end-systolic phases52,247,248. Nevertheless, researchers treating atrial fibrillation and
ventricular tachycardia through cardiac ablation are not considering a motion model of
the heart. For example, when conducting radio-ablation for atrial fibrillation, Maguire et al.
utilized a Synchrony system to track respiratory motion, and then added a margin to the
target volume to compensate for cardiac motion 265. Moreover, several studies state that
an extra margin, on top of the one placed for machine accuracy, does not need to be
generated as the cardiac motion is small and has a likely negligible impact on
dosimetry198,265-269. Dynamic motion modeling of the heart will, however, play a significant
role in treatment planning when techniques like flash RT are used at an ultra-high dose
rate.
The work presented here improved upon studies like that of Luo et al. where
coronary arteries were not considered for automatic segmentation 270. However, there is
still room for improvement in the coronary artery segmentations presented here as DSCs
were less than 0.60. This is complicated as shown by the several studies that have
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experienced increased inter-observer variability when segmenting the coronary arteries
versus other cardiac substructures. While generating a whole heart segmentation atlas,
Feng et al. found when segmenting the heart and left ventricle, there were contour
overlaps greater that 90%141. However, segmentation overlaps of the RCA were only 24%
on average141. Similarly, Zhou et al. had a heightened variability in coronary artery
segmentations than for the chambers and whole heart132. They postulated that fusions of
non-gated CT scans will affect smaller structures more due to imperfect image
resolution132. Luo et al. also claimed that segmenting these smaller structures may also
be complicated by tumor invasion and calcification270.
Although numerous measures were taken to advance automatic cardiac
substructure segmentation, including multi-channel inputs, deep supervision, 3D-CRF,
etc., there may still be room for improvement. In this work, the CRF were implemented as
a post-processing step. In future work, the CRF may be directly embedded into a modified
3D U-Net to create an end-to-end workflow with improved efficiency. This would require
that the CRF be coded as a recurrent network, placed in the final layer271, and trained
together with the 3D U-Net. As a known drawback of skip connections is that they
duplicate low resolution contents, a residual pathway may be included through the use of
a modified U-Net, much like the work by Seo et al.97. For substructure accuracy
improvements in small structures like the coronary arteries, as suggested by Seo et al.,
the number of pooling operations for small structures may also be reduced as compared
to those of large structures due to the resolution loss that occurs after pooling
operations97. The selection of the convergence (i.e. loss) function to be utilized in the
deep learning architecture also will have an effect on the resultant automatic
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segmentation. For example, a generalized Dice loss function may be used in place of a
focal Dice loss function to only consider class imbalances due to size and not
segmentation difficultly183,184. Additionally, loss functions not based on Dice, such as
mean-squared pixelwise error, have shown promise for RT applications and may be
explored in future work272. As it is a known issue in RT that the amount of labeled and/or
paired samples can be severely limited, segmentation accuracy may also be improved by
leveraging the large amount of unpaired, unlabeled, multi-modality cardiac datasets
available at our institution. The use of a cycle-GAN191 architecture would allow for
valuable data without manually drawn ground truth segmentations being used in the
training process. As this data was collected at various sequences, parameters, etc.,
unsupervised domain adaptation may be used which allows for implementation on various
imaging platforms273. Specifically, generative pixel-level domain adaptation models
perform similar distribution alignment in raw pixel space in order to translate source data
to the target domain274. Thus, a deep learning model may be generated to train two
competing networks simultaneously: a generator network to synthesize data and a
discriminator network to distinguish between synthesized and real data, which often
outperforms atlas and convolutional models275. Lastly, implementing optical flow
techniques to both track motion and improve segmentation accuracy may be
incorporated276. Although these presented ideas are outside the scope of this body of
work and would require curated datasets, they may be implemented in the future.
This work may also be incorporated in a prospective clinical trial (viable for studies
in lung, breast, lymphoma, esophageal cancers, etc.) to evaluate the associations
between cardiac substructure dose and survival, cardiac events, and quality of life
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measures in a diverse patient population. These data may then further reveal that
radiation doses to cardiac substructures are more precisely associated with the incidence
of cardiac events and overall survival than whole heart dose metrics, which is the current
standard of care. A reduction in radiation-related cardiac toxicities may be acquired using
the highly effective cardiac substructure sparing techniques mentioned in this work to
maximize therapeutic gain. These results may also be extended to a trial using cardiac
gated

RT for avoidance

or

targeting

of

atrial fibrillation198

and

ventricular

tachycardia262,277. Lastly, future directions may include evaluating changes in radiomics
as imaging biomarkers from serial heart images and integrating functional MRI to facilitate
functional sparing.
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ABSTRACT
INCORPORATING CARDIAC SUBSTRUCTURES INTO RADIATION THERAPY FOR
IMPROVED CARDIAC SPARING
by
ERIC DANIEL MORRIS
August 2020
Advisor: Dr. Carri K. Glide-Hurst
Major: Medical Physics
Degree: Doctor of Philosophy

Growing evidence suggests that radiation therapy (RT) doses to the heart and
cardiac substructures (CS) are strongly linked to cardiotoxicities, though only the whole
heart is considered clinically. This work aimed to utilize the superior soft tissue contrast
of magnetic resonance (MR) to segment CS on non-contrast enhanced computed
tomography (CT) and low-field MR, quantify uncertainties in their position, and assess
their effect on treatment planning.
Automatic segmentation of 12 CS was completed using a novel hybrid MR/CT
atlas method and was improved upon using a 3-dimensional neural network (U-Net) from
deep learning (DL). Intra-fraction motion from respiration was then quantified. Interfraction setup uncertainties were also assessed to derive planning organ at risk volumes
(PRVs) for substructures utilizing a novel MR linear accelerator (MR-linac). Treatment
planning comparisons were performed with and without CS and methods to reduce
radiation dose were evaluated. Lastly, the 3D U-Net was translated to a low-field MRlinac and a segmentation pipeline was generated.
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The hybrid MR/CT atlas was able to generate accurate segmentations for the
chambers and great vessels (Dice similarity coefficient (DSC) ≥0.70) but coronary artery
segmentations were unsuccessful (DSC<0.27). After implementing DL on CT and lowfield MRI, DSC for the chambers and great vessels improved to ≥0.83 along with a
coronary artery enhancement (DSC>0.4). Regarding mean distance to agreement, DL
segmentations were within 2mm (hybrid MR/CT) and 3mm (low-field MR). Autosegmentations

required

~10

minutes/patient

where

DL

only

required

14-20

seconds/patient. Intra-fraction motion caused mean dose variations over 5 Gy for CS in
respiration. PRVs from 3-6mm were determined from inter-fraction motion yielding
anisotropic substructure-specific margins. The inclusion of CS in treatment planning did
not yield statistically significant changes in plan complexity, planning target volume dose,
or organ at risk dose.
Segmentation results from DL pose major efficiency and accuracy gains offering
high potential for rapid implementation into RT planning for improved cardiac sparing.
Introducing CS into treatment planning presented an opportunity for more effective
sparing with limited increase in plan complexity. This work may be applied to a
prospective clinical trial to determine the effect the dosimetric sparing of CS has on clinical
outcomes.
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